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A B S T R A C T
Background
Abnormal blood flow patterns in fetal circulation detected by Doppler ultrasound may indicate poor fetal prognosis. It is also possible
that false positive Doppler ultrasound findings could lead to adverse outcomes from unnecessary interventions, including preterm
delivery.
Objectives
The objective of this review was to assess the effects of Doppler ultrasound used to assess fetal well-being in high-risk pregnancies on
obstetric care and fetal outcomes.
Search methods
Weupdated the search of Cochrane Pregnancy and Childbirth’s Trials Register on 31March 2017 and checked reference lists of retrieved
studies.
Selection criteria
Randomised and quasi-randomised controlled trials of Doppler ultrasound for the investigation of umbilical and fetal vessels waveforms
in high-risk pregnancies compared with no Doppler ultrasound. Cluster-randomised trials were eligible for inclusion but none were
identified.
Data collection and analysis
Two review authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction. Data entry
was checked. We assessed the quality of evidence using the GRADE approach.
Main results
Nineteen trials involving 10,667 women were included. Risk of bias in trials was difficult to assess accurately due to incomplete
reporting. None of the evidence relating to our main outcomes was graded as high quality. The quality of evidence was downgraded
due to missing information on trial methods, imprecision in risk estimates and heterogeneity. Eighteen of these studies compared the
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use of Doppler ultrasound of the umbilical artery of the unborn baby with no Doppler or with cardiotocography (CTG). One more
recent trial compared Doppler examination of other fetal blood vessels (ductus venosus) with computerised CTG.
The use of Doppler ultrasound of the umbilical artery in high-risk pregnancy was associated with fewer perinatal deaths (risk ratio
(RR) 0.71, 95% confidence interval (CI) 0.52 to 0.98, 16 studies, 10,225 babies, 1.2% versus 1.7 %, number needed to treat (NNT)
= 203; 95% CI 103 to 4352, evidence graded moderate). The results for stillbirths were consistent with the overall rate of perinatal
deaths, although there was no clear difference between groups for this outcome (RR 0.65, 95% CI 0.41 to 1.04; 15 studies, 9560
babies, evidence graded low). Where Doppler ultrasound was used, there were fewer inductions of labour (average RR 0.89, 95% CI
0.80 to 0.99, 10 studies, 5633 women, random-effects, evidence graded moderate) and fewer caesarean sections (RR 0.90, 95% CI
0.84 to 0.97, 14 studies, 7918 women, evidence graded moderate). There was no comparative long-term follow-up of babies exposed
to Doppler ultrasound in pregnancy in women at increased risk of complications.
No difference was found in operative vaginal births (RR 0.95, 95%CI 0.80 to 1.14, four studies, 2813 women), nor in Apgar scores less
than seven at five minutes (RR 0.92, 95% CI 0.69 to 1.24, seven studies, 6321 babies, evidence graded low). Data for serious neonatal
morbidity were not pooled due to high heterogeneity between the three studies that reported it (1098 babies) (evidence graded very
low).
The use ofDoppler to evaluate early and late changes in ductus venosus in early fetal growth restriction was not associatedwith significant
differences in any perinatal death after randomisation. However, there was an improvement in long-term neurological outcome in the
cohort of babies in whom the trigger for delivery was either late changes in ductus venosus or abnormalities seen on computerised
CTG.
Authors’ conclusions
Current evidence suggests that the use of Doppler ultrasound on the umbilical artery in high-risk pregnancies reduces the risk of
perinatal deaths and may result in fewer obstetric interventions. The results should be interpreted with caution, as the evidence is not of
high quality. Serial monitoring of Doppler changes in ductus venosus may be beneficial, but more studies of high quality with follow-
up including neurological development are needed for evidence to be conclusive.
P L A I N L A N G U A G E S U M M A R Y
Doppler ultrasound of fetal vessels in pregnancies at increased risk of complications
What is the issue?
Most babies in high-income countries grow well in the womb. However, when the mother has a medical problem such as diabetes,
high blood pressure, heart or kidney problems, or the placenta does not develop properly, this may affect the growth of the baby.
Also, sometimes babies do not grow well for reasons we do not fully understand. Babies with poor growth are more likely to have
complications, resulting in babies being ill or dying. Doppler ultrasound detects changes in the pattern of blood flow through the baby’s
circulation. These changes may identify babies who have problems.
Why is this important?
If babies with growth problems are identified, interventions such as early delivery might help to prevent serious illness and death.
However, using Doppler ultrasound could increase interventions such as caesarean section.
What evidence did we find?
We searched for evidence in March 2017. We found 19 trials involving over 10,000 women. Eighteen of these studies compared the
use of Doppler ultrasound of the umbilical artery of the unborn baby with no Doppler or with cardiotocography (CTG, sometimes
called electronic fetal monitoring). One more recent trial compared Doppler examination of other fetal blood vessels (ductus venosus)
with computerised CTG (short-term variation).
Evidence from included studies was assessed as moderate to very low-quality due to incomplete reporting of methods and uncertainty
of findings; when the strength of the evidence is low or very low, this means future research may change the results and we cannot be
certain about them.
Results showed that Doppler ultrasound of the umbilical artery may decrease the number of babies who die, and may lead to fewer
caesarean sections and inductions of labour. There was no clear difference in the number of stillbirths, births using forceps or ventouse,
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or babies with a low Apgar score five minutes after birth. Findings for serious problems in the neonate were not consistent in different
studies. In babies with growth restriction, when the decision to deliver was based on late ductus venosus changes or abnormalities on
computerised CTG, this appeared to improve long-term (two-year) developmental outcome.
What does this mean?
Doppler ultrasound in high-risk pregnancies appears to reduce the number of babies who die, and may also lead to fewer obstetric
interventions. However, the evidence was of moderate to very low-quality. Further studies of high-quality with long-term follow-up
would help us to be more certain.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Umbilical artery Doppler ultrasound compared to no Doppler ultrasound in high- risk pregnancies
Patient or population: pregnant women at increased risk of fetal complicat ions
Setting: antenatal clinics or inpat ient wards in hospitals in Australia (3) UK (6) US (2) Sweden (1) South Af rica (2) Ireland (1) The Netherlands (1) France (1) Canada (1)
Intervention: umbilical artery Doppler ultrasound
Comparison: no Doppler ultrasound
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with noDoppler ul-
trasound
Risk with umbilical
artery Doppler ultra-
sound
Any perinatal death af -
ter randomisat ion
Study populat ion RR 0.71
(0.52 to 0.98)
10225
(16 RCTs)
⊕⊕⊕©
MODERATE 12
17 per 1000 12 per 1000
(9 to 17)
Serious neonatal mor-
bidity
Study populat ion 1098
(3 RCTs)
⊕©©©
VERY LOW 134
We did not pool the data
for this outcome due to
high heterogeneity (the
direct ion of ef fect in the
2 studies contribut ing
data were not consis-
tent)
St illbirth Study populat ion RR 0.65
(0.41 to 1.04)
9560
(15 RCTs)
⊕⊕©©
LOW 125
9 per 1000 6 per 1000
(4 to 9)
Apgar < 7 at 5 minutes Study populat ion RR 0.92
(0.69 to 1.24)
6321
(7 RCTs)
⊕⊕©©
LOW 15
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29 per 1000 26 per 1000
(20 to 36)
Caesarean sec-
t ion (elect ive and emer-
gency)
Study populat ion RR 0.90
(0.84 to 0.97)
7918
(14 RCTs)
⊕⊕⊕©
MODERATE 12
263 per 1000 237 per 1000
(221 to 255)
Induct ion of labour Study populat ion RR 0.89
(0.80 to 0.99)
5633
(10 RCTs)
⊕⊕⊕©
MODERATE 12
334 per 1000 298 per 1000
(268 to 331)
Long-term infant neu-
rodevelopmental out-
come (impairment at 2
years)
Study populat ion - (0 studies) - There has been no com-
parat ive long-term fol-
low-up of babies ex-
posed to Doppler ul-
trasound in pregnancy
in women at increased
risk of complicat ionssee comment see comment
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 All studies assessed as having design lim itat ions due to lack of information.
2 Although there was some evidence of funnel plot asymmetry suggest ing small-study ef fect (with studies with smaller sample
sizes appearing to have a more pronounced ef fect), we did not downgrade for publicat ion bias because, for our selected
outcomes, individual studies did not reach stat ist ical signif icance and there was low heterogeneity across all studies for this
outcome.5
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3 High heterogeneity (I² stat ist ic 76%) with direct ion of ef fect dif f erent in the 2 studies contribut ing data.
4 95%CI crossing the line of no ef fect. Low event rate.
5 Wide 95%CI crossing the line of no ef fect.
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B A C K G R O U N D
The previous version of this review (Neilson 1996) was split into
two separate reviews, for which new protocols were prepared. This
present review covers Doppler ultrasound of fetal vessels includ-
ing umbilical arteries in women at high risk of fetal compromise.
The other review covers Doppler ultrasound of utero-placental
circulation (Utero-placental Doppler ultrasound for improving preg-
nancy outcome; Stampalija 2010). In addition, we will update the
review of ’routine’ use of Doppler ultrasound in low-risk pregnant
women (Fetal and umbilical Doppler ultrasound in normal preg-
nancy; Alfirevic 2015).
Description of the condition
When it comes to the provision of antenatal care or research,
pregnant women tend to be divided into low- and high-risk pop-
ulations; however, the boundaries between the groups are often
blurred. For most researchers, ‘high-risk status’ includes maternal
conditions associated with increased perinatal mortality and mor-
bidity such as diabetes, hypertensive disorders (chronic hyperten-
sion and pre-eclampsia), cardiac, renal, and autoimmune disor-
ders (Fisk 2001; Graves 2007; Westergaard 2001). More recently,
thrombophilias (congenital and acquired) have been added to this
list (Alfirevic 2002; Greer 1999).
Of the conditions specific to pregnancy, fetal growth restriction,
antepartum haemorrhage, multiple pregnancy, and prolonged
pregnancy tend to be regarded as ‘high risk’ (Bernstein 2000;
Westergaard 2001).
It is important to stress that fetal growth restriction is often con-
fused with the concept of being small-for-gestational age. Some
fetuses are constitutionally small and they do not have increased
perinatal morbidity and mortality. Our inability to distinguish
easily between small, but healthy fetuses and those who are failing
to reach their growth potential has hampered attempts to find ap-
propriate treatment for growth restriction. Growth-restricted fe-
tuses, who may or may not be small-for-dates are at increased risk
of mortality and serious morbidity (intraventricular haemorrhage,
bronchopulmonary dysplasia, necrotising enterocolitis, infection,
pulmonary haemorrhage, hypothermia and hypoglycaemia) (Fisk
2001). Early antenatal detection, treatment where appropriate,
and timely delivery could minimise the risks significantly.
In multiple pregnancies, most of the excess morbidity and mor-
tality can be attributed to preterm birth and to pathology associ-
ated with twin-to-twin transfusion syndrome (TTTS) in mono-
chorionic pregnancies. However, growth discordance or selec-
tive intrauterine growth restriction (IUGR) are more common
that TTTS (Ortibus 2009). The pathophysiological nature of the
TTTS differs from other placental pathology with specific impact
on the fetal haemodynamics. Different monitoring and treatment
strategies are needed for this condition and for this reason we
planned to exclude this subgroup of multiple pregnancies from
this review if such information was available.
The most commonly used methods for the assessment of fetal
well-being in high-risk pregnancies include fetal cardiotocogra-
phy (CTG) (Grivell 2015), biophysical profile (Lalor 2008) and
Doppler studies of the fetal circulation. This review focuses on
the role of fetal and umbilical Doppler ultrasound as a test of fetal
well-being in high-risk pregnancies.
Description of the intervention
The use of Doppler ultrasound to investigate the pattern of wave-
forms in the umbilical artery during pregnancy was first reported
in 1977 from Dublin (Fitzgerald 1977). The waveforms were de-
rived from the changes in the ultrasound frequency of theDoppler
signal, which targeted circulating fetal blood within the umbilical
artery. Such flow velocity waveforms (FVW) from the feto-pla-
cental circulation are dependent on the fetal cardiac contraction
force, density of the blood, the vessel wall elasticity and peripheral
or downstream resistance (Giles 1985; Owen 2001). It was sug-
gested that the FVWs should be obtained with the mother in a
semirecumbent position during a period of fetal inactivity, as the
impedance indices are moderated by fetal breathing and elevated
fetal heart rates (Mires 2000).
Different types of measurements have been described in an at-
tempt to quantify theDoppler signals accurately and reproducibly
(Chen 1996; Mari 2009; Owen 2001). The indices are calculated
as ratios between peak systolic velocity (A), end-diastolic peak ve-
locity (B) and mean velocity. The most common in clinical prac-
tice are pulsatility index (PI = (A - B)/mean)) and resistant index
(RI = (A - B)/A) (Burns 1993). Ideally, the measurements have
to be done on several consecutive identical wave forms with the
angle of the insonation as close to zero as possible (Burns 1993).
Observational studies have demonstrated that, in the presence of
normal placental function, the umbilical artery waveform has a
pattern compatible with a low-resistance system, displaying for-
ward blood flow throughout the cardiac cycle (Neilson 1987).
Initial studies have focused on umbilical arteries and veins, but bet-
ter equipment has allowed studies of carotid and intracranial arter-
ies, aorta, coronary circulation (Baschat 2002), mesenteric artery
and the venous circulation (ductus venosus, inferior vena cava
and vena Galena) (Cheema 2004; Owen 2001). The assessment
of utero-placental arteries has also been investigated (Trudinger
1985a; Trudinger 1985b) and has been reviewed in a separate
Cochrane review (Utero-placental Doppler ultrasound for improving
pregnancy outcome; Stampalija 2010).
When inadequate vascularisation of the placenta occurs (placental
insufficiency), the haemodynamic changes in the feto-placental
circulation develop, often in a progressive fashion.Doppler indices
from the umbilical artery start to increase when approximately
60% to 70% of the placental vascular tree is not functioning (
Thompson 1990). This tends to be followed by a decrease in
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the impedance to blood flow in the middle cerebral artery as a
consequence of ’brain sparing effect’ (Hecher 2001), while the
resistance increases in aortic blood flow (Ferrazzi 2002; Hecher
2001). This redistribution of the blood flow allows preferential
oxygenation of fetal vital organs such as brain and heart. Late
Doppler changes include absent or reverse end diastolic flow in the
umbilical artery (Al-Ghazali 1990;Nicholaides 1988) and increase
in the resistance of venous blood flow (ductus venosus and inferior
vena cava) (Baschat 2001; Ferrazzi 2002). Higher resistance in
venous circulation reflects the elevation of right heart afterload and
increase of the intraventricular pressure caused by hypoxaemia of
the myocardium. Those changes correlate well with fetal acidosis
(Bilardo 1990; Weiner 1990).
How the intervention might work
The time scale over which placental insufficiency and fetal com-
pensatory changes develop varies and depends on underlying ma-
ternal and fetal pathology and gestational age. It is, therefore, dif-
ficult to apply the same management protocol to all women with
abnormal Doppler findings. Normal Doppler findings do provide
some reassurance andmay, in some circumstances, reduce the need
for hospitalisation and additional fetal monitoring, but this is not
always the case. There is also some suggestion that normal umbili-
cal arteryDoppler ultrasound cannot be assumed tomean low risk
where the fetus is small (Figueras 2008). An abnormal Doppler
finding tends to trigger management protocols that vary signifi-
cantly, not only between low- and high-income countries, but also
from unit to unit in the same country. The most important factors
that determine subsequent management are gestation, availability
of additional monitoring methods (computerised CTG, biophys-
ical profile, Doppler), and neonatal intensive care availability.
The Growth Restriction Intervention Trial (GRIT) study showed
that although the delay in delivery (around four days) may lead
to more stillbirths, the overall number of perinatal deaths is not
reduced by an immediate delivery (GRIT 2003). Importantly, the
study showed that at two years follow-up, the immediate delivery
group showed a trend towards more neurological disability (GRIT
2004).
Recently, considerable interest has been generated by observations
that ductus venous flow may be a good predictor of perinatal out-
come (Baschat 2001; Bilardo 2004; Ferrazzi 2002). The TRUF-
FLE study was designed to compare reduced short-term varia-
tion on computerized CTG, early ductus venosus changes or late
ductus venosus changes as a trigger for delivery of the growth-
restricted babies between 26+0-31+6 gestational weeks and results
from that trial have now been published and are included in the
review (Lees 2005; Lees 2015).
Ultimately, the goal of any Doppler-triggered management pro-
tocol is to improve perinatal mortality and morbidity. An unnec-
essary early intervention may result in excess morbidity from pre-
maturity, whilst a delay may result in a stillbirth or severely com-
promised newborn (GRIT 2003).
Why it is important to do this review
The first meta-analysis of umbilical artery Doppler in high-risk
pregnancies was published in 1995 (Alfirevic 1995;Neilson 1995),
demonstrating improvement with Doppler in a number of clinical
outcomes and possible reduction in perinatal deaths. Since then,
ultrasound technology has developed further andmuchmore com-
plex assessment of fetal circulation has become standard clinical
practice in fetal medicine units worldwide. However, the potential
for benefit from the knowledge generated by these new methods
has to be balanced with the potential for harm. Any suggestion of
fetal compromise in high-risk women is likely to lead to consider-
able anxiety in families and clinicians, further diagnostic testing,
and early (possibly very preterm) birth often by caesarean section.
Another Cochrane review analysed the role of Doppler ultrasound
in routine practice (Bricker 2007), with doubts expressed about
its benefit as a screening tool in all pregnancies (Alfirevic 2015).
The use of utero-placental Doppler ultrasound is the subject of
another Cochrane review (Utero-placental Doppler ultrasound for
improving pregnancy outcome; Stampalija 2010). However, when
both fetal and utero-placental Doppler assessments are used in
high-risk pregnancies, the study will be included here because
clinical judgements tend to rest on the fetal assessment.
O B J E C T I V E S
The objective of this review was to assess the effects of Doppler
ultrasound used to assess fetal well-being in high-risk pregnancies
on obstetric care and fetal outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised trials and quasi-randomised studies comparing
Doppler ultrasound (fetal and umbilical circulations) in pregnan-
cies considered to be at high risk of fetal compromise. Cluster-
randomised trials were eligible for inclusion, as were abstracts if
enough information was available for assessment and data extrac-
tion. Cross-over trials were not eligible for inclusion.
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Types of participants
Women with pregnancies considered to be at ’high risk’ for fe-
tal compromise, e.g. intrauterine growth restriction, post-term
pregnancies, previous pregnancy loss, women with hypertension,
women with diabetes, or other maternal pathology (e.g. throm-
bophilia). We planned to include twin pregnancies, separating
monochorionic and dichorionic pregnancies, where possible.
Types of interventions
Doppler ultrasound of the fetal and umbilical vessels for fetal as-
sessment in pregnancies in high-risk populations. We excluded
utero-placental Doppler studies (as these are assessed in a sepa-
rate review). However, where umbilical artery or fetal Doppler
was combined with utero-placental Doppler, the study has been
included in this review.
Comparisons
1. Doppler ultrasound of fetal vessels versus no Doppler
ultrasound of fetal vessels (including comparisons of Doppler
ultrasound of fetal vessels revealed versus Doppler ultrasound of
fetal vessels concealed).
2. Doppler ultrasound of fetal vessels versus other forms of
monitoring, e.g. cardiotocography, biophysical profile.
3. Comparison of different forms of Doppler ultrasound of
fetal vessels versus other types of Doppler ultrasound of fetal
vessels.
4. Combination of umbilical artery or fetal Doppler with
utero-placental Doppler (uterine artery Doppler) versus either
no other monitoring or additional monitoring.
5. Early ductus venosus Doppler ultrasound versus
computerized CTG.
6. Late ductus venosus Doppler ultrasound versus
computerized CTG.
7. Early versus late ductus venosus Doppler ultrasound.
Types of outcome measures
We selected outcome measures with the help of a proposed core
data set of outcome measures (Devane 2007).
Main outcomes
1. Any perinatal death after randomisation.
2. Serious neonatal morbidity - composite outcome including
hypoxic ischaemic encephalopathy, intraventricular haemorrhage
(IVH), bronchopulmonary dysplasia (BPD), necrotising
enterocolitis (NEC).
Additional outcomes of interest
1. Stillbirth.
2. Neonatal death.
3. Any potentially preventable perinatal death*.
4. Fetal acidosis.
5. Apgar score less than seven at five minutes.
6. Caesarean section (both elective and emergency).
7. Spontaneous vaginal birth.
8. Operative vaginal birth.
9. Induction of labour.
10. Oxytocin augmentation.
11. Neonatal resuscitation required.
12. Infant requiring intubation/ventilation.
13. Neonatal fitting/seizures.
14. Preterm labour (onset of labour before 37 completed weeks
of pregnancy).
15. Gestational age at birth.
16. Infant respiratory distress syndrome.
17. Meconium aspiration.
18. Neonatal admission to special care or intensive care unit, or
both.
19. Hypoxic ischaemic encephalopathy (a condition of injury
to the brain).
20. Intraventricular haemorrhage (IVH).
21. Bronchopulmonary dysplasia (BPD).
22. Necrotising enterocolitis (NEC).
23. Infant birthweight.
24. Length of infant hospital stay.
25. Long-term infant/child neurodevelopmental outcome.
26. Women’s views of their care.
* Perinatal death excluding chromosomal abnormalities, termina-
tion of pregnancies, birth before fetal viability (as defined by tri-
alists) and fetal death before use of the intervention.
Non-prespecified outcomes were also reported if we considered
them to be important.
Search methods for identification of studies
The following methods section of this review was based on a stan-
dard template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (31 March 2017).
The Register is a database containing over 22,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter (including the detailed search strategies for CENTRAL,MED-
LINE, Embase and CINAHL), the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
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the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the ‘Specialised Register ’ sec-
tion from the options on the left side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more specific search set which has
been fully accounted for in the relevant review sections (Included
studies; Excluded studies).
Searching other resources
We also planned to look for additional studies in the reference lists
of the studies identified.
We did not apply any language or date restrictions.
Data collection and analysis
Formethods used in the previous version of this review, seeAlfirevic
2013.
For this update, the following methods were used for assessing the
reports that were identified as a result of the updated search.
The following methods section of this review was based on a stan-
dard template used by Cochrane Pregnancy and Childbirth.
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We
resolved any disagreement through discussion or, if required, we
consulted the third review author.
Data extraction and management
We designed a form to extract data. For eligible studies, two re-
view authors extracted the data using the agreed form.We resolved
discrepancies through discussion or, if required, we consulted the
third review author. Data were entered into Review Manager soft-
ware (RevMan 2014) and checked for accuracy.
When information regarding any of the above was unclear, we
planned to contact authors of the original reports to provide fur-
ther details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any nonrandom process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or
nonopaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if theywere blinded, or if we judged that the
lack of blinding was unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high, or unclear risk of bias for participants;
• low, high, or unclear risk of bias for personnel.
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(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high, or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to reinclude missing data in the
analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s
prespecified outcomes and all expected outcomes of interest to
the review have been reported);
• high risk of bias (where not all the study’s prespecified
outcomes have been reported; one or more reported primary
outcomes were not prespecified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011). With
reference to (1) to (6) above, we planned to assess the likely mag-
nitude and direction of the bias and whether we considered it was
likely to impact on the findings. In future updates, we will explore
the impact of the level of bias through undertaking sensitivity
analyses (see Sensitivity analysis).
Assessment of the quality of the evidence using the
GRADE approach
For this update, the quality of the evidence was assessed using
the GRADE approach, as outlined in the GRADE handbook in
order to assess the quality of the body of evidence relating to the
following outcomes for the main comparisons.
1. Any perinatal death after randomisation.
2. Serious neonatal morbidity.
3. Stillbirth.
4. Caesarean section (elective and emergency).
5. Induction of labour.
6. Apgar less than seven at five minutes.
7. Long-term infant neurodevelopmental outcome.
GRADEpro Guideline Development Tool was used to import
data from Review Manager 5 (RevMan 2014) in order to create
’Summary of findings’ tables. A summary of the intervention ef-
fect and a measure of quality for each of the above outcomes was
produced using the GRADE approach. The GRADE approach
uses five considerations (study limitations, consistency of effect,
imprecision, indirectness, and publication bias) to assess the qual-
ity of the body of evidence for each outcome. The evidence can
be downgraded from ’high quality’ by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency, im-
precision of effect estimates, or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratios
with 95% confidence intervals.
Continuous data
We used the mean difference if outcomes were measured in the
same way between trials. If appropriate, we would have used the
standardised mean difference to combine trials that measured the
same outcome, but used different methods.
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Unit of analysis issues
Cluster-randomised trials
We planned to include cluster-randomised trials in the analyses
along with individually-randomised trials. We planned to adjust
their sample sizes using the methods described in the Cochrane
Handbook for Systematic Reviews of Interventions using an estimate
of the intracluster correlation coefficient (ICC) derived from the
trial (if possible), from a similar trial, or from a study of a similar
population. If we had used ICCs from other sources, we planned
to report this and conduct sensitivity analyses to investigate the
effect of variation in the ICC. If we had identified both cluster-
randomised trials and individually-randomised trials, we planned
to synthesise the relevant information.We considered it reasonable
to combine the results from both if there was little heterogeneity
between the study designs and the interaction between the effect of
intervention and the choice of randomisation unit was considered
to be unlikely.
We also planned to acknowledge heterogeneity in the randomisa-
tion unit and perform a sensitivity analysis to investigate the ef-
fects of the randomisation unit.
Cross-over trials
Cross-over trials were not considered eligible for inclusion.
Multiple pregnancies
Trials of multiple pregnancies were eligible for inclusion. We
planned to adjust for clustering to take into account the non-
independence of babies from the same pregnancy (Gates 2004),
however, we were unable to do this because of the lack of reported
intercorrelation coefficients (ICC). Treating babies from multiple
pregnancies as if theywere independent, when they are more likely
to have similar outcomes than babies from different pregnancies,
would overestimate the sample size and give confidence intervals
that were too narrow. Each woman can be considered a cluster in
multiple pregnancy, with the number of individuals in the cluster
being equal to the number of fetuses in her pregnancy. Analysis
using cluster trial methods allows calculation of relative risk and
adjustment of confidence intervals. Usually, this will mean that
the confidence intervals get wider. Although this may make little
difference to the conclusion of a trial, it avoids misleading results
in those trials where the difference may be substantial.
In future updates, if information on ICCs are reported, we will
adjust for clustering in the analyses, wherever possible, and use the
inverse variance method for adjusted analyses, as described in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011).
Studies with multiple treatment groups
Trials with multiple treatment groups were eligible for inclusion.
In trials with multiple intervention groups, we planned to select
one pair of interventions and exclude the others and to include two
or more independent comparisons, as described in section 16.5.4
of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). One of the included trials, (Lees 2013), included
three relevant intervention groups and all were included in three
separate independent comparisons: early ductus venosus Doppler
ultrasound versus CTG; late ductus venosus Doppler ultrasound
versus CTG; and early ductus venosus Doppler ultrasound versus
late.
Dealing with missing data
For included studies, levels of attrition were noted. In future up-
dates, if more eligible studies are included, the impact of including
studies with high levels of missing data in the overall assessment
of treatment effect will be explored by using sensitivity analysis.
For all outcomes, analyses were carried out, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes were known to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau², and the I² and Chi² statistics. We regarded heterogeneity
as substantial if I² was greater than 30%and either Tau²was greater
than zero, or there was a low P value (less than 0.10) in the Chi²
test for heterogeneity. If we identified substantial heterogeneity
(above 30%), we planned to explore it by prespecified subgroup
analysis.
Assessment of reporting biases
If there were 10 or more studies in the meta-analysis, we inves-
tigated reporting biases (such as publication bias) using funnel
plots. We assessed funnel plot asymmetry visually. If asymmetry
was suggested by a visual assessment, we planned to perform ex-
ploratory analyses to investigate it (Harbord 2006).
Data synthesis
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2014).We used fixed-effect meta-analysis for com-
bining data where it was reasonable to assume that studies were
estimating the same underlying treatment effect: i.e. where trials
were examining the same intervention, and the trials’ populations
and methods were judged sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if substan-
tial statistical heterogeneity was detected, we used random-effects
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meta-analysis to produce an overall summary, if an average treat-
ment effect across trials was considered clinically meaningful. The
random-effects summary was treated as the average range of pos-
sible treatment effects and we discussed the clinical implications
of treatment effects differing between trials. If we did not consider
that the average treatment effect was clinically meaningful, we did
not combine trials. If we used random-effects analyses, the results
were presented as the average treatment effect with 95% confi-
dence intervals, and the estimates of Tau² and the I² statistic.
Subgroup analysis and investigation of heterogeneity
Where we identified substantial heterogeneity, we investigated it
using subgroup analyses and sensitivity analyses. We considered
whether an overall summary was meaningful, and if it was, we
used random-effects analysis to produce it.
We planned the following a priori subgroup analyses for all out-
comes, rather than undertaking separate reviews on singleton and
multiple pregnancies:
1. singleton pregnancies versus multiple pregnancies;
2. monochorionic twins versus dichorionic twins.
We presented separate data for singleton versus multiple pregnan-
cies, but there was insufficient information in the trial reports to
carry out planned subgroup analysis for monochorionic versus di-
chorionic twins.
We carried out the following additional a priori subgroup analyses
for the primary outcomes:
1. where the fetus was suspected small-for-gestational age;
2. where the woman had hypertension or pre-eclampsia;
3. where the woman had diabetes;
4. prolonged pregnancy;
5. where there had been previous pregnancy loss.
We assessed subgroup differences by interaction tests available
within RevMan 5 (RevMan 2014).We reported the results of sub-
group analyses quoting the Chi² statistic and P value, and the in-
teraction test I² value.
Sensitivity analysis
We planned sensitivity analyses to explore the effect of trial quality
assessed by adequate labelled sequence generation and adequate
allocation concealment, with poor-quality studies (unclear or high
risk of bias) being excluded from the analyses in order to assess
whether this made any difference to the overall result.
R E S U L T S
Description of studies
Results of the search
In the previous version of the review, the search identified 29
studies, of which 18 were included, and one study was ongoing;
results for this trial have now been published and were included in
this updated version of the review (Lees 2013; Lees 2015) (search
date 31 March 2017, see: Figure 1). Findings were therefore based
on 19 trials involving 10,667 women. In the previous version of
the review, 10 trials were excluded and no further trials have been
excluded in this update. For further details of trial characteristics,
please refer to the tables of Characteristics of included studies and
Characteristics of excluded studies.
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Figure 1. Study flow diagram.
Included studies
Most studies included Doppler assessments of umbilical artery in
both experimental and control groups, with the Doppler results
being revealed to clinicians only in the ’Doppler group’ (Biljan
1992; Burke 1992; De Rochambeau 1992; Giles 2003; Johnstone
1993; Lees 2013; Lees 2015;Neales 1994 [pers comm];Newnham
1991; Nienhuis 1997; Nimrod 1992; Norman 1992; Ott 1998;
Pattinson 1994; Trudinger 1987; Tyrrell 1990). Doppler ultra-
sound of the umbilical artery was used as an addition to the stan-
dard fetal monitoring (e.g. cardiotocography (CTG), biophysical
profile, fetal biometry).
Eight of these studies involved singleton pregnancies only (Biljan
1992; De Rochambeau 1992; Lees 2013; Neales 1994 [pers
comm]; Nienhuis 1997; Ott 1998; Trudinger 1987; Tyrrell 1990)
and one study of 539 women involved twin pregnancies only
(Giles 2003). Two studies assessed a mixture of singleton and mul-
tiple pregnancies with 40/2289 (1.7%) being twin pregnancies
in Johnstone 1993 and 40/505 (7.9%) being twin pregnancies
in Newnham 1991. Four studies did not state whether they in-
cluded just singleton pregnancies or not (Burke 1992; Nimrod
1992; Norman 1992; Pattinson 1994).
Four studies compared Doppler ultrasound alone versus CTG
alone in women whose pregnancies were considered at increased
risk of problems (Almstrom 1992; Haley 1997; Hofmeyr 1991;
Williams 2003). Of these, three involved singleton pregnancies
only (Almstrom 1992;Haley 1997;Williams 2003) and one study
did not specify (Hofmeyr 1991).
Gestational age for inclusion in studies was not reported in six
studies, and the remainder of the studies varied in the gestational
ages they included, from 24 weeks’ gestation to those studies look-
ing at the value of Doppler ultrasound when women had gone
beyond 40 weeks (Characteristics of included studies).
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One study compared three different monitoring strategies to trig-
ger delivery in mothers with early fetal growth restriction: early
changes in ductus venosus (pulsatility index > 95th percentile) ver-
sus late changes in ductus venosus (absent or negative A-wave) ver-
sus short term variation from computerised CTG (cCTG) (Lees
2013). However, all women were monitored by cCTG and safety
net criteria for delivery based on cCTG applied to all women, ir-
respective of randomised group.
Excluded studies
Ten of the 29 potentially eligible studies were excluded. In five
studies, the participants were described as ’unselected populations’
(Davies 1992; Newnham 1993; Omtzigt 1994; Schneider 1992;
Whittle 1994); in one study, the participants were women con-
sidered at low risk of complications (Mason 1993); one study was
not a randomised study (McCowan 1996); in one study, the full
report was not available and there were no data in the conference
abstract (Gonsoulin 1991), and in two studies the information
was considered unreliable (McParland 1988; Pearce 1992).
Risk of bias in included studies
The quality of the 19 completed included studies was difficult to
assess due to lack of information, particularly in terms of randomi-
sation and concealment of allocation (Figure 2). For this reason,
we did not carry out planned sensitivity analysis excluding studies
at high risk of bias.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
Only four studies had adequate sequence generation and allocation
concealment (Haley 1997; Hofmeyr 1991; Lees 2013; Nienhuis
1997). Two studies had adequate sequence generation but al-
location concealment was unclear (Ott 1998; Williams 2003)
and in two studies allocation concealment was adequate, but se-
quence generation was unclear (Giles 2003; Newnham 1991). In
three studies, concealment allocation was judged as adequate, but
sequence generation was unclear (Giles 2003; Johnstone 1993;
Newnham 1991). The remaining 10 studies had both unclear se-
quence generation and unclear concealment allocation (Almstrom
1992; Biljan 1992; Burke 1992; De Rochambeau 1992; Neales
1994 [pers comm];Nimrod 1992;Norman 1992; Pattinson 1994;
Trudinger 1987; Tyrrell 1990).
Blinding
Blinding women and/or staff in these trials was not generally fea-
sible. Even in the studies where Doppler ultrasound was either re-
vealed or concealed, some outcomes, such as induction of labour
and caesarean section were clearly going to be influenced by the
knowledge of Doppler results, but it might have been possible
to avoid bias in neonatal assessment. Unfortunately, the informa-
tion on the attempts to protect against biased assessment was of-
ten not available. In three studies (Lees 2013; Newnham 1991;
Nienhuis 1997), assessors of neonatal outcomes were indeed blind
to Doppler results.
Incomplete outcome data
Incomplete outcome data were addressed adequately in 10 studies
(Almstrom1992; Burke 1992;Giles 2003;Haley 1997; Johnstone
1993; Lees 2013; Neales 1994 [pers comm]; Newnham 1991;
Pattinson 1994; Trudinger 1987) and unclear in nine studies (
Biljan 1992; De Rochambeau 1992; Hofmeyr 1991; Nienhuis
1997; Nimrod 1992; Norman 1992; Ott 1998; Tyrrell 1990;
Williams 2003). Only a few studies provided full information on
the number of women approached to take part in the studies, the
numbers eligible for inclusion, and the overall refusal rate. While
not sources of bias as such, high exclusion and refusal rates might
affect the generalisability of the findings and the interpretation of
the results.
Selective reporting
Almost all the studies, except three, were assessed as at unclear
risk of selective reporting bias because we did not assess the trial
protocols. Two studies were considered to have some degree of
selective reporting bias (Biljan 1992; Neales 1994 [pers comm]).
In one multiple-intervention study, the protocol was available,
there was no evidence of reporting bias, and each group to which
participants were randomised was presented (Lees 2013).
Other potential sources of bias
Ten studies were judged to be free of other sources of bias
(Burke 1992; Giles 2003; Haley 1997; Johnstone 1993; Lees
2013; Newnham 1991; Norman 1992; Ott 1998; Trudinger
1987; Williams 2003); five studies were unclear (Biljan 1992;
De Rochambeau 1992; Neales 1994 [pers comm]; Nimrod 1992;
Tyrrell 1990); and four studies were considered to have some
other source of bias, mainly baseline imbalances (Almstrom 1992;
Hofmeyr 1991; Nienhuis 1997; Pattinson 1994).
Sensitivity analyses
For sensitivity analyses by quality of studies, we used both ade-
quately labelled sequence generation and adequate allocation con-
cealment as essential criteria for high quality. Only three of the
18 studies in the main comparison for umbilical artery met these
criteria (Haley 1997; Hofmeyr 1991; Nienhuis 1997), see Figure
2.
Effects of interventions
See: Summary of findings for the main comparison Umbilical
artery Doppler ultrasound compared to no Doppler ultrasound in
high-risk pregnancies
This review included 19 studies involving 10,667 women.
1) Umbilical artery Doppler ultrasound versus no
Doppler ultrasound (18 studies, 10,156 women)
We included all completed studies examining umbilical artery
Doppler ultrasound, including those that compared Doppler ul-
trasound alone versus CTG alone, as we wished to get an overall
assessment of whether using Doppler ultrasound was beneficial.
Findings for important outcomes for this overall assessment are
set out in Summary of findings for the main comparison.
A separate comparison of studies where Doppler was used as an
alternative to CTG was also undertaken, and these findings are
reported below under 3) ’Umbilical Doppler ultrasound alone
versus CTG alone’.
As mentioned above, the quality of the studies included in this
comparison was often unclear due to lack of information, partic-
ularly in terms of randomisation and concealment allocation.
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Main outcomes
It is important to emphasise that this review still remains un-
derpowered to detect clinically important differences in serious
neonatal morbidity.
Any perinatal mortality after randomisation (16 studies,
10,225 babies)
There was a clear difference in perinatal mortality between the two
groups (risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52
to 0.98, 16 studies, 10,225 babies, 1.2% versus 1.7%, number
needed to treat (NNT) 203, 95% CI 103 to 4352, Analysis 1.1,
evidence graded moderate). A sensitivity analysis including only
the three studies of high quality (low risk of bias for sequence
generation and concealment allocation) (Haley 1997; Hofmeyr
1991; Nienhuis 1997) showed no clear difference, though the
numbers were small and this analysis lacked the power of the
overall analysis (RR 0.61, 95% CI 0.24 to 1.53, three studies,
1197 babies) (data not shown).
There was no evidence that the treatment effect varied between
subgroups as the CIs overlapped (as indicated by the subgroup
interaction test (test for subgroup differences: Chi² = 0.80, df =
2 (P = 0.67), I² = 0%; Analysis 1.1)), although the RR for the
singleton subgroup was somewhat lower compared with the others
(RR0.59 comparedwith 0.88, 0.78 and 0.71). There was evidence
of funnel plot asymmetry (’small-study effects’, P = 0.057, using
Harbord 2006) which might indicate publication bias. We noted
that the results of individual studies all crossed the line of no effect
and therewas overall lowheterogeneity for this outcome, therefore,
we did not downgrade the evidence (Figure 3). However, possible
publication bias was a concern given that the result of the pooled
meta-analysis was borderline.
Figure 3. Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.1 Any
perinatal death after randomisation.
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It is also important to note that we did not adjust for the noninde-
pendence of twins because of the lack of reported intercorrelation
coefficients (ICC).
Serious neonatal morbidity (three studies, 1098 babies)
Only three studies reported relevant neonatal morbidity data
(Newnham 1991; Norman 1992; Tyrrell 1990); one study re-
ported no events and the two studies which contributed data
showed no clear differences in serious perinatal morbidity between
women having Doppler ultrasound and those monitored by stan-
dard methods (Analysis 1.2, evidence graded very low). The het-
erogeneity was high (Tau² = 3.84, Chi²: P = 0.04, I² = 76%) and
the numbers of babies with serious morbidity were too small to
be able to say anything with any degree of certainty. Thus, we
decided, on the advice of our statistician, not to pool the data for
this outcome. No studies reported serious neonatal morbidity in
multiple pregnancies.
Additional outcomes
The data for stillbirths (RR 0.65, 95% CI 0.41 to 1.04, 9560
babies, 15 studies, Analysis 1.3, evidence graded low), neonatal
deaths (RR 0.81, 95% CI 0.53 to 1.24, 8167 babies, 13 studies,
Analysis 1.4) and low Apgar score (RR 0.92, 95%CI 0.69 to 1.24;
6321 babies, 7 studies, I² = 30%, Analysis 1.6, evidence graded
low)were consistent with the overall picture showing fewer adverse
outcomes in the Doppler group, but the CIs crossed the line of no
effect.
The clear difference favouring the Doppler group in perinatal
deaths, seen in Analysis 1.1, was also present when the analysis
focused just on potentially preventable perinatal deaths (RR 0.67,
95% CI 0.46 to 0.98, 16 studies, 10,225 babies, Analysis 1.5).
The reduction in elective and emergency caesarean sections with
the use of Doppler ultrasound was clear (RR 0.90, 95% CI 0.84
to 0.97, 14 studies, 7918 women, Analysis 1.7, evidence graded
moderate), though the upper limit of the CI was close to one.
When caesarean sections were reported as either elective or emer-
gency, the reduction in caesareans appeared to be confined to the
emergency procedures (elective only: RR 1.07, 95% CI 0.93 to
1.22; 6627 women; 11 studies; Analysis 1.8; emergency only: av-
erage RR 0.81, 95% CI 0.67 to 0.98, 6175 women, 10 studies,
Tau² = 0.04; Chi² = 16.21, P = 0.06, I² = 44%, Analysis 1.9). This
is something that will be explored in a meta-regression in future
updates if more data become available.
There was also some evidence of possible publication bias in the
funnel plots (Figure 4; Figure 5; Figure 6). The Harbord test (
Harbord 2006) for all caesarean sections did not suggest evidence
of asymmetry (P = 0.12) but there did appear to be asymmetry by
visual inspection indicating that there might have been some small
studies missing, although none of the individual published studies
showed clear differences between the groups. Possible publication
bias is of concern because the pooled meta-analysis CI was close
to the line of no effect . With elective caesarean sections, there
was evidence of asymmetry (P = 0.1) and the visual assessment
indicating the ’missing’ studies were those below a relative risk of
one, so the pooled result is likely to be even closer to the null. For
emergency caesarean sections, there was evidence of asymmetry
(P = 0.09), again this being a small-study effect. Heterogeneity
can sometimes contribute to funnel plot asymmetry, so overall we
should be cautious about the significance of the pooled result.
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Figure 4. Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.8
Cesarean section (elective and emergency).
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Figure 5. Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.9
Cesarean section - elective.
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Figure 6. Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.10
Cesarean section - emergency.
Caesarean section results for subgroups based on the populations
(singletons,multiples, not specified) were consistent with the over-
all effect in terms of the direction and size. However, the hetero-
geneity in the subgroup of emergency caesarean section was high
and, therefore, a random-effects model was used for pooling (av-
erage RR 0.81, 95% CI 0.67 to 0.98; test for subgroup differ-
ences: Chi² = 7.47, df = 2 (P = 0.02), I² = 73.2%; Analysis 1.9).
This analysis provided evidence that the average RR across stud-
ies was clearly less than one, indicating a reduction in emergency
caesarean section. However, we also calculated the 95% predic-
tion interval (PI) for the underlying effect in any future studies
(PI = 0.49 to 1.35); this indicated that the underlying RR may be
greater than one in an individual study, due to the between-study
heterogeneity.
Overall, there were no clear differences identified in spontaneous
vaginal births (RR 1.04, 95% CI 0.98 to 1.10; 2504 women; 5
studies, Analysis 1.10) and operative vaginal births (RR 0.95, 95%
CI 0.80 to 1.14; 2813women; 4 studies; Analysis 1.11) for women
having the umbilical artery Doppler ultrasound compared with
women not having the Doppler ultrasound.
There was, however, an average reduction in induction of labour
for women with the umbilical artery Doppler intervention (av-
erage RR 0.89, 95% CI 0.80 to 0.99, 10 studies, 5633 women,
random-effects (Tau² = 0.01, Chi²: P = 0.08, I² = 41%), PI 0.68
to 1.16, Analysis 1.12, evidence graded moderate). Although the
average effect across studies was evident, the prediction interval
suggested that, due to the between-study heterogeneity, we could
not rule out the possibility that the underlying effect in a future
study might actually increase induction of labour. There might be
some clinical heterogeneity around the assessment of induction of
labour due to the varying methods and timings of this interven-
tion.
There was no difference identified overall in intubation or venti-
lation (average RR 1.42, 95% CI 0.87 to 2.30, six studies, 3136
babies, Analysis 1.13). Again, random-effects were used because
of high heterogeneity (Tau² = 0.14, Chi²: P = 0.09, I² = 47%) and
a wide prediction interval was estimated due to the large hetero-
geneity and small number of studies in the meta-analysis (PI 0.41
to 4.94, Analysis 1.13).
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There was evidence of a difference between subgroups (interaction
test for inverse variance analysis: Chi² = 8.67, df = 2 (P = 0.01))
suggesting that there might be an effect in singletons, but not in
multiple pregnancies. The data were limited because there is only
one trial in multiples and one with singleton and multiples com-
bined. Further studies are needed to confirm if there is a difference
here or not.
There was no clear difference identified in neonatal fitting/seizures
(RR 0.35, 95% CI 0.01 to 8.49, 150 babies, 1 study, Analysis
1.14), or preterm labour (RR 1.12, 95% CI 0.72 to 1.75; 626
women, 2 studies Analysis 1.15), though sample sizes were small
for both outcomes.
Overall, there was a small increase in gestational age (weeks) for
babies exposed to umbilical artery Doppler ultrasound (average
mean difference (MD) 0.21, 95% CI -0.02 to 0.43, eight studies,
4066 babies, random-effects (Tau²= 0.04, Chi²: P = 0.11, I² =
40%, Analysis 1.16). However, the prediction interval suggested
that, due to between-study heterogeneity, we cannot rule out that a
future study might show a decrease in gestational age. This finding
should, therefore, be interpreted with caution.
There were no clear differences found in risk of infant respiratory
distress syndrome (RDS) in singleton pregnancies (no study re-
ported multiples) (RR 1.06, 95% CI 0.07 to 16.48, 107 babies; 1
study; Analysis 1.17), neonatal admission to special care baby unit
(SCBU) and/or neonatal intensive care unit (NICU) (RR 0.95,
95% CI 0.89 to 1.03, 9334 babies, 12 studies, Analysis 1.18) , hy-
poxic ischaemic encephalopathy (average RR 0.65, 95% CI 0.01
to 33.07, 1045 babies, 2 studies, I² = 72%, Analysis 1.19), intra-
ventricular haemorrhage (RR 1.42, 95% CI 0.47 to 4.30, 2008
babies, 4 studies, Analysis 1.20), or birthweight (MD 31.33, 95%
CI -8.70 to 71.37; 3887 babies; 7 studies; Analysis 1.21).
There was a reduction in the length of infant hospital stay (days)
in singleton pregnancies that had umbilical artery Doppler inter-
vention, (standardised MD (SMD) -0.28, 95% CI -0.40 to -0.16,
three studies, 1076 babies, Analysis 1.22).
We also included reported data for all other prespecified secondary
outcomes when available, none of which conclusively showed clin-
ically important differences between groups.
Non-prespecified outcomes
For completeness, we also included the graphs for eight clini-
cally relevant outcomes that were not prespecified in our protocol.
There were fewer antenatal admissions in the Doppler group (RR
0.72, 95% CI 0.60 to 0.88, 893 women, 2 studies, Analysis 1.24)
but all other outcomes showed no clear difference between the
groups.
• Birth less than 34 weeks (RR 2.04, 95% CI 0.62 to 6.69,
976 women, 2 studies, I² = 52%, Analysis 1.23);
• Phototherapy for neonatal jaundice (RR 0.15, 95% CI 0.01
to 2.87, 150 babies, 1 study, Analysis 1.25);
• Abnormal neurological development at 9 months (RR 0.61,
95% CI 0.26 to 1.45, 137 babies, 1 study, Analysis 1.26);
• Hospitalisation for IUGR neonatal (RR 1.03, 95% CI 0.75
to 1.41, 142 babies, 1 study, Analysis 1.27);
• Fetal distress in labour (RR 0.35, 95% CI 0.10 to 1.22, 289
women, 1 study, Analysis 1.28);
• Birthweight < 5 percentile (RR 1.16, 95% CI 0.51 to 2.64;
289 babies, 1 study, Analysis 1.29);
• Periventricular leucomalacia (RR 0.33, 95% CI 0.01 to
8.00, 545 babies, 1 study, Analysis 1.30);
• Antenatal hospital stay (days) (MD -0.60, 95% CI -2.39 to
1.19, 426 women, 1 study, Analysis 1.31).
Oxytocin augmentation, requirement for neonatal resuscitation,
preterm labour (onset of labour before 37 completed weeks of
pregnancy), meconium aspiration, bronchopulmonary dysplasia
(BPD), necrotising enterocolitis (NEC), long-term infant/child
neurodevelopmental outcome, and women’s views of their care
were not reported in any trial under this comparison.
2) Umbilical artery Doppler ultrasound versus no
Doppler ultrasound (all subgroups)
Six studies reported main outcomes by subgroups.
Any perinatal mortality after randomisation
Five studies assessed women with suspected small-for-gestational
age (SGA)/IUGR (Almstrom 1992; Haley 1997; Neales 1994
[pers comm]; Nienhuis 1997; Pattinson 1994) (RR 0.72, 95% CI
0.38 to 1.35; 1292 women; 5 studies), one study assessed women
with hypertension/pre-eclampsia (Pattinson 1994) (RR3.57, 95%
CI 0.42 to 30.73; 89 women; 1 study) and one study assessed
women with a previous pregnancy loss (Norman 1992) (RR 0.26,
95% CI 0.03 to 2.17; 53 women; 1 study). Findings are reported
in Analysis 2.1. No clear differences were found in any of the
subgroups. As only one study assessed women with hypertension/
pre-eclampsia, and women with a previous pregnancy loss, there
were not enough data to perform a meaningful subgroup analysis
and therefore data were not pooled for this analysis.
One small study (Norman 1992) assessed serious neonatal mor-
bidity in women with a previous pregnancy loss but did not report
any morbidity in either group (Analysis 2.2). We were unable to
carry out planned subgroup analysis examining monochorionic
twins versus dichorionic twins due to lack of data.
No additional outcomes were reported under this comparison.
3) Umbilical artery Doppler ultrasound as an
alternative to CTG monitoring (four studies, 2834
women)
Four trials were included in this comparison (Almstrom 1992;
Haley 1997; Hofmeyr 1991; Williams 2003). Unfortunately, this
analysis had much less power for assessing main clinical outcomes
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than the main comparison (which included 12 studies where ad-
ditional methods of fetal monitoring were used in both groups).
In terms of quality, two of the four studies were judged to be
at low risk of bias (Haley 1997; Hofmeyr 1991) whilst the rest
were classified as ’unclear’ because of the lack of information on
randomisation and the allocation process.
Main outcomes
Any perinatal mortality after randomisation
Overall, there was no clear difference identified in perinatal mor-
tality (RR 0.45, 95% CI 0.17 to 1.15, four studies, 2813 ba-
bies, Analysis 3.1). Only two studies were judged to have ad-
equate sequence generation and allocation concealment (Haley
1997; Hofmeyr 1991) and using only these in a sensitivity analysis
similarly showed no clear difference identified in perinatal mor-
tality (RR 0.58, 95% CI 0.20 to 1.73, two studies, 1047 babies,
data not shown).
There was no evidence that the treatment effect varied between
subgroups as the CIs overlapped.
None of the studies provided data on serious perinatal morbidity.
Additional outcomes
There were no clear differences between groups for stillbirths (RR
0.48, 95% CI 0.14 to 1.71, four studies, 2813 babies, Analysis
3.2), neonatal death (RR 0.52, 95%CI 0.16 to 1.72, three studies,
1473 babies, Analysis 3.3), potentially preventable deaths (RR
0.38, 95% CI 0.12 to 1.18, four studies, 2813 babies, Analysis
3.4), andApgar score < 7 at fiveminutes (RR 0.86, 95%CI 0.54 to
1.37; 2663 babies; three studies; Analysis 3.5). The same was true
for all other additional outcomes, with the exception of caesarean
section rate and length of hospital stay for neonates.
Overall rates of caesarean section, when both elective and emer-
gency caesareans were combined, showed fewer caesareans in the
umbilical artery Doppler group (RR 0.89, 95% CI 0.79 to 1.01,
four studies, 2813 babies, Analysis 3.6). Interestingly, the results
from three studies that reported emergency and elective caesareans
separately showed fewer emergency caesareans (RR 0.66, 95% CI
0.52 to 0.84, three studies, 1473 women, Analysis 3.8) and more
elective caesareans (RR 1.53, 95% CI 1.12 to 2.09, three studies,
1473 women, Analysis 3.7) in the umbilical arteryDoppler group.
There were too few studies to explore this differential effect in a
formal meta-regression, but lack of heterogeneity for these out-
comes suggested that the effect of the umbilical artery Doppler
studies on the type of caesareans was real.
There were no clear differences between the groups for sponta-
neous vaginal birth (RR 1.06, 95%CI 0.97 to 1.15, 1323 women,
2 studies, Analysis 3.9), operative vaginal birth (RR 0.98, 95% CI
0.81 to 1.17, 2663 women, 3 studies, Analysis 3.10), induction
of labour (RR 0.67, 95% CI 0.32 to 1.40, 576 women, 2 studies,
I² = 74%, Analysis 3.11), infant requiring intubation/ventilation
(RR 1.54, 95% CI 0.26 to 9.08, 576 babies, 2 studies, Analysis
3.12), neonatal fitting/seizures (RR 0.35, 95% CI 0.01 to 8.49,
150 babies, 1 study, Analysis 3.13), gestational age at birth (MD
0.23, 95%CI -0.00 to 0.47; 1473 babies, 3 studies, Analysis 3.14),
neonatal admission to SCBU and/or NICU (RR 0.87, 95% CI
0.73 to 1.03, 2813 babies, 4 studies, Analysis 3.15), and infant
birthweight (MD 38.41, 95% CI -6.14 to 82.97, 2813 babies, 4
studies, Analysis 3.16).
There was a reduction in the length of infant hospital stay with
umbilical artery Doppler ultrasound compared with CTG (SMD
-0.25, 95% CI -0.41 to -0.08, two studies, 576 babies, Analysis
3.17). The two studies that reported this outcome included just
singleton pregnancies. However, the number of babies involved
was too small to be able to say anythingwith any degree of certainty.
Fetal acidosis, oxytocin augmentation, requirement for neona-
tal resuscitation, preterm labour (onset of labour before 37
completed weeks of pregnancy), infant respiratory distress syn-
drome, meconium aspiration, hypoxic ischaemic encephalopathy
(a condition of injury to the brain), intraventricular haemorrhage
(IVH), bronchopulmonary dysplasia (BPD), necrotising entero-
colitis (NEC), long-term infant/child neurodevelopmental out-
come, and women’s views of their care were not reported in any
trial under this outcome.
Non-prespecified outcomes
For completeness, we also included the graphs for three clini-
cally relevant outcomes that were not prespecified in our protocol.
There were fewer antenatal admissions in the Doppler group (RR
0.70, 95% CI 0.55 to 0.90, 426 women, 1 study, Analysis 3.18),
but no clear difference between groups in phototherapy rates for
neonatal jaundice (RR 0.15, 95% CI 0.01 to 2.87, 150 babies, 1
study, Analysis 3.19), or antenatal hospital stay (days) (MD -0.60,
95% CI -2.39 to 1.19, 426 women, 1 study, Analysis 3.20).
4) Umbilical artery Doppler ultrasound as an
alternative to CTG monitoring (all subgroups)
Three studies reported primary outcomes by subgroups. Two stud-
ies assessed women with suspected SGA/IUGR (Almstrom 1992;
Haley 1997) and one study assessed women with hypertension/
pre-eclampsia (Pattinson 1994). There was no clear difference in
perinatal mortality between groups for women with suspected
SGA/IUGR (RR 0.33, 95% CI 0.05 to 2.09; 572 women; 2 stud-
ies) or women with hypertension/pre-eclampsia (RR 3.57, 95%
CI 0.42 to 30.73, 89 women,1 study). Findings were reported in
Analysis 4.1. Studies assessed only perinatal mortality and none
assessed serious neonatal morbidity. It was not possible to carry
out any meaningful subgroup analysis due to a lack of data.
No additional outcomes were reported in any trials under this
comparison.
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5) Early ductus venosus Doppler ultrasound versus
computerised CTG (one study, 333 women)
Two arms of a three-arm trial recruiting women with singleton
pregnancies compared these interventions (Lees 2013). This study
was of high quality (low risk of bias for sequence generation and
concealment allocation).
Main outcomes
There was no clear difference in any perinatal death after ran-
domisation (RR 0.84, 95% CI 0.39 to 1.82; 333 infants, Analysis
5.1). Serious neonatal morbidity was reported separately as death
or survival following severe morbidity; for the infants surviving
following severe morbidity, there was no clear evidence of a differ-
ence between groups (RR 1.10, 95%CI 0.75 to 1.61; 333 women,
Analysis 5.2).
Additional outcomes
Therewere insufficient data to showclear differences between early
ductus venosus Doppler ultrasound versus CTG for stillbirth (RR
1.99, 95% CI 0.37 to 10.71, 333 babies, 1 study, Analysis 5.3),
neonatal death (RR 0.60, 95% CI 0.22 to 1.60, 333 babies, 1
study, Analysis 5.4), any potentially preventable perinatal death
(RR 0.83, 95% CI 0.37 to 1.86, 333 babies, 1 study, Analysis
5.5), fetal acidosis (RR 0.25, 95% CI 0.03 to 2.20, 333 babies,
1 study, Analysis 5.6), Apgar less than seven at five minutes (RR
0.87, 95% CI 0.44 to 1.72, 333 babies, 1 study, Analysis 5.7),
infant requiring intubation/ventilation (RR 0.87, 95% CI 0.67
to 1.13, 333 babies, 1 study, Analysis 5.8), intraventricular haem-
orrhage (RR 8.95, 95% CI 0.49 to 164.87, 333 babies, 1 study,
Analysis 5.9), bronchopulmonary dysplasia (RR 0.87, 95% CI
0.55 to 1.38, 333 babies, 1 study, Analysis 5.10), necrotising en-
terocolitis (RR 0.33, 95% CI 0.03 to 3.15; 333 babies, 1 study,
Analysis 5.11), infant birthweight (grams) (MD 38.00, 95% CI -
31.53 to 107.53, 333 babies, 1 study, Analysis 5.12), long-term in-
fant neurodevelopmental outcome (impairment at two years) (RR
0.60, 95% CI 0.30 to 1.18; 333 infants, 1 study, Analysis 5.13),
long-term infant neurodevelopmental outcome (cerebral palsy at
two years) (RR 0.20, 95% CI 0.02 to 1.68, 333 infants, 1 study,
Analysis 5.14), infant survival at two years without neurodevelop-
mental impairment (RR 1.07, 95% CI 0.92 to 1.23, 333 infants,
1 study, Analysis 5.15), and sepsis (proven) (RR 0.93, 95% CI
0.60 to 1.45, 333 babies, 1 study, Analysis 5.16).
Caesarean section (both elective and emergency), spontaneous
vaginal birth, operative vaginal birth, inductionof labour, oxytocin
augmentation, requirement for neonatal resuscitation, neonatal
fitting/seizures, preterm labour (onset of labour before 37 com-
pleted weeks of pregnancy), gestational age at birth, infant respira-
tory distress syndrome, meconium aspiration, neonatal admission
to special care or intensive care unit, or both, hypoxic ischaemic
encephalopathy (a condition of injury to the brain), length of in-
fant hospital stay, and women’s views of their care were not re-
ported in this trial.
6) Late ductus venosus Doppler ultrasound versus
computerised CTG (one study, 336 women)
Two arms of a three-arm trial compared these interventions (Lees
2013). This trial recruitedwomenwith singletonpregnancies only.
The study was of high quality (low risk of bias for sequence gen-
eration and concealment allocation).
Main outcomes
There was no clear difference in any perinatal death after ran-
domisation (RR 1.28, 95% CI 0.64 to 2.55, 336 infants, 1 study
Analysis 6.1). For the infants surviving following severe morbid-
ity, there was no clear evidence of difference between groups (RR
0.98, 95% CI 0.66 to 1.45; 336 infants, 1 study, Analysis 6.2).
Additional outcomes
Fewer infants whose birth was triggered by late ductus venosus
Doppler ultrasound had long-term infant neurodevelopmental
impairment at two years (RR 0.34, 95% CI 0.15 to 0.79; 336
infants, 1 study, Analysis 6.13).
There were insufficient data to show clear differences between late
ductus venosus Doppler ultrasound versus CTG for stillbirth (RR
2.93, 95% CI 0.60 to 14.31, 336 babies; 1 study, Analysis 6.3),
neonatal death (RR 1.07, 95% CI 0.47 to 2.46, 336 babies, 1
study, Analysis 6.4), any potentially preventable perinatal death
(RR 1.22, 95%CI 0.59 to 2.53, 336 babies, 1 study, Analysis 6.5),
fetal acidosis (RR 0.11, 95% CI 0.01 to 2.00; 336 babies; 1 study;
Analysis 6.6), Apgar less than seven at five minutes (RR 1.28, 95%
CI 0.69 to 2.37, 336 babies, 1 study, Analysis 6.7), infant requir-
ing intubation/ventilation (RR 0.94, 95% CI 0.73 to 1.20, 336
babies, 1 study, Analysis 6.8), intraventricular haemorrhage (RR
16.60, 95% CI 0.97 to 285.35, 336 babies, 1 study, Analysis 6.9),
bronchopulmonary dysplasia (RR 0.95, 95%CI 0.61 to 1.48; 336
babies, 1 study, Analysis 6.10), necrotising enterocolitis (RR 0.98,
95% CI 0.20 to 4.77; 336 babies, 1 study, Analysis 6.11), infant
birthweight (grams) (MD 25.00, 95% CI -40.06 to 90.06; 336
babies, 1 study, Analysis 6.12), long-term infant neurodevelop-
mental outcome (cerebral palsy at two years) (RR 0.09, 95% CI
0.00 to 1.59, 336 infants, 1 study, Analysis 6.14), infant survival
at two years without neurodevelopmental impairment (RR 1.17,
95% CI 1.02 to 1.34, 336 infants, 1 study, Analysis 6.15), and
sepsis (proven) (RR 0.68, 95% CI 0.42 to 1.11, 336 babies, 1
study, Analysis 6.16).
Caesarean section (both elective and emergency), spontaneous
vaginal birth, operative vaginal birth, inductionof labour, oxytocin
augmentation, requirement for neonatal resuscitation, neonatal
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fitting/seizures, preterm labour (onset of labour before 37 com-
pleted weeks of pregnancy), gestational age at birth, infant respira-
tory distress syndrome, meconium aspiration, neonatal admission
to special care or intensive care unit, or both, hypoxic ischaemic
encephalopathy (a condition of injury to the brain), length of in-
fant hospital stay, and women’s views of their care were not re-
ported in this trial.
7) Early ductus venosus Doppler ultrasound versus
late ductus venosus Doppler ultrasound (one study,
337 women)
The three-arm trial by Lees 2013, including women with single-
ton pregnancies, allowed comparison of early versus late ductus
venosus Doppler ultrasound. The study was of high quality (low
risk of bias for sequence generation and concealment allocation).
Main outcomes
There was no clear difference in any perinatal death after randomi-
sation (RR 0.66, 95% CI 0.32 to 1.36; one study, 337 infants,
Analysis 7.1). For the infants surviving following severemorbidity,
there was no clear evidence of any difference between groups (RR
1.13, 95% CI 0.77 to 1.65, 337 infants, Analysis 7.2).
Additional outcomes
Therewere insufficient data to showclear differences between early
ductus venosus Doppler ultrasound changes versus late changes
for stillbirth (RR 0.68, 95% CI 0.20 to 2.36; 337 babies; 1 study,
Analysis 7.3), neonatal death (RR 0.56, 95%CI 0.21 to 1.47, 337
babies, 1 study, Analysis 7.4), any potentially preventable perinatal
death (RR0.68, 95%CI0.31 to 1.47, 337 babies, 1 study, Analysis
7.5), fetal acidosis (RR 3.05, 95% CI 0.13 to 74.43; 337 babies; 1
study, Analysis 7.6), Apgar less than seven at fiveminutes (RR0.68,
95% CI 0.36 to 1.29, 337 babies, 1 study, Analysis 7.7), infant
requiring intubation/ventilation (RR 0.93, 95% CI 0.71 to 1.21;
337 babies, 1 study, Analysis 7.8), intraventricular haemorrhage
(RR 0.51, 95% CI 0.16 to 1.66; 337 babies, 1 study, Analysis
7.9), bronchopulmonary dysplasia (RR 0.92, 95% CI 0.58 to
1.46; 337 babies, 1 study, Analysis 7.10), necrotising enterocolitis
(RR 0.34, 95% CI 0.04 to 3.23, 337 babies, 1 study, Analysis
7.11), infant birthweight (grams) (MD 13.00, 95% CI -59.31
to 85.31, 337 babies, 1 study, Analysis 7.12), long-term infant
neurodevelopmental outcome (any impairment at two years) (RR
1.75, 95% CI 0.70 to 4.32, 337 infants, 1 study, Analysis 7.13),
cerebral palsy at two years (RR 3.05, 95% CI 0.13 to 74.43, 337
babies, 1 study, Analysis 7.14)), infant survival at two yearswithout
neurodevelopmental impairment (RR 0.91, 95% CI 0.80 to 1.03,
337 infants, 1 study, Analysis 7.15), and sepsis (proven) (RR 1.37,
95% CI 0.84 to 2.25, 337 babies, 1 study, Analysis 7.16).
Caesarean section (both elective and emergency), spontaneous
vaginal birth, operative vaginal birth, inductionof labour, oxytocin
augmentation, requirement for neonatal resuscitation, neonatal
fitting/seizures, preterm labour (onset of labour before 37 com-
pleted weeks of pregnancy), gestational age at birth, infant respira-
tory distress syndrome, meconium aspiration, neonatal admission
to special care or intensive care unit, or both, hypoxic ischaemic
encephalopathy (a condition of injury to the brain), length of in-
fant hospital stay, and women’s views of their care were not re-
ported in this trial.
Subgroup analysis
A single study examined early or late ductus venosus Doppler ul-
trasound changes compared with CTG and no data were available
to examine outcomes in clinical subgroups.
D I S C U S S I O N
Summary of main results
Nineteen trials involving 10,667 women were included in this
update of the review.
Overall, the use of Doppler ultrasound versus no Doppler ultra-
sound in high-risk pregnancy was associated with a reduction in
perinatal deaths. There were also fewer inductions of labour and
fewer caesarean sections. No clear difference was found in still-
birth, operative vaginal births, nor in Apgar score less than seven
at five minutes. Serious neonatal morbidity was not pooled due to
high heterogeneity between the three studies that reported it.
Four of the trials included in the main comparison compared the
use of umbilical artery Doppler ultrasound with CTG. In these
studies there was insufficient evidence to detect a clear difference
in perinatal mortality. There were no clear differences between
groups for other primary or secondary outcomes, apart from length
of hospital stay which appeared to be reduced in the umbilical
artery Doppler ultrasound group although the number of babies
involved was too small to be able to say anything with any degree
of certainty.
This update included one new three-arm trial (Lees 2013) exam-
ining early and late ductus venosus Doppler changes, which was
not incorporated into the main meta-analyses. This study was at
low risk of bias and included follow-up to age two, however, it
was underpowered to detect clinically important differences in the
main outcomes of this review. The observed improvement in long-
term neurological outcomes in the cohort of babies in whom trig-
gers for delivery were late changes in ductus venosus are of con-
siderable interest. Ideally, this observation should be replicated in
adequately powered studies. It is important to stress that all ran-
domised women in Lees 2013 were also monitored with comput-
erised cardiotocography and there were clearly defined safety net
criteria. In effect, the beneficial effect in this high-risk group of
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fetuses, if present, came from a comprehensive and serial assess-
ment of fetal well-being that included combination of Doppler
ultrasound and computerised cardiotocography.
Overall completeness and applicability of
evidence
The first meta-analysis showing that Doppler studies of the umbil-
ical artery, when used in singleton high-risk pregnancies, resulted
in the reduction in perinatal deaths without an increase in ob-
stetric interventions was published in 1995 (Alfirevic 1995). This
Cochrane review update confirms these results, although formal
quality assessment of the included studies revealed very few studies
of high quality by today’s standards. An international agreement
on howbest to report clinical trials is relatively recent (CONSORT
2001) and most studies simply did not report information on ran-
dom sequence generation and allocation blinding that is nowa-
days considered essential for quality assessment. This makes for-
mal quality assessment of older studies very imprecise, resulting in
most them being labelled as ’of unclear quality’.
The other criticism of the current evidence is lack of a hitherto
agreed intervention(s) that should follow an abnormal Doppler
finding.Doppler ultrasound can be regarded as a screening or diag-
nostic test and as such cannot, by itself, influence clinically impor-
tant outcomes. It is the clinical decisions influenced by Doppler
findings that may or may not change the outcome. The evidence
from this review suggested that better timing of caesarean sections
may be the ’cause’ of reduced perinatal mortality. An overall de-
crease in caesarean sections appeared to be confined to emergency
procedures which led us to believe that clinicians with no access
to Doppler studies are more often faced with a seriously compro-
mised baby in labour.
It is difficult to say towhat extent this review constitutes the ’defini-
tive’ evidence of benefit (and absence of harm) for Doppler ultra-
sound. Some may argue that this meta-analysis is an ideal example
of the epidemiological evidence that should trigger a definitive,
high-quality large multi-centre clinical trial with an agreed treat-
ment protocol that follows an abnormal Doppler finding in the
umbilical artery.Most clinicians feel that a window of opportunity
for such a trial is long gone, at least in singleton pregnancies with
suspected ’placental insufficiency’. However, it is quite possible
that for some ’high-risk’ groups, Doppler of the umbilical artery
does not offer any protection (e.g. post-term pregnancy, uncom-
plicated dichorionic pregnancy). Large enough clinical trials of
umbilical artery Doppler in these groups of women are unlikely to
be funded as clinical attention focuses onmore sophisticated use of
Doppler ultrasound. It is hoped that more clinical trials evaluating
such techniques (e.g. Doppler studies of the fetal ductus venosus
and cerebroplacental ratio) will be of high quality, with adequate
power to detect important differences in neonatal morbidity.
Quality of the evidence
The trials were generally at unclear risk of bias due to incomplete
reporting of methods (see Figure 2), and there was evidence of
possible publication bias, shown by asymmetric funnel plots for
some analyses (see Figure 3; Figure 4; Figure 5; Figure 6).
GRADE assessments of the evidence were moderate for three out-
comes: perinatal death, caesarean section, and induction of labour,
low for stillbirth and Apgar score less than seven at five minutes,
and very low for serious neonatal mortality for singletons. No
trials reported serious neonatal morbidity for multiples. Overall,
the evidence was downgraded due to missing information on trial
methods (all outcomes), heterogeneity (neonatal morbidity) and
imprecision (neonatal morbidity, stillbirth, Apgar score less than
seven at five minutes), and we also suspected possible publication
bias for several outcomes, although we did not downgrade for this
reason (perinatal death, caesarean section, induction of labour,
and Apgar score less than seven at five minutes) (see Summary of
findings for the main comparison).
Only three studies in themain comparison (Haley 1997;Hofmeyr
1991; Nienhuis 1997) and one study in an additional compari-
son (Lees 2013) had adequate sequence generation and allocation
concealment. Blinding women and/or staff in these trials was not
generally feasible, and may have biased treatment decisions. In
just three studies (Lees 2013; Newnham 1991; Nienhuis 1997),
assessors of neonatal outcomes were blind to Doppler results. Full
information on the number of women approached to take part
in the studies, the numbers eligible for inclusion, and the overall
refusal rate were not provided in most studies. While not sources
of bias as such, high exclusion and refusal rates may affect the gen-
eralisability of the findings and the interpretation of the results.
These limitations in the current evidence mean that the results
should be interpreted with some caution. Future research may
change the results and our certainty about them.
To try to avoid bias associated with uneven post-randomisation
exclusions, we used the number of randomised women as our
denominators. Where there is loss to follow-up or missing data,
using the number randomised as the denominator results in a
more conservative effect estimate. If trial investigators used other
denominators (e.g. the numbers included at different stages of
follow-up), it would mean that results in this review and those in
published trial reports might differ slightly.
Potential biases in the review process
The assessment of risk of bias involves subjective judgements.
This potential limitation is minimised by following the procedures
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011), with two or more review authors independently
assessing studies and resolving any disagreement through discus-
sion, and, if required, involving a third assessor in the decision.
We undertook a comprehensive, systematic search of databases
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to reduce the potential for publication bias, without language or
publication status restrictions.
Agreements and disagreements with other
studies or reviews
Systematic reviews and meta-analysis
Imdad 2011 reviewed published literature on the effectiveness of
fetal movement monitoring and Doppler velocimetry for the de-
tection and surveillance of high risk pregnancies, and their effect
in the prevention of stillbirths. Pooled results from sixteen studies
showed that Doppler velocimetry of umbilical and fetal arteries
in high risk pregnancies leads to a reduction of 29% in perinatal
mortality compared with no Doppler velocimetry (RR 0.71, 95%
CI 0.52 to 0.98). The pooled results for impact of Doppler ultra-
sound versus no ultrasound on stillbirths showed a reduction of
35% (RR 0.65, 95% CI 0.41 to 1.04), although the result did not
reach statistical significance. These results are in agreement with
our findings.
In a critical appraisal of the use of umbilical artery Doppler ultra-
sound in high risk pregnancies, Westergaard 2001 aimed to deter-
mine which high-risk pregnancies benefit from the use of Doppler
velocimetry. Thirteen randomised controlled trials were divided
into a “well-defined studies”, meaning studies that included preg-
nancies with strictly defined IUGR and/or hypertensive disease of
pregnancy (six studies), and “general risk studies”, meaning studies
that included a variety of high-risk pregnancies.
The Odds Ratio (OR) for perinatal mortality (singleton pregnan-
cies and not-malformed fetuses) was 0.66 (95% CI 0.36 to 1.22)
in “well-defined studies”, and 0.68 (95%CI 0.43 to 1.08) in “gen-
eral risk studies”, respectively. (The same paper reported an audit
of perinatal deaths by 32 international experts which concluded
that more perinatal deaths were potentially avoidable by use of
Doppler velocimetry in “well-defined studies” than in “general risk
studies”.)
In the meta-analysis for the “well-defined studies” there was a
significant reduction in antenatal admission (OR 0.56; 95% CI
0.43 to 0.72), inductions of labor and elective caesarean sections
(OR 0.73; 95% CI 0.61 to 0.88), and overall caesarean sections
(OR 0.78; 95% CI 0.65 to 0.94) respectively. Thus, the authors
concluded that only in pregnancies with suspected IUGR and/
or hypertensive disease of pregnancy would the use of umbilical
artery Doppler velocimetry reduce the number of perinatal deaths
and unnecessary obstetric interventions.
In the meta-analysis in this review subgroup analysis for primary
outcomes only was defined a priori in the protocol. We considered
separately pregnancies with small for gestational age fetuses from
those with hypertensive disease of pregnancy (Analysis 2.1). We
didnot include data from the study by Johnstone (Johnstone 1993)
in the subgroup analysis, as this trial included pregnancies as being
at risk by referral, although there was a subset of women with
hypertension or suspected IUGR (754/2289).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Doppler studies of the umbilical artery improves perinatal out-
comes in high-risk pregnancies thought to be at risk of placen-
tal insufficiency. The clear definition of suspected placental in-
sufficiency, frequency of Doppler studies and timing of delivery
in the presence of abnormal umbilical artery Doppler studies re-
mains elusive. Women with hypertensive disorders and small-for-
date fetuses are obvious candidates, whilst the role of umbilical
artery Doppler in other risk groups like post-term, diabetes and
uncomplicated dichorionic twin pregnancy is still debatable.
Implications for research
As discussed, a case could be made for a larger trial of umbilical
artery Doppler ultrasound than has been mounted hitherto, par-
ticularly in risk groups where the risk of fetal growth restriction
caused by impaired placental blood flow is relatively low. Obser-
vational studies suggest that fetal vessels other than the umbilical
artery may be better markers of fetal well-being, fetal ductus veno-
sus and middle cerebral artery, in particular. It is hoped that fu-
ture clinical studies evaluating the possible added benefit of these
tests will comply with the most recent CONSORT statement (
www.consort-statement.org) and use clinical outcomes from this
Cochrane review as the minimum data set.
Further studies of management protocols based on fetal monitor-
ing of ductus venosus and middle cerebral artery with or without
computerised cardiotocography should be encouraged. It is crit-
ically important that such studies collect all clinically important
information including long-term neurological follow-up data.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Almstrom 1992
Methods 2-arm prospective RCT; randomised block design; individual women
Participants Singleton pregnancies with suspected IUGR at 31 completed weeks of pregnancy. IUGR
if fetal weight < 2 SD below the mean at 31 weeks
N = 427 women.
Interventions Intervention: Doppler of umbilical artery only every 2 weeks till birth unless:
• fetal weight 28% to 33% below mean, then every week;
• fetal weight > 34% below the mean, then twice a week and admission to hospital.
Comparison: CTG (NST).
Outcomes Primary: GA at delivery, frequency of CS, frequency of operative delivery for fetal distress,
CS, vacuum, forceps, length of stay at NICU
Secondary: number of fetal monitoring occasions, duration of antenatal hospital stay,
frequency of labour induction, birthweight, frequency of small-for-dates infants, Apgar
score at 1 min and 5 min, need for respiratory support
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised block design.
No information about how the randomisa-
tion was performed.
Allocation concealment (selection bias) Unclear risk Sealed numbered envelopes according to a
randomisation block design
This may mean separate randomisation
schedules for the 4 different hospitals. No
mention of whether the envelopes were
opaque
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
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Almstrom 1992 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No women were lost to follow-up.
3 women declined to take part in the trial.
1 woman in the CTG group had to be
excluded from data analysis since all her
records were mislaid before evaluation
All women seemed to get their allocated
Doppler or CTG, so this was an ITT anal-
ysis
Selective reporting (reporting bias) Unclear risk All outcomes were described in results sec-
tion, but we did not assess the trial protocol
Other bias High risk The study was not stopped earlier.
Baseline imbalance:
• significantly more operations
(elective CS) due to breech presentation
and suspected feto-pelvic disproportion in
the Doppler group;
• the proportion of smokers was
higher in the Doppler group than in the
CTG group.
Differential diagnosis: Almstrom 1995
concluded that obstetriciansmay have been
influenced by the knowledge of a normal
umbilical Doppler examination when as-
sessing the CTG in labour. This might
have contributed bias to the finding of
fewer emergency CS for fetal distress in the
Doppler group than in the CTG group
Biljan 1992
Methods Randomised controlled study.
Participants Women with high-risk singleton pregnancies.
N = 674 women randomised.
Interventions Intervention: Doppler of umbilical artery revealed. N = 338.
Comparison: no Doppler. N = 336.
Outcomes Elective births; GA at birth; birthweight; Apgar scores, admissions to NICU, length of
time in NICU, number of babies ventilated, length of ventilation, perinatal mortality
Notes The information came only from the 2 conference abstracts and personal communication
(ZA). Sadly, Dr Biljan has died, so further detailed information on the study is not
available. The information on the number of women randomised to each group was
obtained from previous published version of this systematic review (Alfirevic 1995), and
data on ’potentially preventable perineal deaths’ was calculated from data in a previous
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Biljan 1992 (Continued)
version of this Cochrane review (Neilson 1996).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...were randomised...”
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information provided in the conference ab-
stract to assess this
Selective reporting (reporting bias) High risk Only gave data for the significant findings and reported
the nonsignificant findings just as lower but not statis-
tically significant
Other bias Unclear risk Insufficient information provided in the conference ab-
stract to assess this
Burke 1992
Methods Prospective RCT, individual women, 2 trial arms.
Participants Women with high-risk pregnancies (suspected IUGR, hypertensive disorders, previous
baby < 2.5 kg, antepartum haemorrhage, previous perinatal death, diminished fetal
movements, post maturity, diabetes, and others)
N = 476 women.
Interventions Intervention: Doppler of umbilical artery and fetal biometry and BPP scoring
Comparison: fetal biometry and BPP scoring.
Outcomes Primary outcomes: induction of labour, elective and emergency CS, preterm delivery,
and perinatal loss
Notes
Risk of bias
36Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Burke 1992 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation by a random number se-
quence but it was unclear whether this was
made by a third independent person
Allocation concealment (selection bias) Unclear risk Sealed numbered envelopes but there was
no informationwhether the envelopes were
opaque and whether there was an ordered
numbered sequence
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Low risk No exclusions after randomisation.
Reported as ITT.
Selective reporting (reporting bias) Unclear risk All outcomes were described in the results
section, but we did not assess the trial pro-
tocol
Other bias Low risk The study was not stopped early.
Baseline imbalance: “Doppler examina-
tions were not carried out in the control
group unless specifically requested by the
consultant in charge of patients” - 2women
in the control group had a Doppler and
were not excluded
De Rochambeau 1992
Methods 2-arm RCT of individual women.
Participants Women with singleton post-term pregnancies (40 + 3 weeks to 42 + 3 weeks)
N = 107 women.
Interventions Intervention: Doppler US of umbilical artery.
Comparison: no Doppler US, and standard care (FHR).
Outcomes CS, RDS and post maturity.
Notes Paper in Frenchwith English abstract, paper was translated.Most of the dataweremissing
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De Rochambeau 1992 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women “...were randomly divided...”.
No information on how the random sequence was
generated.
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-up at
each data collection point:
• none reported.
Describe any exclusion of participants after ran-
domisation:
• there appeared to be none.
Was the analysis ITT? If not, have the data been
able to be reincluded?
• probably.
Selective reporting (reporting bias) Unclear risk There was no list of prespecified outcomes as far as
we could ascertain and we did not assess the trial
protocol
Other bias Unclear risk If the study was stopped early, explain the reasons:
• no.
Describe any baseline imbalance:
• no information provided.
Describe any differential diagnosis:
• unclear.
Giles 2003
Methods Multi-centred RCT; block randomisation, block of 20.
Individual women, 2-arm trial.
Participants Women with twin pregnancies (monochorionic and dichorionic) at 25 weeks. 2 viable
apparently normally formed fetuses seen on US scan
Exclusions: fetal anomalies; polyhydramnios/oligohydramnios; demise of 1 twin before
25 weeks
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Giles 2003 (Continued)
Significance of chorionicity not realised at time randomisation began so no attempt was
made to assess chorionicity
N = 539 women.
Interventions Intervention: Doppler and biometry US.
• Doppler + biometry at 25, 30 and 35 weeks;
• “the clinicians were advised to undertake interventions if there was an abnormal
umbilical artery Doppler study (> 95th centile systolic diastolic ratio) or abnormal
ultrasound biometry indicating discordant growth. The suggested intervention was
intensive surveillance by obstetrics caregivers...if other indicators of fetal well-being
(lack of serial growth, decreased amniotic fluid or abnormal fetal monitoring) were
abnormal, the early delivery was advised after 25 weeks;
• “An abnormality of Doppler waveforms themselves was not considered an
indication for immediate delivery unless there was absence of diastolic flow velocity at
> 32 weeks of gestation”.
Comparison: biometry US.
• Biometry only at 25, 30 and 35 weeks.
Outcomes Maternal: antenatal admission, presence of hypertension, gestation at delivery, indication
for delivery and mode of delivery
Fetal: US biometry measurements, umbilical artery doppler systolic diastolic ratios and
the occurrence of fetal death and causative factors
Neonatal: birthweight, Apgar scores, admission to NICU, admission to special care
nursery, requirements for ventilation and occurrence of neonatal death (up to 28 days
of life)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “....opaque sealed envelopes containing the
randomisation code the envelope being
opened by an observer remote from patient
care”
Allocation concealment (selection bias) Low risk “....opaque sealed envelopes containing the
randomisation code the envelope being
opened by an observer remote from patient
care”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
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Giles 2003 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Describe any loss of participants to follow-
up at each data collection point:
• 539 women were randomised in
Doppler Assessment in Multiple
Pregnancy (DAMP) study: Doppler 268
and control 271. 13 were lost to follow-up
after randomisation at 25 weeks and were
not included in the results. This left 526
women with complete follow-up: 262 in
Doppler and 264 in no Doppler.
Describe any exclusion of participants after
randomisation:
Was the analysis ITT? If not, have the data
been able to be reincluded?
• 7 women in the no Doppler group
had Doppler.
Selective reporting (reporting bias) Unclear risk There seemed to be no evidence of selective
reporting bias, but we did not assess the
trial protocol
Other bias Low risk If the study was stopped early, explain the
reasons:
• not stopped early, but PNM findings
in study much lower than expected. Power
calc was based on 85.7/1000 (but PNM in
study was 11/1000), so study significantly
underpowered - needed 3300 per arm.
Describe any baseline imbalance:
• no imbalances.
Haley 1997
Methods 2-arm RCT with stratified block randomisation producing 4 groups: Caucasian primi-
parous and multiparous women, and Asian primiparous and multiparous women. Ran-
domised in blocks of 8 using table of random numbers. However, the results are not
reported by any of these subgroups - only Doppler vs CTG overall
Randomisation was of individual women.
Participants Women with singleton fetuses with US examination showing the abdominal circumfer-
ence < 2 SD of the mean for the GA FHR on charts recommended by British Medical
Ultrasound Society. There was no GA constraint although all women were > 26 weeks’
gestation
N = 150 women.
Interventions Intervention: Doppler of umbilical artery and no CTG.
Comparison: CTG.
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Haley 1997 (Continued)
Outcomes Primary: duration of hospital antenatal admission, induction of labour rates
Secondary: number of investigations (CTG or Doppler), number of outpatient visits to
hospital, emergency CS rate, length of stay on the NICU, birthweight, and 1 min and
5 min Apgar score
All women were sent a questionnaire asking their views on the process of their care
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Blocks of 8 using a table of random num-
bers.
Allocation concealment (selection bias) Low risk “...randomisation only possible by tele-
phone .... sequentially numbered sealed
opaque envelopes...”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss of participants at follow-up.
No exclusion after the randomisation.
ITT analysis.
Selective reporting (reporting bias) Unclear risk We did not assess the trial protocol. Also,
despite the stratified randomisation to look
at ethnicity and parity, the results are not
reported by any of these subgroups, only
Doppler vs CTG overall
Other bias Low risk Study went to completion.
Baseline imbalance: more women had no
live-in support at home in the CTG group
Differential diagnosis: “...there was not a
rigid protocol except that clinicians usually
felt that a CTG record gave reassurance for
48 to 72 hours and a Doppler examination
for a week or more ...”
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Hofmeyr 1991
Methods 2-arm RCT, but with additional evaluation by the nonallocated technique
Randomisation was of individual women.
Participants Women undergoing evaluation of fetal well-being in the high-risk obstetric unit. 867
women randomised
N = 897 women.
Interventions Intervention: Doppler US of umbilical artery.
Comparison: computerised CTG.
Outcomes Number and duration of tests; perinatal outcomes.
“Our objective was to determine whether the experimental policy of Doppler study
followed when necessary by FHR testing would take less time than routine FHR testing
alone”
Notes We contacted the authors to ask for clarification of the phrase, “computer generated
algorithm based on the hospital number”. They kindly responded with an explanation:
“allocation was done automatically by a computer programme. Although the algorithm
made use of the woman’s hospital number, it was impossible for the midwife performing
the fetal assessment to predict to which group the women would be allocated. The
’algorithm’ was simply a mathematical sequence which was applied to the woman’s
hospital number to generate an allocation”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...computer generated algorithm based on
the hospital number...”. We sought clari-
fication from the authors who kindly re-
sponded:
“allocation was done automatically by a
computer programme”.
Allocation concealment (selection bias) Low risk Not described in the paper but wewrote for
clarification from the authors who kindly
responded:
“although the algorithm made use of the
woman’s hospital number, it was impossi-
ble for the midwife performing the fetal
assessment to predict to which group the
womenwould be allocated.The ’algorithm’
was simply a mathematical sequence which
was applied to the woman’s hospital num-
ber to generate an allocation”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
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Hofmeyr 1991 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-
up at each data collection point:
• none apparent.
Describe any exclusion of participants after
randomisation:
• none apparent.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• it would appear so.
Selective reporting (reporting bias) Unclear risk There was no list of prespecified outcomes
from the protocol, and we did not assess
the trial protocol
Other bias High risk If the study was stopped early, explain the
reasons:
• not stopped early as far as could
ascertain.
Describe any baseline imbalance:
• imbalance in numbers in each group:
439 Doppler vs 459 FHR;
• unspecified number of women in
CTG group had also Doppler evaluation -
assessment by the alternate nonallocated
method was required on 1241 (66%) of
1869 occasions in which the allocated
method was Doppler, and 804 (39%) of
2069 occasions when the allocated
method was FHR testing.
Johnstone 1993
Methods 2-arm RCT. Randomisation by Zelen method - only those randomised to Doppler were
invited to participate in the trial. Those allocated to CTG were being given normal care
so their permission was regarded as not required
Randomisation was of individual women.
Participants Women with pregnancies identified clinically as being at increased risk (N = 2289 out
of the 8018 women giving birth at the hospital during the time of the study)
Doppler or CTG or BPP was given to pregnant women where there was concern bymed-
ical staff about antenatal fetal well-being by random allocation. Women were admitted
to the trial if there was a wish for Doppler studies or a referral for AN fetal monitoring
(CTG or BPP). So, all women meeting these criteria were randomised regardless of risk
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Johnstone 1993 (Continued)
N = 2289 women.
Interventions Intervention: Doppler US of umbilical artery (and other monitoring)
Comparison: no Doppler - but other monitoring used (CTG/BPP)
Outcomes Fetal mortality and morbidity; obstetric interventions; use of other tests of fetal monitor-
ing; impact on obstetric decision making; health and personal costs; women’s satisfaction
(to be presented in a separate report)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Just described as randomised.
Allocation concealment (selection bias) Low risk “Sequentially numbered opaque sealed en-
velopeswere attachedby stapling to the case
notes of all women attending this hospital.
Randomisation was carried out by opening
the envelope for every woman whomet the
criteria described above.”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Low risk Describe any loss of participants to follow-
up at each data collection point:
• all women seemed to have data
collected.
Describe any exclusion of participants after
randomisation:
• of the 1114 women allocated to
Doppler, 24 did not have Doppler
assessment (2%);
• 3 women got ’Doppler’ though they
were randomised to ’no Doppler’;
• uneven, but numbers were small
relative to the size of the study.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• “data analysis was on an ITT basis”.
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Johnstone 1993 (Continued)
Selective reporting (reporting bias) Unclear risk They seemed to report on their prespecified
outcomes but we did not assess the trial
protocol.
Other bias Low risk If the study was stopped early, explain the
reasons:
• no.
Describe any baseline imbalance:
• none reported in the text.
Describe any differential diagnosis:
• seemed okay.
Receiving the other intervention:
• 24 women allocated to Doppler did
not have it performed;
• 3 women in No Doppler had
Doppler.
Lees 2013
Methods 3-arm prospective randomised controlled study of individual women
Participants Study in 20 tertiary care hospitals in 5 European countries (Austria, Germay, Italy, The
Netherlands, UK)
Women over 18 years capable of giving consent. Singleton pregnancy at 26 + 0 to 31
+ 6 weeks’ gestation with FGR (defined as abdominal circumference below the 10th
percentile based on local standards and abnormal umbilical artery Doppler pulsatility
index (PI) above the 95th percentile based on local standards irrespective of the presence
or absence of reversed end-diastolic flow). In all cases, estimated fetal weight was > 500
g. Short-term variation after 1 hour of CTG tracing had to be > 3.5 ms at 26 to 28 weeks
and > 4 at 29 to 31 weeks with ductus venosus PI < 95th percentile. (GA determined by
US at 14 and between 14 to 21 + 6 weeks)
Women with known or planned impending delivery, major structural abnormality or
fetal karyotype abnormality were excluded
N = 511 randomised (8 subsequently excluded).
Interventions Randomisation groups:
1. Cardiotocograph short term variation (CTG STV) and timing of delivery was assessed
with a criterion for reduced STV. Umbilical artery Doppler measurements were taken
but no waveform measurements of the ductus venosus were recorded. (166 allocated, 21
lost to follow-up, 1 missing neonatal data, 144 in primary analysis)
2. Early abnormality of ductus venosus prompted delivery (early changes pulsatility index
> 95th percentile) (n = 167, 25 lost to follow-up, 142 in primary analysis)
3. Late ductus venosus changes (a wave indicated no or reversed flow) (n = 170, 13 lost
to follow-up, 157 in primary analysis)
All measurements were confirmed by a second measurement at least 24 hours later.
Monitoring in all groups included umbilical arteryDoppler and CTGwas recommended
at least once a week but could be more frequent depending on local protocol. Irrespective
of randomised group, there was a cutoff rescue value for STV based on CTG at 26 to 28.
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Lees 2013 (Continued)
9 weeks that prompted delivery. At 32 weeks, deliveries were according to local protocol
In all groups, delivery could be undertaken based on a maternal indication such as severe
pre-eclampsia or clear CTG abnormalities such as recurrent late decelerations
Outcomes Primary outcome: survival without cerebral palsy or neurosensory impairment, or a
Bayley III developmental score of less than 85 at 2 years of age
Secondary outcomes: composite of adverse neonatal outcome defined as fetal or postnatal
death (between trial entry in-utero and discharge home from neonatal services) or 1
or more of the following severe morbidities: BPD (defined as supplemental oxygen to
maintain SATs > 90% at 36 weeks), severe cerebral haemorrhage (IVH grade III or IV)
cystic periventricular leukomalacia, proven neonatal sepsis (blood culture and requiring
antibiotics) or NEC (presence of pneumatosis or perforation on X-ray or disease present
on laparotomy)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Through central randomisation website.
Random block design, stratified by gesta-
tion (< 29 vs > 29 weeks) and centre
Allocation concealment (selection bias) Low risk Through central randomisation website.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk It was not feasible to blind clinicians to in-
tervention group. Women may have been
aware of randomisation group
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Neonatal outcome data entered directly
from records and entered into database
Not possible to blind outcome assessment
for all outcomes, however, the assessor of
the primary outcome was blinded
“Concealment of the allocated monitoring
regime was not possible, and clinicians re-
sponsible for the care of the women entered
in the study and women themselves were
aware of the treatment allocation. How-
ever, the paediatrician doing the follow-up
examination was masked to follow-up as-
sessment and data entry allocation”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of 511 randomised, missing data for 8
women and babies for the primary out-
come. There was some attrition at 2-year
follow-up (59 lost to follow-up)
ITT analysis.
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Lees 2013 (Continued)
Selective reporting (reporting bias) Low risk Protocol available and no evidence of out-
come reporting bias
Other bias Low risk Demographic data given for whole sample
and those with poor composite outcome.
Groups appeared similar at baseline
Neales 1994 [pers comm]
Methods 2-arm randomised controlled study of individual women.
Participants Women of 24 weeks or greater gestation with a singleton pregnancy, and ultrasonic
evidence of IUGR (abdominal circumference on or below 5th centile for GA).
N = 467 women.
Interventions Intervention: Doppler US of umbilical artery revealed, weekly or more often if indicated.
Documented in notes. Discussed with registrar
Comparison: Doppler US weekly but recorded in separate file and not disclosed to
clinicians
Outcomes Obstetric management: gestation at birth, time from enrolment to birth, mode of birth/
onset of labour, fetal distress in labour
Neonatal outcome: perinatal mortality, birthweight, admission to NICU, neonatal out-
come
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information other than ’randomised’.
Allocation concealment (selection bias) Unclear risk Sealed envelopes but there was no infor-
mation as to whether the envelopes were
opaque and whether they were distributed
in a sequential order
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
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Neales 1994 [pers comm] (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Describe any loss of participants to follow-
up at each data collection point:
• no withdrawals reported.
Describe any exclusion of participants after
randomisation: no exclusion:
• no withdrawals reported.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• ITT as far as able to assess. Not
specifically stated as such.
Selective reporting (reporting bias) High risk Not all outcomes available and we did not
assess the trial protocol
Other bias Unclear risk If the study was stopped early, explain the
reasons:
• not stopped early for benefit, but
underpowered due to ’cannot do a large
enough study’.
Newnham 1991
Methods 2-arm RCT, stratified for twin pregnancies.
Randomisation was of individual women.
Participants Women with high-risk pregnancies, singletons and twins.
Defined as those disorders of pregnancy in which an increased risk of retarded fetal
growth or impaired fetal well-being were considered likely
N = 505 women.
Interventions Intervention: Doppler of umbilical and utero-placental (within the placental bed) artery
• N = 254, including 21 twins.
• Performed immediately after randomisation and then frequency by clinical
judgement.
• ”The ratio of peak systolic (S) to least diastolic (D) Doppler shift frequency was
calculated from waveforms obtained from an umbilical artery and from a maternal
uteroplacental artery within the placental bed. These ratios were not adjusted to
standard fetal or maternal heart rates”.
Comparison: no Doppler.
• N = 251, including 19 twins.
Outcomes Primary: duration of neonatal stay in hospital.
Secondary: number and type of fetal heart monitoring studies, obstetric interventions,
frequency of fetal distress, birthweight, Apgar score, and need for NICU
Notes
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Newnham 1991 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Just described as random.
Allocation concealment (selection bias) Low risk Numbered opaque sealed envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors of neonatal outcomes were blind
to Doppler results
Incomplete outcome data (attrition bias)
All outcomes
Low risk Describe any loss of participants to follow-
up at each data collection point:
• no loss reported.
Describe any exclusion of participants after
randomisation:
• none described.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• apparently yes.
Selective reporting (reporting bias) Unclear risk Reported outcomes were the same as those
prespecified but we did not assess the trial
protocol
Other bias Low risk If the study was stopped early, explain the
reasons:
• no.
Describe any baseline imbalance:
• groups comparable for maternal age,
height, parity, smoking and GA. No ’P’
values given but looked alright.
Describe any differential diagnosis:
• seemed alright.
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Nienhuis 1997
Methods Randomised controlled study - stratified randomisation and block randomisation
Stratification by GA (< 32 weeks and > 32 weeks) and smoking (regardless of number
of cigarettes smoked)
Randomisation by individual women, 2-arm trial.
Participants Women with clinically suspected IUGR of > 2 weeks diagnosed by fundal height mea-
surements at the outpatient clinic. Singleton pregnancies
Exclusions: multiple pregnancies, uncertain GA, nonCaucasian origin, maternal or fetal
conditional requiring immediate hospitalisation or intervention
N = 161 women.
Interventions Intervention: Doppler US of umbilical artery revealed:
• done weekly until birth;
• maintaining outpatient management while the Doppler was in the normal range,
in a setting whereby hospitalisation was the management of choice where significant
IUGR was suspected.
Comparison: Doppler US of umbilical artery concealed:
• the PIs were not calculated until after birth and the results were concealed from
the clinicians in charge;
• standard clinical management for suspected IUGR.
Outcomes Effect on costs in terms of hospitalisation, perinatal outcome, neurological development
and postnatal catchup growth, onset and mode of birth, birthweight, and GA at birth
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk • Randomised numbers from a
published table of random numbers from
a person not involved in patient
management.
• However, study stated “....even
number allocated the participant to the
intervention group....uneven numbers
were allocated to the control group”
(Nienhuis 1995).
• A block size of 10 was used.
Allocation concealment (selection bias) Low risk • “A randomisation number was
requested over the telephone from an
independent person not involved in
patient management”.
• After the stratification, the next
number of 1 of the 4 randomisation lists
was read.
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Nienhuis 1997 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors of neonatal outcomes were blind
to Doppler results
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-
up at each data collection point:
• 11 women refused to participate in
the study.
Describe any exclusion of participants after
randomisation:
• 8 cases were excluded (4 in
intervention group and 4 in control
group) because of congenital defects.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• not for some outcomes - not able to
reinclude;
• authors took out protocol violation
and re-evaluated because they said: “14
participants were admitted during
pregnancy despite a normal Doppler.
Suspected IUGR was the sole reason and
they should not have been admitted. The
authors recalculated excluding these 14
and this is inappropriate as it is likely to
reflect real life”.
Selective reporting (reporting bias) Unclear risk All the outcomes were reported but we did
not assess the trial protocol
Other bias High risk If the study was stopped early, explain the
reasons:
• not reported as stopping early.
Describe any baseline imbalance:
• slight difference in primipara:
Doppler 34/74 (46%) and control 43/76
(57%) but reported as NS;
• 58.1% boys in intervention group
and 36.8% boys in control group;
• 4.1% breech in intervention group
and 18.4% breech in control group;
• in the analysis, the possible influence
of the skewed distribution of sex was
reduced by using sex-specific growth
reference.
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Nimrod 1992
Methods RCT; 2-arm trial randomising individual women.
Participants Pregnant women seen at the ’Fetal Assessment Unit’ over 40 weeks’ gestation
Interventions Intervention: pulsed Doppler revealed. Fetal aorta and umbilical artery assessed. BPP
and NST also undertaken
Comparison: pulsed Doppler concealed. BPP and NST were reported
Outcomes CS; gestation at birth; meconium in amniotic fluid; need for phototherapy
Notes Conference abstract available, but no full publication.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information available.
Allocation concealment (selection bias) Unclear risk No information available.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information available.
Selective reporting (reporting bias) Unclear risk Very limited data in the conference ab-
stract. We did not assess the trial protocol
Other bias Unclear risk No information available onwhich to judge
this aspect.
Norman 1992
Methods RCT. Individual women randomised in 2 arms.
Participants Women with high-risk pregnancies with recurrent pregnancy loss (2 or more mid
trimester or early third trimester losses which resulted in IUFD, stillbirth or neonatal
death) at least 24 weeks’ pregnant. 54 women randomised
N = 54 women.
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Norman 1992 (Continued)
Interventions Intervention: Doppler velocimetry of umbilical artery revealed
Comparison: Doppler velocimetry of umbilical artery concealed
Outcomes Maternal intervention, hospital stay, induction of labour, CS, perinatal mortality and
morbidity
Notes A conference poster (incomplete data).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were randomly allocated.
Allocation concealment (selection bias) Unclear risk Sealed envelope, but no mention of how
they were distributed nor whether they
were opaque
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-
up at each data collection point:
• 1 woman lost to follow-up, but no
explanation.
Describe any exclusion of participants after
randomisation:
• no information.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• no information.
Selective reporting (reporting bias) Unclear risk No information in the poster to enable this
to be assessed. Also we did not assess the
trial protocol
Other bias Low risk If the study was stopped early, explain the
reasons:
• was not stopped early.
Describe any baseline imbalance:
• “...both groups were comparable at
study entry as regards maternal age,
53Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Norman 1992 (Continued)
number of previous losses and GA”.
Describe any differential diagnosis:
• seemed fine.
Ott 1998
Methods 2-arm RCT of individual women.
Participants Women referred to the perinatal laboratory so high-risk pregnancies (risk of UPI; fetal
risk; postdates; maternal diabetes; PROM/PTL; fluid abnormalities)
N = 715 women.
Interventions Intervention: fetal and umbilical Doppler + modified BPP.
Comparison: no Doppler but modified BPP.
Outcomes Primary outcome: neonatal morbidity rate (admission toNICU, length of stay in NICU,
significant neonatal morbidity)
Secondary outcome: GA at delivery, neonatal weight, CS for fetal distress
Notes The outcome of ’significant neonatal morbidity’ assessed in this study included cen-
tral nervous system complications, sepsis, acidosis/asphyxia, cardiomyopathy, anaemia,
metabolic outcomes but excluded RDS. Anaemia and metabolic outcomes were not
defined. We considered this outcome to be sufficiently different from the review’s pri-
mary outcome of ’serious neonatal morbidity (composite outcome including hypoxic
ischaemic encephalopathy, IVH, BPD, NEC)’ that we did not include these data in the
meta-analysis. This study found no significant difference in ’significant neonatal com-
plications’ between the Doppler group (8%) and the no Doppler group (6.6%)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer-generated random number allocation
system.”
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-up at
each data collection point:
• 20.5% participants refused to participate in
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Ott 1998 (Continued)
the study;
• 50/715 participants (7.0%) withdrew from
the study - delivered at another institution or
were lost to follow-up;
• 37 (11.7%) women in control arm had
Doppler US at physician’s request.
Describe any exclusion of participants after ran-
domisation:
• see above.
Was the analysis ITT? If not, have the data been
able to be reincluded?
• no, not ITT. It was not reported how many
women were randomised to each group, only
given how many analysed in each group and this
had to be calculated from the information on
reasons for testing in Table 2.
Selective reporting (reporting bias) Unclear risk Although the prespecified outcomes in the pa-
per were reported. we were not able to assess
the protocol, so are not sure whether there was
outcome reporting bias. The authors reported
only on CS for fetal distress, and not on all
CS.
Other bias Low risk If the study was stopped early, explain the reasons:
• no, not stopped early.
Describe any baseline imbalance:
• seemed that the groups were balanced.
Describe any differential diagnosis:
• 37 (11.7%) women in control arm had
Doppler US at physician’s request.
Pattinson 1994
Methods RCT; block randomisation of individual women:
• 2-arm RCT but with 3 subgroups: group 1. women with fetuses with AEDV;
group 2: women with hypertension but fetuses with EDV and group 3: women with
fetuses suspected of being SGA but with EDV present;
• 3 groups were created based on clinical picture and Doppler results;
• if the woman was hypertensive and fetus had EDV and was suspected of being
small, then she went to HT group;
• each subset was managed differently;
• balanced block randomisation in blocks of 10 for AEDV and 20 for other groups.
There were equal numbers of women in each group;
• data analysed at completion of each block;
• in each group, Doppler revealed and Doppler concealed.
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Pattinson 1994 (Continued)
Participants Women > 28 weeks’ pregnant with hypertension and/or suspected SGA fetuses were
referred for Doppler US. 212 women with singleton pregnancies
N = 212 women.
Interventions Intervention: Doppler velocimetry of umbilical artery revealed:
• other tests available, e.g. sonar and AN FHR.
Comparison: Doppler velocimetry of umbilical artery concealed:
• other test available, e.g. sonar and AN FHR.
Outcomes Perinatal mortality and morbidity, antenatal hospitalisation, maternal intervention, ad-
mission to the NICU, and hospitalisation until discharge from the neonatal wards
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomisation was performed by the
person doing the Doppler velocity .......”
Allocation concealment (selection bias) Unclear risk “......opaque sealed envelopes......”, but no
mention of numbered and sequentially or-
dered envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Low risk Describe any loss of participants to follow-
up at each data collection point:
• none were lost.
Describe any exclusion of participants after
randomisation:
• not apparent.
Was the analysis ITT? If not, have the data
been able to be reincluded?
• probably.
Selective reporting (reporting bias) Unclear risk All the outcomes were reported but we did
not assess the trial protocol
Other bias High risk If the study was stopped early, explain the
reasons:
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Pattinson 1994 (Continued)
• in the group of AEDV (20 women),
there were 6 perinatal deaths in the
control group and 1 perinatal death in the
study group. The trial was stopped at this
point because significantly more fetuses
had died in the control group.
Describe any differential diagnosis:
• if AEDF detected, then Doppler was
repeated the following day. In the control
group, Doppler was repeated weekly if the
woman was in hospital and fortnightly if
the woman was an outpatient;
• in the AEDV group, the authors
stated that “by giving the responsible
clinician a management guideline for a
fetus with ADEV we might have biased
the outcome because the clinician was
aware we were specifically interested in the
outcome and so more care might have
been taken”;
• women in the control group were
managed by consultants who might have
had an infertility or gynaecology
speciality, where women with problems
identified were managed with a specific
management plan. So it is possible that
there might not have been a difference in
a hospital where all high-risk pregnancies
were managed by clinicians who were
subspecialists in perinatal medicine.
Trudinger 1987
Methods 2-arm RCT of Individual women.
Participants Women with high fetal risk (singletons). More than 28 weeks’ gestation
N = 300 women.
Interventions Intervention: Doppler of umbilical artery revealed:
• full access to other methods of fetal assessment, e.g. fetal movements chart, CTG,
US measurements and imaging, maternal estrogens, placental lactogens.
Comparison: Doppler of umbilical artery concealed:
• full access to other methods of fetal assessment e.g. fetal movements chart, CTG,
US measurements and imaging, maternal estrogens, placental lactogens.
Outcomes Perinatal mortality, CS, induction of labour, etc.
Notes
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Trudinger 1987 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random number though no information on how
they were generated and by whom
Allocation concealment (selection bias) Unclear risk “Each patient was asked to draw an envelope con-
taining a random number and those with even
numbers were allocated to the Doppler report
available group”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not
generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Low risk Describe any loss of participants to follow-up at
each data collection point:
• 11 women gave birth at other hospitals (6
Doppler and 5 controls) - left Doppler with 127
women and control with 162 women.
Was the analysis ITT? If not, have the data been
able to be reincluded?
• available case analysis.
Selective reporting (reporting bias) Unclear risk No outcome listed in methods section and we did
not assess the trial protocol.
Other bias Low risk If the study was stopped early, explain the reasons:
• not stopped.
Describe any baseline imbalance:
• fine.
Describe any differential diagnosis:
• seemed OK.
Tyrrell 1990
Methods RCT; pragmatic 2-arm trial.
Participants Women with high-risk singleton pregnancies.
Specifically, 500 pregnant women at high risk of growth retardation or stillbirth. IUGR
clinically suspected or by US scan, previous SGA baby, previous antepartum haemor-
rhage, hypertension
Exclusions: women with diabetes, twin pregnancies.
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Tyrrell 1990 (Continued)
N = 500 women.
Interventions Intervention: routine use of Doppler and BPP testing + other tests:
• Doppler of umbilical and uteroplacental arteries;
• testing at 28 weeks’ gestation, or at the time of presentation if risk factors
appeared later than this. Thereafter, they had weekly Doppler and fetal biophysical
assessment for 3 weeks, followed by fortnightly examinations until delivery.
Comparison: no Doppler and no biophysical assessment but other tests only:
• ”clinicians responsible for the care of women in the selectively investigated arm
could only obtain Doppler and biophysical assessment on special request, and this
happened in only 12 pregnancies”.
Outcomes Total number of days of antenatal admission, rate of induction of labour (by anymethod)
, mode of birth (elective CS and emergency CS), 1 and 5 min Apgar, birthweight,
admission to NICU
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk • “...random number sequence...” though it is not
clear how this was generated;
• ”...the randomisation was performed by the 2
ultrasonographers involved in the study neither of
whom knew anything about the patients or was
involved in their clinical management...“.
Allocation concealment (selection bias) Unclear risk • ”...sealed, sequentially numbered envelopes..”
though it is not clear whether these were opaque.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not gen-
erally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials was not gen-
erally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-up at each data
collection point:
• “...the data on duration of antenatal stay and
induction of labour were obtained retrospectively, and
the case notes could not be traced in 15% of the
women”.
Describe any exclusion of participants after randomisa-
tion:
• no exclusion.
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Was the analysis ITT? If not, have the data been able to
be reincluded?
• 12 women in ’no Doppler’ group had Doppler
and BPP at specific request of obstetrician. These
seemed to be assessed in the group to which women
were randomised, so appeared to be ITT.
Selective reporting (reporting bias) Unclear risk Not all outcomes were reported, emergency CS just re-
ported in the text. We did not assess the trial protocol
Other bias Unclear risk If the study was stopped early, explain the reasons:
• not reported;
• the registered study aimed for 28,000 over 7 years,
but this was probably impractical.
Describe any baseline imbalance:
• “clinicians responsible for the care of women in
the selectively investigated arm could only obtain
Doppler and biophysical assessment on special request,
and this happened in only 12 pregnancies”.
Describe any differential diagnosis:
• seemed alright.
Williams 2003
Methods Randomised controlled study; block randomisation (block of 4 and 6)
Individual women.
Participants Women with high-risk pregnancies: singletons (IUGR 7%, hypertension 10%, diabetes
11%, prolonged pregnancy 43%, decreased fetal movements 22%). GA > 32 weeks
N = 1360 women.
Interventions Intervention: umbilical artery Doppler:
• if Doppler normal, then women seen twice a week; if equivocal, then amniotic
fluid index done; if abnormal, then proceeded to induction/delivery within 24 hours.
Comparison: electronic FHR with NST:
• twice a week; Kulbi score (5 components). If equivocal (identified Kulbi = 6),
then assessment of amniotic fluid volume; if abnormal (identified Kulbi = 4), then
induction/delivery within 24 hours.
Outcomes Primary outcome: incidence of CS for fetal distress in labour (nonreassuring FHR)
Secondary outcome: total CS, Apgar score 1 and 5 min, the incidence of stillbirth, the
presence of meconium, and the incidence of transfer to the NICU with severe neonatal
morbidity
Notes
Risk of bias
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Williams 2003 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table with a variable
block size of 4 and 6.
Allocation concealment (selection bias) Unclear risk Sequentially numbered opaque envelopes
althoughno information as towhether they
were sealed
“...envelopes were kept in a locked drawer
that was accessible only to the unit clerk.
The envelops was opened by the nurse/
sonographer in the presence of the patient”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding women and/or staff in these trials
was not generally feasible
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Describe any loss of participants to follow-
up at each data collection point:
• no final outcome data were available
for 16 women (10 in NST group and 6 in
Doppler group).
Describe any exclusion of participants after
randomisation:
• 4 women were assigned in error, did
not have the identified high-risk
condition, and were removed from further
analysis; 1356 women in study.
Was the analysis ITT?
• “once assigned randomly to
particular group, the patient remained in
that group for any subsequent assessment
that took place in that pregnancy”.
Selective reporting (reporting bias) Unclear risk All the outcomes were reported but we did
not assess the trial protocol
Other bias Low risk If the study was stopped early, explain the
reasons:
• study not stopped early for benefit.
Describe any baseline imbalance:
• this seemed fine.
Describe any differential diagnosis:
• this seemed alright.
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AEDF :absent enddiastolicf low
AEDV: absent end diastolic velocity
AN: antenatal
BPD: bronchopulmonary dysplasia
BPP: biophysical profile
CS: caesarean section
CTG: cardiotocography
D:
EDV: end diastolic velocities
FHR: fetal heart rate
GA: gestational age
HT :
ITT: intention-to-treat
IUFD: intrauterine fetal death
IUGR: intrauterine growth retardation
IVH: intraventricular haemorrhage
min: minute
NEC: necrotising enterocolitis
NICU: neonatal intensive care unit
NS: not significant
NST: nonstress test
PNM:
PT L:pretermlabour
PROM: preterm rupture of membranes
RCT: randomised controlled trial
RDS: respiratory distress syndrome
S:
SAT :
SD:standarddeviation
SGA: small-for-gestational age
ST V :
UPI :
US: ultrasound
vs: versus
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Davies 1992 Participants were an “unselected population”.
Gonsoulin 1991 Full report not available.
Mason 1993 Participants were “low-risk primigravid women”.
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(Continued)
McCowan 1996 Conference abstract only but outcomes were comparing women with normal and abnormal Doppler ultrasound
readings, so not a randomised comparison
McParland 1988 This study was never reported in full although it has been partly reported in a review article (McParland 1988)
and a full manuscript was given to the review authors by Dr Pearce, who has been accused of publishing reports
of trials whose veracity cannot be confirmed (BJOG 1995). Consequently, the Doppler trial data are not now
thought by the review authors to be sufficiently reliable to be retained within this review.
Newnham 1993 Participants were an “unselected population”.
Omtzigt 1994 Participants were a “non-selected University Hospital population”
Pearce 1992 Dr Pearce has been accused of publishing reports of trials whose veracity cannot be confirmed (BJOG 1995).
Consequently, the Doppler trial data are not now thought by the reviewers to be sufficiently reliable to be retained
within this review.
Schneider 1992 Participants were an “unselected pregnant population”.
Whittle 1994 Participants were an “unselected population”.
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D A T A A N D A N A L Y S E S
Comparison 1. Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
16 10225 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.52, 0.98]
1.1 Singleton pregnancy 9 4661 Risk Ratio (M-H, Fixed, 95% CI) 0.59 [0.35, 1.01]
1.2 Multiple pregnancy 1 1052 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.32, 2.41]
1.3 Singleton plus multiple
pregnancies, or not stated
6 4512 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.51, 1.19]
2 Serious neonatal morbidity 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Singleton pregnancy 1 500 Risk Ratio (M-H, Random, 95% CI) 0.13 [0.02, 0.99]
2.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 Singleton plus multiple
pregnancies, or not stated
2 598 Risk Ratio (M-H, Random, 95% CI) 2.95 [0.31, 28.14]
3 Stillbirth 15 9560 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.41, 1.04]
3.1 Singleton pregnancy 8 3996 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.31, 1.19]
3.2 Multiple pregnancy 1 1052 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.11, 4.00]
3.3 Singleton plus multiple
pregnancy, or not stated
6 4512 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.35, 1.39]
4 Neonatal death 13 8167 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.53, 1.24]
4.1 Singleton pregnancy 7 2656 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.31, 1.53]
4.2 Multiple pregnancy 1 1052 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.29, 3.46]
4.3 Singleton plus multiple
pregnancies, or not stated
5 4459 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.48, 1.45]
5 Any potentially preventable
perinatal death*
16 10225 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.46, 0.98]
5.1 Singleton pregnancy 9 4661 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.30, 1.13]
5.2 Multiple pregnancy 1 1052 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.32, 2.41]
5.3 Singleton plus multiple
pregnancies or not stated
6 4512 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.41, 1.15]
6 Apgar < 7 at 5 minutes 7 6321 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.69, 1.24]
6.1 Singleton pregnancy 4 2555 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.45, 1.09]
6.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Singleton plus multiple
pregnancies or not stated
3 3766 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.77, 1.73]
7 Caesarean section (elective and
emergency)
14 7918 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.84, 0.97]
7.1 Singleton pregnancy 7 2929 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.75, 0.95]
7.2 Multiple pregnancy 1 526 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.77, 1.19]
7.3 Singleton plus multiple
pregnancies or not stated
6 4463 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.84, 1.05]
8 Caesarean section - elective 11 6627 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.93, 1.22]
8.1 Singleton pregnancy 6 1934 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.90, 1.38]
8.2 Multiple pregnancy 1 526 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.77, 1.47]
8.3 Singleton plus multiple
pregnancies or not stated
4 4167 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.84, 1.26]
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9 Caesarean section - emergency 10 6175 Risk Ratio (M-H, Random, 95% CI) 0.81 [0.67, 0.98]
9.1 Singleton pregnancy 5 1482 Risk Ratio (M-H, Random, 95% CI) 0.58 [0.43, 0.78]
9.2 Multiple pregnancy 1 526 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.57, 1.23]
9.3 Singleton plus multiple
pregnancies or not stated
4 4167 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.77, 1.20]
10 Spontaneous vaginal birth 5 2504 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.98, 1.10]
10.1 Singleton pregnancy 2 576 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.96, 1.18]
10.2 Multiple pregnancy 1 526 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.90, 1.19]
10.3 Singleton plus multiple
pregnancies or not stated
2 1402 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.95, 1.12]
11 Operative vaginal birth 4 2813 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.80, 1.14]
11.1 Singleton pregnancy 3 1916 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.78, 1.22]
11.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.68, 1.25]
12 Induction of labour 10 5633 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.80, 0.99]
12.1 Singleton pregnancy 5 1784 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.64, 0.97]
12.2 Multiple pregnancy 1 526 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.80, 1.50]
12.3 Singleton plus multiple
pregnancies or not stated
4 3323 Risk Ratio (M-H, Random, 95% CI) 0.95 [0.86, 1.04]
13 Infant requiring
intubation/ventilation
6 3136 Risk Ratio (M-H, Random, 95% CI) 1.42 [0.87, 2.30]
13.1 Singleton pregnancy 4 1539 Risk Ratio (M-H, Random, 95% CI) 2.89 [1.40, 5.96]
13.2 Multiple pregnancy 1 1052 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.59, 1.25]
13.3 Singleton plus multiple
pregnancies or not stated
1 545 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.79, 1.98]
14 Neonatal fitting/seizures 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.01, 8.49]
14.1 Singleton pregnancy 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.01, 8.49]
14.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Preterm labour 2 626 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.72, 1.75]
15.1 Singleton pregnancy 1 150 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.51, 2.07]
15.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.3 Singleton plus multiple
pregnancy or not stated
1 476 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.66, 2.11]
16 Gestational age at birth (weeks) 8 4066 Mean Difference (IV, Random, 95% CI) 0.21 [-0.02, 0.43]
16.1 Singleton pregnancy 3 1043 Mean Difference (IV, Random, 95% CI) 0.54 [-0.00, 1.09]
16.2 Multiple pregnancy 1 1052 Mean Difference (IV, Random, 95% CI) 0.10 [-0.24, 0.44]
16.3 Singleton plus multiple
pregnancies or not stated
4 1971 Mean Difference (IV, Random, 95% CI) 0.06 [-0.19, 0.31]
17 Infant respiratory distress
syndrome (RDS)
1 107 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.07, 16.48]
17.1 Singleton pregnancy 1 107 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.07, 16.48]
17.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Neonatal admission to SCBU
and/or NICU
12 9334 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.89, 1.03]
18.1 Singleton pregnancy 8 4511 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.80, 1.06]
18.2 Multiple pregnancy 1 1052 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.88, 1.05]
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18.3 Singleton plus multiple
pregnancies or not stated
3 3771 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.85, 1.14]
19 Hypoxic ischaemic
encephalopathy
2 1045 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.01, 33.07]
19.1 Singleton pregnancy 1 500 Risk Ratio (M-H, Random, 95% CI) 0.09 [0.01, 1.64]
19.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
19.3 Singleton plus multiple
pregnancies or not stated
1 545 Risk Ratio (M-H, Random, 95% CI) 4.91 [0.24, 101.79]
20 Intraventricular haemorrhage 4 2008 Risk Ratio (M-H, Fixed, 95% CI) 1.42 [0.47, 4.30]
20.1 Singleton pregnancy 3 1463 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [0.38, 4.16]
20.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 Singleton plus multiple
pregnancies or not stated
1 545 Risk Ratio (M-H, Fixed, 95% CI) 2.95 [0.12, 71.99]
21 Birthweight (grams) 7 3887 Mean Difference (IV, Fixed, 95% CI) 31.33 [-8.70, 71.37]
21.1 Singleton pregnancy 3 1916 Mean Difference (IV, Fixed, 95% CI) 49.34 [-0.62, 99.31]
21.2 Multiple pregnancy 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21.3 Singleton plus multiple
pregnancies or not stated
4 1971 Mean Difference (IV, Fixed, 95% CI) -0.95 [-67.84, 65.
95]
22 Length of infant hospital stay
(days)
3 1076 Std. Mean Difference (IV, Fixed, 95% CI) -0.28 [-0.40, -0.16]
22.1 Singleton pregnancy 3 1076 Std. Mean Difference (IV, Fixed, 95% CI) -0.28 [-0.40, -0.16]
22.2 Multiple pregnancy 0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
22.3 Singleton plus multiple
pregnancies or not stated
0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Birth < 34 weeks (not
prespecified)
2 976 Risk Ratio (M-H, Random, 95% CI) 2.04 [0.62, 6.69]
23.1 Singleton pregnancy 1 500 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.40, 3.42]
23.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
23.3 Singleton plus multiple
pregnancies or not stated
1 476 Risk Ratio (M-H, Random, 95% CI) 3.90 [1.11, 13.65]
24 Antenatal admissions (not
prespecified)
2 893 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.60, 0.88]
24.1 Singleton pregnancy 2 893 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.60, 0.88]
24.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
25 Phototherapy for neonatal
jaundice (not prespecified)
1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.15 [0.01, 2.87]
25.1 Singleton pregnancy 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.15 [0.01, 2.87]
25.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
25.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
26 Abnormal neurological
development at 9 months (not
prespecified)
1 137 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.26, 1.45]
26.1 Singleton pregnancy 1 137 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.26, 1.45]
26.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
26.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
27 Hospitalisation for IUGR
neonatal (not prespecified)
1 142 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.75, 1.41]
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27.1 Singleton pregnancy 1 142 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.75, 1.41]
27.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
27.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
28 Fetal distress in labour (not
prespecified)
1 289 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.10, 1.22]
28.1 Singleton pregnancy 1 289 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.10, 1.22]
28.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
28.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
29 Birthweight < 5 percentile (not
prespecified)
1 289 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.51, 2.64]
29.1 Singleton pregnancy 1 289 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.51, 2.64]
29.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
29.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
30 Periventricular leucomalacia
(not prespecified)
1 545 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.00]
30.1 Singleton pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
30.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
30.3 Singleton plus multiple
pregnancies or not stated
1 545 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.00]
31 Antenatal hospital stay (days)
(not prespecified)
1 426 Mean Difference (IV, Fixed, 95% CI) -0.60 [-2.39, 1.19]
31.1 Singleton pregnancy 1 426 Mean Difference (IV, Fixed, 95% CI) -0.60 [-2.39, 1.19]
31.2 Multiple pregnancy 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
31.3 Singleton plus multiple
pregnancies or not stated
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 2. Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 SGA/IUGR 5 1292 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.38, 1.35]
1.2 Hypertension/pre-
eclampsia
1 89 Risk Ratio (M-H, Fixed, 95% CI) 3.57 [0.42, 30.73]
1.3 Diabetes 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Prolonged pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Previous pregnancy loss 1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.26 [0.03, 2.17]
2 Serious neonatal morbidity 1 53 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.1 SGA/IUGR 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Hypertension/pre-
eclampsia
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 Diabetes 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.4 Prolonged pregnancy 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.5 Previous pregnancy loss 1 53 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 3. Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
4 2813 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.17, 1.15]
1.1 Singleton pregnancy 3 1916 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.07, 1.68]
1.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.52 [0.16, 1.73]
2 Stillbirth 4 2813 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.14, 1.71]
2.1 Singleton pregnancy 3 1916 Risk Ratio (M-H, Fixed, 95% CI) 0.28 [0.05, 1.70]
2.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.15, 7.41]
3 Neonatal death 3 1473 Risk Ratio (M-H, Fixed, 95% CI) 0.52 [0.16, 1.72]
3.1 Singleton pregnancy 2 576 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.15, 7.10]
3.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.07, 1.72]
4 Any potentially preventable
perinatal death*
4 2813 Risk Ratio (M-H, Fixed, 95% CI) 0.38 [0.12, 1.18]
4.1 Singleton pregnancy 3 1916 Risk Ratio (M-H, Fixed, 95% CI) 0.41 [0.08, 2.11]
4.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.07, 1.72]
5 Apgar < 7 at 5 minutes 3 2663 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.54, 1.37]
5.1 Singleton pregnancy 2 1766 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.49, 1.43]
5.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.36, 2.39]
6 Caesarean section (elective and
emergency)
4 2813 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.79, 1.01]
6.1 Singleton pregnancy 3 1916 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.77, 1.02]
6.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.14]
7 Caesarean section - elective 3 1473 Risk Ratio (M-H, Fixed, 95% CI) 1.53 [1.12, 2.09]
7.1 Singleton pregnancy 2 576 Risk Ratio (M-H, Fixed, 95% CI) 1.69 [1.07, 2.67]
7.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 1.40 [0.91, 2.15]
8 Caesarean section - emergency 3 1473 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.52, 0.84]
8.1 Singleton pregnancy 2 576 Risk Ratio (M-H, Fixed, 95% CI) 0.55 [0.36, 0.83]
8.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.73 [0.55, 0.98]
9 Spontaneous vaginal birth 2 1323 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.97, 1.15]
9.1 Singleton pregnancy 1 426 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.91, 1.19]
9.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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9.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.95, 1.19]
10 Operative vaginal birth 3 2663 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.81, 1.17]
10.1 Singleton pregnancy 2 1766 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.80, 1.27]
10.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.68, 1.25]
11 Induction of labour 2 576 Risk Ratio (M-H, Random, 95% CI) 0.67 [0.32, 1.40]
11.1 Singleton pregnancy 2 576 Risk Ratio (M-H, Random, 95% CI) 0.67 [0.32, 1.40]
11.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
11.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
12 Infant requiring
intubation/ventilation
2 576 Risk Ratio (M-H, Fixed, 95% CI) 1.54 [0.26, 9.08]
12.1 Singleton pregnancy 2 576 Risk Ratio (M-H, Fixed, 95% CI) 1.54 [0.26, 9.08]
12.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Neonatal fitting/seizures 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.01, 8.49]
13.1 Singleton pregnancy 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.01, 8.49]
13.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Gestational age at birth 3 1473 Mean Difference (IV, Fixed, 95% CI) 0.23 [-0.00, 0.47]
14.1 Singleton pregnancy 2 576 Mean Difference (IV, Fixed, 95% CI) 0.26 [-0.06, 0.59]
14.2 Multiple pregnancy 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 Singleton plus multiple
pregnancies or not stated
1 897 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.15, 0.55]
15 Neonatal admission to SCBU
and/or NICU
4 2813 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.73, 1.03]
15.1 Singleton pregnancy 3 1916 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.64, 0.99]
15.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.3 Singleton plus multiple
pregnancies or not stated
1 897 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.73, 1.37]
16 Infant birthweight (grams) 4 2813 Mean Difference (IV, Fixed, 95% CI) 38.41 [-6.14, 82.97]
16.1 Singleton pregnancy 3 1916 Mean Difference (IV, Fixed, 95% CI) 49.34 [-0.62, 99.31]
16.2 Multiple pregnancy 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.3 Singleton plus multiple
pregnancies or not stated
1 897 Mean Difference (IV, Fixed, 95% CI) -4.0 [-102.42, 94.
42]
17 Length of infant hospital stay
(days)
2 576 Std. Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.41, -0.08]
17.1 Singleton pregnancy 2 576 Std. Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.41, -0.08]
17.2 Multiple pregnancy 0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17.3 Singleton plus multiple
pregnancies or not stated
0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Antenatal admissions (not
prespecified)
1 426 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.55, 0.90]
18.1 Singleton pregnancy 1 426 Risk Ratio (M-H, Fixed, 95% CI) 0.70 [0.55, 0.90]
18.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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19 Phototherapy for neonatal
jaundice (not prespecified)
1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.15 [0.01, 2.87]
19.1 Singleton pregnancy 1 150 Risk Ratio (M-H, Fixed, 95% CI) 0.15 [0.01, 2.87]
19.2 Multiple pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.3 Singleton plus multiple
pregnancies or not stated
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Antenatal hospital stay (days)
(not prespecified)
1 426 Mean Difference (IV, Fixed, 95% CI) -0.60 [-2.39, 1.19]
20.1 Singleton pregnancy 1 426 Mean Difference (IV, Fixed, 95% CI) -0.60 [-2.39, 1.19]
20.2 Multiple pregnancy 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.3 Singleton plus multiple
pregnancies or not stated
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 4. Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 SGA/IUGR 2 572 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.05, 2.09]
1.2 Hypertension/pre-
eclampsia
1 89 Risk Ratio (M-H, Fixed, 95% CI) 3.57 [0.42, 30.73]
1.3 Diabetes 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Prolonged pregnancy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Previous pregnancy loss 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 5. Early ductus venosus Doppler ultrasound versus CTG
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.39, 1.82]
1.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.39, 1.82]
2 Survival following severe
neonatal morbidity
1 333 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.75, 1.61]
3 Stillbirth 1 333 Risk Ratio (M-H, Fixed, 95% CI) 1.99 [0.37, 10.71]
3.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 1.99 [0.37, 10.71]
4 Neonatal death 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.22, 1.60]
4.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.22, 1.60]
5 Any potentially preventable
perinatal death*
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.37, 1.86]
5.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.37, 1.86]
6 Fetal acidosis 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.25 [0.03, 2.20]
6.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.25 [0.03, 2.20]
7 Apgar < 7 at 5 minutes 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.44, 1.72]
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7.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.44, 1.72]
8 Infant requiring
intubation/ventilation
1 333 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.67, 1.13]
8.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.67, 1.13]
9 Intraventricular haemorrhage 1 333 Risk Ratio (M-H, Fixed, 95% CI) 8.95 [0.49, 164.87]
9.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 8.95 [0.49, 164.87]
10 Bronchopulmonary dysplasia 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.55, 1.38]
10.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.55, 1.38]
11 Necrotising enterocolitis 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.03, 3.15]
11.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.03, 3.15]
12 Infant birthweight (grams) 1 333 Mean Difference (IV, Fixed, 95% CI) 38.0 [-31.53, 107.
53]
12.1 Singleton pregnancy 1 333 Mean Difference (IV, Fixed, 95% CI) 38.0 [-31.53, 107.
53]
13 Long-term infant
neurodevelopmental outcome
(impairment at 2 years)
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.30, 1.18]
13.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.30, 1.18]
14 Long-term infant
neurodevelopmental outcome
(cerebral palsy at 2 years)
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.02, 1.68]
14.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.02, 1.68]
15 Infant survival at 2 years
without neurodevelopmental
impairment (not prespecified)
1 333 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.92, 1.23]
15.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.92, 1.23]
16 Sepsis (proven) (not
prespecified)
1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.60, 1.45]
16.1 Singleton pregnancy 1 333 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.60, 1.45]
Comparison 6. Late ductus venosus Doppler ultrasound versus CTG
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.64, 2.55]
1.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.64, 2.55]
2 Survival following severe
neonatal morbidity
1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.66, 1.45]
3 Stillbirth 1 336 Risk Ratio (M-H, Fixed, 95% CI) 2.93 [0.60, 14.31]
3.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 2.93 [0.60, 14.31]
4 Neonatal death 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.47, 2.46]
4.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.47, 2.46]
5 Any potentially preventable
perinatal death*
1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.59, 2.53]
5.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.59, 2.53]
6 Fetal acidosis 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.11 [0.01, 2.00]
6.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.11 [0.01, 2.00]
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7 Apgar < 7 at 5 minutes 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.69, 2.37]
7.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.69, 2.37]
8 Infant requiring
intubation/ventilation
1 336 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.73, 1.20]
8.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.73, 1.20]
9 Intraventricular haemorrhage 1 336 Risk Ratio (M-H, Fixed, 95% CI) 16.60 [0.97, 285.35]
9.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 16.60 [0.97, 285.35]
10 Bronchopulmonary dysplasia 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.61, 1.48]
10.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.61, 1.48]
11 Necrotising enterocolitis 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.20, 4.77]
11.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.20, 4.77]
12 Infant birthweight (grams) 1 336 Mean Difference (IV, Fixed, 95% CI) 25.0 [-40.06, 90.06]
12.1 Singleton pregnancy 1 336 Mean Difference (IV, Fixed, 95% CI) 25.0 [-40.06, 90.06]
13 Long-term infant
neurodevelopmental outcome
(impairment at 2 years)
1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.15, 0.79]
13.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.15, 0.79]
14 Long-term infant
neurodevelopmental outcome
(cerebral palsy at 2 years)
1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.09 [0.00, 1.59]
14.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.09 [0.00, 1.59]
15 Infant survival at 2 years
without neurodevelopmental
impairment (not prespecified)
1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [1.02, 1.34]
15.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [1.02, 1.34]
16 Sepsis (proven) (not
prespecified)
1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.42, 1.11]
16.1 Singleton pregnancy 1 336 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.42, 1.11]
Comparison 7. Early ductus venosus Doppler ultrasound versus late
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any perinatal death after
randomisation
1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.32, 1.36]
1.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.32, 1.36]
2 Survival following severe
neonatal morbidity
1 337 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.77, 1.65]
3 Stillbirth 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.20, 2.36]
3.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.20, 2.36]
4 Neonatal death 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.21, 1.47]
4.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.21, 1.47]
5 Any potentially preventable
perinatal death*
1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.31, 1.47]
5.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.31, 1.47]
6 Fetal acidosis 1 337 Risk Ratio (M-H, Fixed, 95% CI) 3.05 [0.13, 74.43]
6.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 3.05 [0.13, 74.43]
7 Apgar < 7 at 5 minutes 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.36, 1.29]
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7.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.36, 1.29]
8 Infant requiring
intubation/ventilation
1 337 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.71, 1.21]
8.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.71, 1.21]
9 Intraventricular haemorrhage 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.16, 1.66]
9.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.16, 1.66]
10 Bronchopulmonary dysplasia 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.58, 1.46]
10.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.58, 1.46]
11 Necrotising enterocolitis 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.04, 3.23]
11.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.04, 3.23]
12 Infant birthweight (grams) 1 337 Mean Difference (IV, Fixed, 95% CI) 13.0 [-59.31, 85.31]
12.1 Singleton pregnancy 1 337 Mean Difference (IV, Fixed, 95% CI) 13.0 [-59.31, 85.31]
13 Long-term infant
neurodevelopmental outcome
(impairment at 2 years)
1 337 Risk Ratio (M-H, Fixed, 95% CI) 1.75 [0.70, 4.32]
13.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 1.75 [0.70, 4.32]
14 Long-term infant
neurodevelopmental outcome
(cerebral palsy at 2 years)
1 337 Risk Ratio (M-H, Fixed, 95% CI) 3.05 [0.13, 74.43]
14.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 3.05 [0.13, 74.43]
15 Infant survival at 2 years
without neurodevelopmental
impairment (not prespecified)
1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.80, 1.03]
15.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.80, 1.03]
16 Sepsis (proven) (not
prespecified)
1 337 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.84, 2.25]
16.1 Singleton pregnancy 1 337 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.84, 2.25]
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Analysis 1.1. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 1
Any perinatal death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Trudinger 1987 1/127 5/162 4.9 % 0.26 [ 0.03, 2.16 ]
Tyrrell 1990 3/250 3/250 3.3 % 1.00 [ 0.20, 4.91 ]
Biljan 1992 1/338 4/336 4.5 % 0.25 [ 0.03, 2.21 ]
Almstrom 1992 0/214 3/212 3.9 % 0.14 [ 0.01, 2.72 ]
Neales 1994 [pers comm] 11/236 14/231 15.7 % 0.77 [ 0.36, 1.66 ]
Nienhuis 1997 2/74 3/76 3.3 % 0.68 [ 0.12, 3.98 ]
Haley 1997 1/73 1/77 1.1 % 1.05 [ 0.07, 16.55 ]
Ott 1998 1/348 1/317 1.2 % 0.91 [ 0.06, 14.50 ]
Williams 2003 0/649 1/691 1.6 % 0.35 [ 0.01, 8.70 ]
Subtotal (95% CI) 2309 2352 39.4 % 0.59 [ 0.35, 1.01 ]
Total events: 20 (Doppler US), 35 (No Doppler US)
Heterogeneity: Chi2 = 3.35, df = 8 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.054)
2 Multiple pregnancy
Giles 2003 7/524 8/528 8.9 % 0.88 [ 0.32, 2.41 ]
Subtotal (95% CI) 524 528 8.9 % 0.88 [ 0.32, 2.41 ]
Total events: 7 (Doppler US), 8 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.81)
3 Singleton plus multiple pregnancies, or not stated
Newnham 1991 9/275 9/270 10.1 % 0.98 [ 0.40, 2.44 ]
Hofmeyr 1991 4/438 8/459 8.7 % 0.52 [ 0.16, 1.73 ]
Norman 1992 1/26 4/27 4.4 % 0.26 [ 0.03, 2.17 ]
Burke 1992 4/241 3/235 3.4 % 1.30 [ 0.29, 5.75 ]
Johnstone 1993 12/1132 16/1197 17.3 % 0.79 [ 0.38, 1.67 ]
Pattinson 1994 6/108 7/104 7.9 % 0.83 [ 0.29, 2.37 ]
Subtotal (95% CI) 2220 2292 51.7 % 0.78 [ 0.51, 1.19 ]
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(. . . Continued)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 36 (Doppler US), 47 (No Doppler US)
Heterogeneity: Chi2 = 2.17, df = 5 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 1.15 (P = 0.25)
Total (95% CI) 5053 5172 100.0 % 0.71 [ 0.52, 0.98 ]
Total events: 63 (Doppler US), 90 (No Doppler US)
Heterogeneity: Chi2 = 5.99, df = 15 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.037)
Test for subgroup differences: Chi2 = 0.80, df = 2 (P = 0.67), I2 =0.0%
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
Analysis 1.2. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 2
Serious neonatal morbidity.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 2 Serious neonatal morbidity
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Tyrrell 1990 1/250 8/250 100.0 % 0.13 [ 0.02, 0.99 ]
Subtotal (95% CI) 250 250 100.0 % 0.13 [ 0.02, 0.99 ]
Total events: 1 (Doppler US), 8 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.97 (P = 0.049)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies, or not stated
Newnham 1991 3/275 1/270 100.0 % 2.95 [ 0.31, 28.14 ]
0.01 0.1 1 10 100
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(. . . Continued)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Norman 1992 0/26 0/27 Not estimable
Subtotal (95% CI) 301 297 100.0 % 2.95 [ 0.31, 28.14 ]
Total events: 3 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Chi2 = 4.09, df = 1 (P = 0.04), I2 =76%
0.01 0.1 1 10 100
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Analysis 1.3. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 3
Stillbirth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 3 Stillbirth
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 0/214 2/212 5.6 % 0.20 [ 0.01, 4.10 ]
Biljan 1992 1/338 2/336 4.5 % 0.50 [ 0.05, 5.46 ]
Haley 1997 0/73 1/77 3.3 % 0.35 [ 0.01, 8.49 ]
Neales 1994 [pers comm] 6/236 9/231 20.4 % 0.65 [ 0.24, 1.80 ]
Nienhuis 1997 1/74 3/76 6.6 % 0.34 [ 0.04, 3.22 ]
Trudinger 1987 1/127 2/162 3.9 % 0.64 [ 0.06, 6.95 ]
Tyrrell 1990 3/250 1/250 2.2 % 3.00 [ 0.31, 28.65 ]
Williams 2003 0/649 1/691 3.3 % 0.35 [ 0.01, 8.70 ]
Subtotal (95% CI) 1961 2035 49.8 % 0.61 [ 0.31, 1.19 ]
Total events: 12 (Doppler US), 21 (No Doppler US)
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(. . . Continued)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 2.97, df = 7 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.44 (P = 0.15)
2 Multiple pregnancy
Giles 2003 2/524 3/528 6.7 % 0.67 [ 0.11, 4.00 ]
Subtotal (95% CI) 524 528 6.7 % 0.67 [ 0.11, 4.00 ]
Total events: 2 (Doppler US), 3 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
3 Singleton plus multiple pregnancy, or not stated
Burke 1992 3/241 2/235 4.5 % 1.46 [ 0.25, 8.67 ]
Hofmeyr 1991 2/438 2/459 4.4 % 1.05 [ 0.15, 7.41 ]
Johnstone 1993 4/1132 4/1197 8.7 % 1.06 [ 0.27, 4.22 ]
Newnham 1991 3/275 2/270 4.5 % 1.47 [ 0.25, 8.74 ]
Norman 1992 1/26 4/27 8.8 % 0.26 [ 0.03, 2.17 ]
Pattinson 1994 0/108 5/104 12.5 % 0.09 [ 0.00, 1.56 ]
Subtotal (95% CI) 2220 2292 43.5 % 0.70 [ 0.35, 1.39 ]
Total events: 13 (Doppler US), 19 (No Doppler US)
Heterogeneity: Chi2 = 4.67, df = 5 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.01 (P = 0.31)
Total (95% CI) 4705 4855 100.0 % 0.65 [ 0.41, 1.04 ]
Total events: 27 (Doppler US), 43 (No Doppler US)
Heterogeneity: Chi2 = 7.87, df = 14 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.80 (P = 0.072)
Test for subgroup differences: Chi2 = 0.08, df = 2 (P = 0.96), I2 =0.0%
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Analysis 1.4. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 4
Neonatal death.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 4 Neonatal death
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Trudinger 1987 0/127 3/162 6.5 % 0.18 [ 0.01, 3.49 ]
Tyrrell 1990 0/250 2/250 5.3 % 0.20 [ 0.01, 4.14 ]
Almstrom 1992 0/214 1/212 3.2 % 0.33 [ 0.01, 8.06 ]
Biljan 1992 0/338 1/336 3.2 % 0.33 [ 0.01, 8.11 ]
Neales 1994 [pers comm] 5/236 5/231 10.7 % 0.98 [ 0.29, 3.34 ]
Nienhuis 1997 1/74 0/76 1.0 % 3.08 [ 0.13, 74.42 ]
Haley 1997 1/73 0/77 1.0 % 3.16 [ 0.13, 76.40 ]
Subtotal (95% CI) 1312 1344 31.0 % 0.69 [ 0.31, 1.53 ]
Total events: 7 (Doppler US), 12 (No Doppler US)
Heterogeneity: Chi2 = 3.87, df = 6 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 0.91 (P = 0.36)
2 Multiple pregnancy
Giles 2003 5/524 5/528 10.5 % 1.01 [ 0.29, 3.46 ]
Subtotal (95% CI) 524 528 10.5 % 1.01 [ 0.29, 3.46 ]
Total events: 5 (Doppler US), 5 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
3 Singleton plus multiple pregnancies, or not stated
Hofmeyr 1991 2/438 6/459 12.4 % 0.35 [ 0.07, 1.72 ]
Johnstone 1993 8/1132 12/1197 24.7 % 0.70 [ 0.29, 1.72 ]
Newnham 1991 6/275 7/270 15.0 % 0.84 [ 0.29, 2.47 ]
Burke 1992 1/241 1/235 2.1 % 0.98 [ 0.06, 15.50 ]
Pattinson 1994 6/108 2/104 4.3 % 2.89 [ 0.60, 13.99 ]
Subtotal (95% CI) 2194 2265 58.5 % 0.84 [ 0.48, 1.45 ]
Total events: 23 (Doppler US), 28 (No Doppler US)
Heterogeneity: Chi2 = 3.68, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.52)
Total (95% CI) 4030 4137 100.0 % 0.81 [ 0.53, 1.24 ]
Total events: 35 (Doppler US), 45 (No Doppler US)
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(. . . Continued)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 7.67, df = 12 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.98 (P = 0.33)
Test for subgroup differences: Chi2 = 0.29, df = 2 (P = 0.86), I2 =0.0%
0.02 0.1 1 10 50
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Analysis 1.5. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 5
Any potentially preventable perinatal death*.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 5 Any potentially preventable perinatal death*
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 0/214 2/212 3.8 % 0.20 [ 0.01, 4.10 ]
Biljan 1992 1/338 3/336 4.6 % 0.33 [ 0.03, 3.17 ]
Haley 1997 1/73 1/77 1.5 % 1.05 [ 0.07, 16.55 ]
Neales 1994 [pers comm] 8/236 9/231 13.9 % 0.87 [ 0.34, 2.22 ]
Nienhuis 1997 1/74 2/76 3.0 % 0.51 [ 0.05, 5.54 ]
Ott 1998 0/348 0/317 Not estimable
Trudinger 1987 0/127 2/162 3.4 % 0.25 [ 0.01, 5.26 ]
Tyrrell 1990 1/250 2/250 3.1 % 0.50 [ 0.05, 5.48 ]
Williams 2003 0/649 1/691 2.2 % 0.35 [ 0.01, 8.70 ]
Subtotal (95% CI) 2309 2352 35.5 % 0.58 [ 0.30, 1.13 ]
Total events: 12 (Doppler US), 22 (No Doppler US)
Heterogeneity: Chi2 = 2.02, df = 7 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 1.59 (P = 0.11)
2 Multiple pregnancy
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(. . . Continued)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Giles 2003 7/524 8/528 12.2 % 0.88 [ 0.32, 2.41 ]
Subtotal (95% CI) 524 528 12.2 % 0.88 [ 0.32, 2.41 ]
Total events: 7 (Doppler US), 8 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.81)
3 Singleton plus multiple pregnancies or not stated
Burke 1992 3/241 2/235 3.1 % 1.46 [ 0.25, 8.67 ]
Hofmeyr 1991 2/438 6/459 9.0 % 0.35 [ 0.07, 1.72 ]
Johnstone 1993 5/1132 8/1197 11.9 % 0.66 [ 0.22, 2.01 ]
Newnham 1991 7/275 7/270 10.8 % 0.98 [ 0.35, 2.76 ]
Norman 1992 0/26 4/27 6.7 % 0.12 [ 0.01, 2.04 ]
Pattinson 1994 6/108 7/104 10.9 % 0.83 [ 0.29, 2.37 ]
Subtotal (95% CI) 2220 2292 52.4 % 0.69 [ 0.41, 1.15 ]
Total events: 23 (Doppler US), 34 (No Doppler US)
Heterogeneity: Chi2 = 3.45, df = 5 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.43 (P = 0.15)
Total (95% CI) 5053 5172 100.0 % 0.67 [ 0.46, 0.98 ]
Total events: 42 (Doppler US), 64 (No Doppler US)
Heterogeneity: Chi2 = 5.82, df = 14 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 2.05 (P = 0.040)
Test for subgroup differences: Chi2 = 0.46, df = 2 (P = 0.79), I2 =0.0%
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Analysis 1.6. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 6
Apgar < 7 at 5 minutes.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 6 Apgar < 7 at 5 minutes
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 4/214 5/212 5.6 % 0.79 [ 0.22, 2.91 ]
Trudinger 1987 6/127 8/162 7.8 % 0.96 [ 0.34, 2.69 ]
Tyrrell 1990 3/250 12/250 13.3 % 0.25 [ 0.07, 0.88 ]
Williams 2003 19/649 24/691 25.7 % 0.84 [ 0.47, 1.52 ]
Subtotal (95% CI) 1240 1315 52.4 % 0.70 [ 0.45, 1.09 ]
Total events: 32 (Doppler US), 49 (No Doppler US)
Heterogeneity: Chi2 = 3.35, df = 3 (P = 0.34); I2 =10%
Test for overall effect: Z = 1.57 (P = 0.12)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 8/438 9/459 9.7 % 0.93 [ 0.36, 2.39 ]
Johnstone 1993 26/1128 29/1196 31.2 % 0.95 [ 0.56, 1.60 ]
Newnham 1991 15/275 6/270 6.7 % 2.45 [ 0.97, 6.23 ]
Subtotal (95% CI) 1841 1925 47.6 % 1.16 [ 0.77, 1.73 ]
Total events: 49 (Doppler US), 44 (No Doppler US)
Heterogeneity: Chi2 = 3.25, df = 2 (P = 0.20); I2 =38%
Test for overall effect: Z = 0.72 (P = 0.47)
Total (95% CI) 3081 3240 100.0 % 0.92 [ 0.69, 1.24 ]
Total events: 81 (Doppler US), 93 (No Doppler US)
Heterogeneity: Chi2 = 8.57, df = 6 (P = 0.20); I2 =30%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Chi2 = 2.70, df = 1 (P = 0.10), I2 =63%
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Analysis 1.7. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 7
Caesarean section (elective and emergency).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 7 Caesarean section (elective and emergency)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 58/214 62/212 6.0 % 0.93 [ 0.68, 1.26 ]
De Rochambeau 1992 2/52 7/55 0.7 % 0.30 [ 0.07, 1.39 ]
Haley 1997 16/73 19/77 1.8 % 0.89 [ 0.50, 1.59 ]
Neales 1994 [pers comm] 59/236 76/231 7.4 % 0.76 [ 0.57, 1.01 ]
Nienhuis 1997 8/74 11/76 1.0 % 0.75 [ 0.32, 1.75 ]
Trudinger 1987 38/127 59/162 5.0 % 0.82 [ 0.59, 1.15 ]
Williams 2003 183/649 223/691 20.8 % 0.87 [ 0.74, 1.03 ]
Subtotal (95% CI) 1425 1504 42.6 % 0.84 [ 0.75, 0.95 ]
Total events: 364 (Doppler US), 457 (No Doppler US)
Heterogeneity: Chi2 = 2.92, df = 6 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 2.86 (P = 0.0043)
2 Multiple pregnancy
Giles 2003 98/262 103/264 9.9 % 0.96 [ 0.77, 1.19 ]
Subtotal (95% CI) 262 264 9.9 % 0.96 [ 0.77, 1.19 ]
Total events: 98 (Doppler US), 103 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
3 Singleton plus multiple pregnancies or not stated
Burke 1992 58/241 50/235 4.9 % 1.13 [ 0.81, 1.58 ]
Hofmeyr 1991 107/438 123/459 11.5 % 0.91 [ 0.73, 1.14 ]
Johnstone 1993 170/1114 198/1175 18.5 % 0.91 [ 0.75, 1.09 ]
Newnham 1991 94/254 89/251 8.6 % 1.04 [ 0.83, 1.32 ]
Nimrod 1992 20/116 30/127 2.8 % 0.73 [ 0.44, 1.21 ]
Norman 1992 10/26 13/27 1.2 % 0.80 [ 0.43, 1.49 ]
Subtotal (95% CI) 2189 2274 47.5 % 0.94 [ 0.84, 1.05 ]
Total events: 459 (Doppler US), 503 (No Doppler US)
Heterogeneity: Chi2 = 3.41, df = 5 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.29)
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Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 3876 4042 100.0 % 0.90 [ 0.84, 0.97 ]
Total events: 921 (Doppler US), 1063 (No Doppler US)
Heterogeneity: Chi2 = 8.44, df = 13 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 2.68 (P = 0.0073)
Test for subgroup differences: Chi2 = 2.15, df = 2 (P = 0.34), I2 =7%
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Analysis 1.8. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 8
Caesarean section - elective.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 8 Caesarean section - elective
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 37/214 22/212 6.2 % 1.67 [ 1.02, 2.73 ]
Haley 1997 7/73 4/77 1.1 % 1.85 [ 0.56, 6.04 ]
Neales 1994 [pers comm] 43/236 56/231 15.9 % 0.75 [ 0.53, 1.07 ]
Nienhuis 1997 6/74 4/76 1.1 % 1.54 [ 0.45, 5.24 ]
Trudinger 1987 25/127 28/162 6.9 % 1.14 [ 0.70, 1.85 ]
Tyrrell 1990 26/230 20/222 5.7 % 1.25 [ 0.72, 2.18 ]
Subtotal (95% CI) 954 980 36.9 % 1.11 [ 0.90, 1.38 ]
Total events: 144 (Doppler US), 134 (No Doppler US)
Heterogeneity: Chi2 = 8.47, df = 5 (P = 0.13); I2 =41%
Test for overall effect: Z = 0.96 (P = 0.34)
2 Multiple pregnancy
Giles 2003 58/262 55/264 15.4 % 1.06 [ 0.77, 1.47 ]
Subtotal (95% CI) 262 264 15.4 % 1.06 [ 0.77, 1.47 ]
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(. . . Continued)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 58 (Doppler US), 55 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
3 Singleton plus multiple pregnancies or not stated
Burke 1992 37/241 30/235 8.5 % 1.20 [ 0.77, 1.88 ]
Hofmeyr 1991 44/438 33/459 9.0 % 1.40 [ 0.91, 2.15 ]
Johnstone 1993 63/1114 73/1175 19.9 % 0.91 [ 0.66, 1.26 ]
Newnham 1991 29/254 36/251 10.2 % 0.80 [ 0.50, 1.26 ]
Subtotal (95% CI) 2047 2120 47.7 % 1.03 [ 0.84, 1.26 ]
Total events: 173 (Doppler US), 172 (No Doppler US)
Heterogeneity: Chi2 = 4.15, df = 3 (P = 0.25); I2 =28%
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 3263 3364 100.0 % 1.07 [ 0.93, 1.22 ]
Total events: 375 (Doppler US), 361 (No Doppler US)
Heterogeneity: Chi2 = 12.74, df = 10 (P = 0.24); I2 =22%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Chi2 = 0.25, df = 2 (P = 0.88), I2 =0.0%
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Analysis 1.9. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 9
Caesarean section - emergency.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 9 Caesarean section - emergency
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Almstrom 1992 21/214 40/212 9.6 % 0.52 [ 0.32, 0.85 ]
Haley 1997 9/73 15/77 5.1 % 0.63 [ 0.30, 1.36 ]
Neales 1994 [pers comm] 16/236 20/231 6.8 % 0.78 [ 0.42, 1.47 ]
Nienhuis 1997 2/74 7/76 1.5 % 0.29 [ 0.06, 1.37 ]
Trudinger 1987 13/127 31/162 7.3 % 0.53 [ 0.29, 0.98 ]
Subtotal (95% CI) 724 758 30.2 % 0.58 [ 0.43, 0.78 ]
Total events: 61 (Doppler US), 113 (No Doppler US)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.93, df = 4 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 3.65 (P = 0.00026)
2 Multiple pregnancy
Giles 2003 40/262 48/264 12.7 % 0.84 [ 0.57, 1.23 ]
Subtotal (95% CI) 262 264 12.7 % 0.84 [ 0.57, 1.23 ]
Total events: 40 (Doppler US), 48 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.89 (P = 0.37)
3 Singleton plus multiple pregnancies or not stated
Burke 1992 21/241 20/235 7.6 % 1.02 [ 0.57, 1.84 ]
Hofmeyr 1991 63/438 90/459 16.0 % 0.73 [ 0.55, 0.98 ]
Johnstone 1993 117/1114 125/1175 18.4 % 0.99 [ 0.78, 1.25 ]
Newnham 1991 65/254 53/251 15.1 % 1.21 [ 0.88, 1.67 ]
Subtotal (95% CI) 2047 2120 57.1 % 0.96 [ 0.77, 1.20 ]
Total events: 266 (Doppler US), 288 (No Doppler US)
Heterogeneity: Tau2 = 0.02; Chi2 = 5.38, df = 3 (P = 0.15); I2 =44%
Test for overall effect: Z = 0.35 (P = 0.72)
Total (95% CI) 3033 3142 100.0 % 0.81 [ 0.67, 0.98 ]
Total events: 367 (Doppler US), 449 (No Doppler US)
Heterogeneity: Tau2 = 0.04; Chi2 = 16.21, df = 9 (P = 0.06); I2 =44%
Test for overall effect: Z = 2.13 (P = 0.033)
Test for subgroup differences: Chi2 = 7.47, df = 2 (P = 0.02), I2 =73%
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Analysis 1.10. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
10 Spontaneous vaginal birth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 10 Spontaneous vaginal birth
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 148/214 141/212 18.5 % 1.04 [ 0.91, 1.19 ]
Nienhuis 1997 63/74 57/76 7.3 % 1.14 [ 0.97, 1.33 ]
Subtotal (95% CI) 288 288 25.8 % 1.07 [ 0.96, 1.18 ]
Total events: 211 (Doppler US), 198 (No Doppler US)
Heterogeneity: Chi2 = 0.72, df = 1 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 1.22 (P = 0.22)
2 Multiple pregnancy
Giles 2003 157/262 153/264 19.9 % 1.03 [ 0.90, 1.19 ]
Subtotal (95% CI) 262 264 19.9 % 1.03 [ 0.90, 1.19 ]
Total events: 157 (Doppler US), 153 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.65)
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 264/438 260/459 33.1 % 1.06 [ 0.95, 1.19 ]
Newnham 1991 160/254 162/251 21.2 % 0.98 [ 0.86, 1.11 ]
Subtotal (95% CI) 692 710 54.3 % 1.03 [ 0.95, 1.12 ]
Total events: 424 (Doppler US), 422 (No Doppler US)
Heterogeneity: Chi2 = 0.98, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
Total (95% CI) 1242 1262 100.0 % 1.04 [ 0.98, 1.10 ]
Total events: 792 (Doppler US), 773 (No Doppler US)
Heterogeneity: Chi2 = 2.20, df = 4 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Chi2 = 0.29, df = 2 (P = 0.87), I2 =0.0%
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Analysis 1.11. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
11 Operative vaginal birth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 11 Operative vaginal birth
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 8/214 9/212 4.4 % 0.88 [ 0.35, 2.24 ]
Nienhuis 1997 3/74 8/76 3.9 % 0.39 [ 0.11, 1.40 ]
Williams 2003 112/649 117/691 55.4 % 1.02 [ 0.81, 1.29 ]
Subtotal (95% CI) 937 979 63.7 % 0.97 [ 0.78, 1.22 ]
Total events: 123 (Doppler US), 134 (No Doppler US)
Heterogeneity: Chi2 = 2.18, df = 2 (P = 0.34); I2 =8%
Test for overall effect: Z = 0.26 (P = 0.80)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 67/438 76/459 36.3 % 0.92 [ 0.68, 1.25 ]
Subtotal (95% CI) 438 459 36.3 % 0.92 [ 0.68, 1.25 ]
Total events: 67 (Doppler US), 76 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.61)
Total (95% CI) 1375 1438 100.0 % 0.95 [ 0.80, 1.14 ]
Total events: 190 (Doppler US), 210 (No Doppler US)
Heterogeneity: Chi2 = 2.28, df = 3 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
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Analysis 1.12. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
12 Induction of labour.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 12 Induction of labour
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Almstrom 1992 22/214 46/212 4.5 % 0.47 [ 0.30, 0.76 ]
Haley 1997 17/73 18/77 3.1 % 1.00 [ 0.56, 1.78 ]
Neales 1994 [pers comm] 78/236 107/231 12.3 % 0.71 [ 0.57, 0.90 ]
Trudinger 1987 57/127 79/162 11.2 % 0.92 [ 0.72, 1.18 ]
Tyrrell 1990 69/230 73/222 10.1 % 0.91 [ 0.69, 1.20 ]
Subtotal (95% CI) 880 904 41.2 % 0.79 [ 0.64, 0.97 ]
Total events: 243 (Doppler US), 323 (No Doppler US)
Heterogeneity: Tau2 = 0.03; Chi2 = 8.45, df = 4 (P = 0.08); I2 =53%
Test for overall effect: Z = 2.20 (P = 0.028)
2 Multiple pregnancy
Giles 2003 62/262 57/264 8.3 % 1.10 [ 0.80, 1.50 ]
Subtotal (95% CI) 262 264 8.3 % 1.10 [ 0.80, 1.50 ]
Total events: 62 (Doppler US), 57 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
3 Singleton plus multiple pregnancies or not stated
Burke 1992 88/241 83/235 11.7 % 1.03 [ 0.81, 1.31 ]
Johnstone 1993 334/1114 371/1175 20.0 % 0.95 [ 0.84, 1.07 ]
Newnham 1991 96/254 101/251 13.0 % 0.94 [ 0.76, 1.17 ]
Norman 1992 15/26 20/27 5.9 % 0.78 [ 0.52, 1.16 ]
Subtotal (95% CI) 1635 1688 50.5 % 0.95 [ 0.86, 1.04 ]
Total events: 533 (Doppler US), 575 (No Doppler US)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.46, df = 3 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.29)
Total (95% CI) 2777 2856 100.0 % 0.89 [ 0.80, 0.99 ]
Total events: 838 (Doppler US), 955 (No Doppler US)
Heterogeneity: Tau2 = 0.01; Chi2 = 15.36, df = 9 (P = 0.08); I2 =41%
Test for overall effect: Z = 2.07 (P = 0.038)
Test for subgroup differences: Chi2 = 3.53, df = 2 (P = 0.17), I2 =43%
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Analysis 1.13. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
13 Infant requiring intubation/ventilation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 13 Infant requiring intubation/ventilation
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Almstrom 1992 1/214 1/212 2.9 % 0.99 [ 0.06, 15.74 ]
Biljan 1992 7/338 2/336 8.0 % 3.48 [ 0.73, 16.63 ]
Haley 1997 2/73 1/77 3.8 % 2.11 [ 0.20, 22.77 ]
Trudinger 1987 15/127 6/162 17.3 % 3.19 [ 1.27, 7.98 ]
Subtotal (95% CI) 752 787 32.0 % 2.89 [ 1.40, 5.96 ]
Total events: 25 (Doppler US), 10 (No Doppler US)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.74, df = 3 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 2.87 (P = 0.0042)
2 Multiple pregnancy
Giles 2003 47/524 55/528 35.7 % 0.86 [ 0.59, 1.25 ]
Subtotal (95% CI) 524 528 35.7 % 0.86 [ 0.59, 1.25 ]
Total events: 47 (Doppler US), 55 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
3 Singleton plus multiple pregnancies or not stated
Newnham 1991 37/275 29/270 32.3 % 1.25 [ 0.79, 1.98 ]
Subtotal (95% CI) 275 270 32.3 % 1.25 [ 0.79, 1.98 ]
Total events: 37 (Doppler US), 29 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
Total (95% CI) 1551 1585 100.0 % 1.42 [ 0.87, 2.30 ]
Total events: 109 (Doppler US), 94 (No Doppler US)
Heterogeneity: Tau2 = 0.14; Chi2 = 9.45, df = 5 (P = 0.09); I2 =47%
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Chi2 = 8.67, df = 2 (P = 0.01), I2 =77%
0.1 0.2 0.5 1 2 5 10
Favours Doppler Favours no Doppler
89Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.14. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
14 Neonatal fitting/seizures.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 14 Neonatal fitting/seizures
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Haley 1997 0/73 1/77 100.0 % 0.35 [ 0.01, 8.49 ]
Subtotal (95% CI) 73 77 100.0 % 0.35 [ 0.01, 8.49 ]
Total events: 0 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 73 77 100.0 % 0.35 [ 0.01, 8.49 ]
Total events: 0 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
15 Preterm labour.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 15 Preterm labour
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Nienhuis 1997 13/74 13/76 40.0 % 1.03 [ 0.51, 2.07 ]
Subtotal (95% CI) 74 76 40.0 % 1.03 [ 0.51, 2.07 ]
Total events: 13 (Doppler US), 13 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancy or not stated
Burke 1992 23/241 19/235 60.0 % 1.18 [ 0.66, 2.11 ]
Subtotal (95% CI) 241 235 60.0 % 1.18 [ 0.66, 2.11 ]
Total events: 23 (Doppler US), 19 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.56 (P = 0.58)
Total (95% CI) 315 311 100.0 % 1.12 [ 0.72, 1.75 ]
Total events: 36 (Doppler US), 32 (No Doppler US)
Heterogeneity: Chi2 = 0.09, df = 1 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.49 (P = 0.62)
Test for subgroup differences: Chi2 = 0.09, df = 1 (P = 0.76), I2 =0.0%
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Analysis 1.16. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
16 Gestational age at birth (weeks).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 16 Gestational age at birth (weeks)
Study or subgroup Doppler US No Doppler US
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Singleton pregnancy
Almstrom 1992 214 38.8 (2) 212 38.6 (2.2) 16.7 % 0.20 [ -0.20, 0.60 ]
Haley 1997 73 39.2 (1.7) 77 38.8 (1.9) 10.8 % 0.40 [ -0.18, 0.98 ]
Neales 1994 [pers comm] 236 38.6 (3.5) 231 37.4 (4.2) 8.1 % 1.20 [ 0.50, 1.90 ]
Subtotal (95% CI) 523 520 35.7 % 0.54 [ 0.00, 1.09 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 5.91, df = 2 (P = 0.05); I2 =66%
Test for overall effect: Z = 1.94 (P = 0.052)
2 Multiple pregnancy
Giles 2003 524 35.8 (2.8) 528 35.7 (2.9) 19.2 % 0.10 [ -0.24, 0.44 ]
Subtotal (95% CI) 524 528 19.2 % 0.10 [ -0.24, 0.44 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
3 Singleton plus multiple pregnancies or not stated
Burke 1992 241 39.1 (2.6) 235 39.1 (2.3) 15.1 % 0.0 [ -0.44, 0.44 ]
Hofmeyr 1991 438 38.6 (2.51) 459 38.4 (2.78) 19.1 % 0.20 [ -0.15, 0.55 ]
Newnham 1991 275 36.9 (3.7) 270 37.1 (3.6) 9.9 % -0.20 [ -0.81, 0.41 ]
Norman 1992 27 34.2 (5.2) 26 35 (3.7) 0.9 % -0.80 [ -3.22, 1.62 ]
Subtotal (95% CI) 981 990 45.0 % 0.06 [ -0.19, 0.31 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.87, df = 3 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
Total (95% CI) 2028 2038 100.0 % 0.21 [ -0.02, 0.43 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 11.64, df = 7 (P = 0.11); I2 =40%
Test for overall effect: Z = 1.75 (P = 0.080)
Test for subgroup differences: Chi2 = 2.50, df = 2 (P = 0.29), I2 =20%
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Analysis 1.17. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
17 Infant respiratory distress syndrome (RDS).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 17 Infant respiratory distress syndrome (RDS)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
De Rochambeau 1992 1/52 1/55 100.0 % 1.06 [ 0.07, 16.48 ]
Subtotal (95% CI) 52 55 100.0 % 1.06 [ 0.07, 16.48 ]
Total events: 1 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.97)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 52 55 100.0 % 1.06 [ 0.07, 16.48 ]
Total events: 1 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
18 Neonatal admission to SCBU and/or NICU.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 18 Neonatal admission to SCBU and/or NICU
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 76/214 92/212 10.1 % 0.82 [ 0.65, 1.04 ]
Biljan 1992 27/338 20/336 2.2 % 1.34 [ 0.77, 2.35 ]
Haley 1997 12/73 17/77 1.8 % 0.74 [ 0.38, 1.45 ]
Neales 1994 [pers comm] 40/236 45/231 5.0 % 0.87 [ 0.59, 1.28 ]
Ott 1998 60/348 49/317 5.6 % 1.12 [ 0.79, 1.58 ]
Trudinger 1987 27/127 38/162 3.6 % 0.91 [ 0.59, 1.40 ]
Tyrrell 1990 18/250 19/250 2.1 % 0.95 [ 0.51, 1.76 ]
Williams 2003 16/649 23/691 2.4 % 0.74 [ 0.39, 1.39 ]
Subtotal (95% CI) 2235 2276 32.8 % 0.92 [ 0.80, 1.06 ]
Total events: 276 (Doppler US), 303 (No Doppler US)
Heterogeneity: Chi2 = 4.83, df = 7 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
2 Multiple pregnancy
Giles 2003 329/524 345/528 37.5 % 0.96 [ 0.88, 1.05 ]
Subtotal (95% CI) 524 528 37.5 % 0.96 [ 0.88, 1.05 ]
Total events: 329 (Doppler US), 345 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 66/438 69/459 7.4 % 1.00 [ 0.73, 1.37 ]
Johnstone 1993 96/1132 101/1197 10.7 % 1.01 [ 0.77, 1.31 ]
Newnham 1991 103/275 106/270 11.7 % 0.95 [ 0.77, 1.18 ]
Subtotal (95% CI) 1845 1926 29.7 % 0.98 [ 0.85, 1.14 ]
Total events: 265 (Doppler US), 276 (No Doppler US)
Heterogeneity: Chi2 = 0.12, df = 2 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.84)
Total (95% CI) 4604 4730 100.0 % 0.95 [ 0.89, 1.03 ]
Total events: 870 (Doppler US), 924 (No Doppler US)
Heterogeneity: Chi2 = 5.53, df = 11 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Chi2 = 0.43, df = 2 (P = 0.81), I2 =0.0%
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Analysis 1.19. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
19 Hypoxic ischaemic encephalopathy.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 19 Hypoxic ischaemic encephalopathy
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Tyrrell 1990 0/250 5/250 50.7 % 0.09 [ 0.01, 1.64 ]
Subtotal (95% CI) 250 250 50.7 % 0.09 [ 0.01, 1.64 ]
Total events: 0 (Doppler US), 5 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.63 (P = 0.10)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Newnham 1991 2/275 0/270 49.3 % 4.91 [ 0.24, 101.79 ]
Subtotal (95% CI) 275 270 49.3 % 4.91 [ 0.24, 101.79 ]
Total events: 2 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
Total (95% CI) 525 520 100.0 % 0.65 [ 0.01, 33.07 ]
Total events: 2 (Doppler US), 5 (No Doppler US)
Heterogeneity: Tau2 = 5.76; Chi2 = 3.52, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi2 = 3.48, df = 1 (P = 0.06), I2 =71%
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Analysis 1.20. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
20 Intraventricular haemorrhage.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 20 Intraventricular haemorrhage
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Biljan 1992 2/338 0/336 9.4 % 4.97 [ 0.24, 103.15 ]
Trudinger 1987 0/127 1/162 24.8 % 0.42 [ 0.02, 10.33 ]
Tyrrell 1990 3/250 3/250 56.3 % 1.00 [ 0.20, 4.91 ]
Subtotal (95% CI) 715 748 90.5 % 1.26 [ 0.38, 4.16 ]
Total events: 5 (Doppler US), 4 (No Doppler US)
Heterogeneity: Chi2 = 1.31, df = 2 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.37 (P = 0.71)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Newnham 1991 1/275 0/270 9.5 % 2.95 [ 0.12, 71.99 ]
Subtotal (95% CI) 275 270 9.5 % 2.95 [ 0.12, 71.99 ]
Total events: 1 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Total (95% CI) 990 1018 100.0 % 1.42 [ 0.47, 4.30 ]
Total events: 6 (Doppler US), 4 (No Doppler US)
Heterogeneity: Chi2 = 1.59, df = 3 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Chi2 = 0.24, df = 1 (P = 0.62), I2 =0.0%
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Analysis 1.21. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
21 Birthweight (grams).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 21 Birthweight (grams)
Study or subgroup Doppler US No Doppler US
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 2599 (478) 212 2536 (538) 17.1 % 63.00 [ -33.68, 159.68 ]
Haley 1997 73 2629 (433) 77 2572 (485) 7.4 % 57.00 [ -89.97, 203.97 ]
Williams 2003 649 3572 (552) 691 3530 (635) 39.6 % 42.00 [ -21.60, 105.60 ]
Subtotal (95% CI) 936 980 64.2 % 49.34 [ -0.62, 99.31 ]
Heterogeneity: Chi2 = 0.14, df = 2 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.94 (P = 0.053)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Burke 1992 241 3104 (738) 235 3073 (617) 10.8 % 31.00 [ -91.08, 153.08 ]
Hofmeyr 1991 438 2972 (733) 459 2976 (771) 16.5 % -4.00 [ -102.42, 94.42 ]
Newnham 1991 275 2697 (860) 270 2745 (861) 7.7 % -48.00 [ -192.49, 96.49 ]
Norman 1992 27 2600 (833) 26 2520 (788) 0.8 % 80.00 [ -356.43, 516.43 ]
Subtotal (95% CI) 981 990 35.8 % -0.95 [ -67.84, 65.95 ]
Heterogeneity: Chi2 = 0.81, df = 3 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 0.03 (P = 0.98)
Total (95% CI) 1917 1970 100.0 % 31.33 [ -8.70, 71.37 ]
Heterogeneity: Chi2 = 2.34, df = 6 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.53 (P = 0.13)
Test for subgroup differences: Chi2 = 1.39, df = 1 (P = 0.24), I2 =28%
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Analysis 1.22. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
22 Length of infant hospital stay (days).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 22 Length of infant hospital stay (days)
Study or subgroup Doppler US No Doppler US
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 12.5 (12) 212 16.3 (15) 39.6 % -0.28 [ -0.47, -0.09 ]
Haley 1997 73 1.34 (4.21) 77 2.22 (6.81) 14.0 % -0.15 [ -0.47, 0.17 ]
Tyrrell 1990 250 26.5 (22.2) 250 33.6 (21.5) 46.3 % -0.32 [ -0.50, -0.15 ]
Subtotal (95% CI) 537 539 100.0 % -0.28 [ -0.40, -0.16 ]
Heterogeneity: Chi2 = 0.84, df = 2 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 4.61 (P < 0.00001)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 537 539 100.0 % -0.28 [ -0.40, -0.16 ]
Heterogeneity: Chi2 = 0.84, df = 2 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 4.61 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.23. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
23 Birth < 34 weeks (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 23 Birth < 34 weeks (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Tyrrell 1990 7/250 6/250 53.6 % 1.17 [ 0.40, 3.42 ]
Subtotal (95% CI) 250 250 53.6 % 1.17 [ 0.40, 3.42 ]
Total events: 7 (Doppler US), 6 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Burke 1992 12/241 3/235 46.4 % 3.90 [ 1.11, 13.65 ]
Subtotal (95% CI) 241 235 46.4 % 3.90 [ 1.11, 13.65 ]
Total events: 12 (Doppler US), 3 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 2.13 (P = 0.033)
Total (95% CI) 491 485 100.0 % 2.04 [ 0.62, 6.69 ]
Total events: 19 (Doppler US), 9 (No Doppler US)
Heterogeneity: Tau2 = 0.38; Chi2 = 2.08, df = 1 (P = 0.15); I2 =52%
Test for overall effect: Z = 1.18 (P = 0.24)
Test for subgroup differences: Chi2 = 2.05, df = 1 (P = 0.15), I2 =51%
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Analysis 1.24. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
24 Antenatal admissions (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 24 Antenatal admissions (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 69/214 97/212 56.9 % 0.70 [ 0.55, 0.90 ]
Neales 1994 [pers comm] 56/236 73/231 43.1 % 0.75 [ 0.56, 1.01 ]
Subtotal (95% CI) 450 443 100.0 % 0.72 [ 0.60, 0.88 ]
Total events: 125 (Doppler US), 170 (No Doppler US)
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 3.34 (P = 0.00082)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 450 443 100.0 % 0.72 [ 0.60, 0.88 ]
Total events: 125 (Doppler US), 170 (No Doppler US)
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 3.34 (P = 0.00082)
Test for subgroup differences: Not applicable
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Analysis 1.25. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
25 Phototherapy for neonatal jaundice (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 25 Phototherapy for neonatal jaundice (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Haley 1997 0/73 3/77 100.0 % 0.15 [ 0.01, 2.87 ]
Subtotal (95% CI) 73 77 100.0 % 0.15 [ 0.01, 2.87 ]
Total events: 0 (Doppler US), 3 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 73 77 100.0 % 0.15 [ 0.01, 2.87 ]
Total events: 0 (Doppler US), 3 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 1.26. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
26 Abnormal neurological development at 9 months (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 26 Abnormal neurological development at 9 months (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Nienhuis 1997 7/67 12/70 100.0 % 0.61 [ 0.26, 1.45 ]
Subtotal (95% CI) 67 70 100.0 % 0.61 [ 0.26, 1.45 ]
Total events: 7 (Doppler US), 12 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 67 70 100.0 % 0.61 [ 0.26, 1.45 ]
Total events: 7 (Doppler US), 12 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
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Analysis 1.27. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
27 Hospitalisation for IUGR neonatal (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 27 Hospitalisation for IUGR neonatal (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Nienhuis 1997 37/70 37/72 100.0 % 1.03 [ 0.75, 1.41 ]
Subtotal (95% CI) 70 72 100.0 % 1.03 [ 0.75, 1.41 ]
Total events: 37 (Doppler US), 37 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 70 72 100.0 % 1.03 [ 0.75, 1.41 ]
Total events: 37 (Doppler US), 37 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours Doppler Favours no Doppler
103Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.28. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
28 Fetal distress in labour (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 28 Fetal distress in labour (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Trudinger 1987 3/127 11/162 100.0 % 0.35 [ 0.10, 1.22 ]
Subtotal (95% CI) 127 162 100.0 % 0.35 [ 0.10, 1.22 ]
Total events: 3 (Doppler US), 11 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.099)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 127 162 100.0 % 0.35 [ 0.10, 1.22 ]
Total events: 3 (Doppler US), 11 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.099)
Test for subgroup differences: Not applicable
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Analysis 1.29. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
29 Birthweight < 5 percentile (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 29 Birthweight < 5 percentile (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Trudinger 1987 10/127 11/162 100.0 % 1.16 [ 0.51, 2.64 ]
Subtotal (95% CI) 127 162 100.0 % 1.16 [ 0.51, 2.64 ]
Total events: 10 (Doppler US), 11 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.72)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 127 162 100.0 % 1.16 [ 0.51, 2.64 ]
Total events: 10 (Doppler US), 11 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Not applicable
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Analysis 1.30. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
30 Periventricular leucomalacia (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 30 Periventricular leucomalacia (not prespecified)
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Newnham 1991 0/275 1/270 100.0 % 0.33 [ 0.01, 8.00 ]
Subtotal (95% CI) 275 270 100.0 % 0.33 [ 0.01, 8.00 ]
Total events: 0 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.49)
Total (95% CI) 275 270 100.0 % 0.33 [ 0.01, 8.00 ]
Total events: 0 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.49)
Test for subgroup differences: Not applicable
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Analysis 1.31. Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome
31 Antenatal hospital stay (days) (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Outcome: 31 Antenatal hospital stay (days) (not prespecified)
Study or subgroup Doppler US No Doppler US
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 9 (10.4) 212 9.6 (8.4) 100.0 % -0.60 [ -2.39, 1.19 ]
Subtotal (95% CI) 214 212 100.0 % -0.60 [ -2.39, 1.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 214 212 100.0 % -0.60 [ -2.39, 1.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all
subgroups), Outcome 1 Any perinatal death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups)
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 SGA/IUGR
Almstrom 1992 0/214 3/212 15.9 % 0.14 [ 0.01, 2.72 ]
Haley 1997 1/73 1/73 4.5 % 1.00 [ 0.06, 15.69 ]
Neales 1994 [pers comm] 11/236 14/231 64.0 % 0.77 [ 0.36, 1.66 ]
Nienhuis 1997 2/74 3/76 13.4 % 0.68 [ 0.12, 3.98 ]
Pattinson 1994 1/51 0/52 2.2 % 3.06 [ 0.13, 73.36 ]
Subtotal (95% CI) 648 644 100.0 % 0.72 [ 0.38, 1.35 ]
Total events: 15 (Doppler US), 21 (No Doppler US)
Heterogeneity: Chi2 = 2.04, df = 4 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
2 Hypertension/pre-eclampsia
Pattinson 1994 4/47 1/42 100.0 % 3.57 [ 0.42, 30.73 ]
Subtotal (95% CI) 47 42 100.0 % 3.57 [ 0.42, 30.73 ]
Total events: 4 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.16 (P = 0.25)
3 Diabetes
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Prolonged pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 Previous pregnancy loss
Norman 1992 1/26 4/27 100.0 % 0.26 [ 0.03, 2.17 ]
Subtotal (95% CI) 26 27 100.0 % 0.26 [ 0.03, 2.17 ]
Total events: 1 (Doppler US), 4 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.24 (P = 0.21)
Test for subgroup differences: Chi2 = 3.00, df = 2 (P = 0.22), I2 =33%
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Analysis 2.2. Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all
subgroups), Outcome 2 Serious neonatal morbidity.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups)
Outcome: 2 Serious neonatal morbidity
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 SGA/IUGR
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Hypertension/pre-eclampsia
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Diabetes
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Prolonged pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 Previous pregnancy loss
Norman 1992 0/26 0/27 Not estimable
Subtotal (95% CI) 26 27 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 26 27 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 0.0, df = -1 (P = 0.0), I2 =0.0%
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Analysis 3.1. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 1 Any
perinatal death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 0/214 3/212 25.6 % 0.14 [ 0.01, 2.72 ]
Haley 1997 1/73 1/77 7.1 % 1.05 [ 0.07, 16.55 ]
Williams 2003 0/649 1/691 10.6 % 0.35 [ 0.01, 8.70 ]
Subtotal (95% CI) 936 980 43.2 % 0.34 [ 0.07, 1.68 ]
Total events: 1 (Doppler ultrasound), 5 (CTG)
Heterogeneity: Chi2 = 0.98, df = 2 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 4/438 8/459 56.8 % 0.52 [ 0.16, 1.73 ]
Subtotal (95% CI) 438 459 56.8 % 0.52 [ 0.16, 1.73 ]
Total events: 4 (Doppler ultrasound), 8 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.06 (P = 0.29)
Total (95% CI) 1374 1439 100.0 % 0.45 [ 0.17, 1.15 ]
Total events: 5 (Doppler ultrasound), 13 (CTG)
Heterogeneity: Chi2 = 1.04, df = 3 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.095)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
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Analysis 3.2. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 2
Stillbirth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 2 Stillbirth
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 0/214 2/212 34.0 % 0.20 [ 0.01, 4.10 ]
Haley 1997 0/73 1/77 19.8 % 0.35 [ 0.01, 8.49 ]
Williams 2003 0/649 1/691 19.7 % 0.35 [ 0.01, 8.70 ]
Subtotal (95% CI) 936 980 73.5 % 0.28 [ 0.05, 1.70 ]
Total events: 0 (Doppler ultrasound), 4 (CTG)
Heterogeneity: Chi2 = 0.09, df = 2 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 1.38 (P = 0.17)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 2/438 2/459 26.5 % 1.05 [ 0.15, 7.41 ]
Subtotal (95% CI) 438 459 26.5 % 1.05 [ 0.15, 7.41 ]
Total events: 2 (Doppler ultrasound), 2 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
Total (95% CI) 1374 1439 100.0 % 0.48 [ 0.14, 1.71 ]
Total events: 2 (Doppler ultrasound), 6 (CTG)
Heterogeneity: Chi2 = 1.01, df = 3 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Chi2 = 0.94, df = 1 (P = 0.33), I2 =0.0%
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Analysis 3.3. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 3
Neonatal death.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 3 Neonatal death
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 0/214 1/212 19.2 % 0.33 [ 0.01, 8.06 ]
Haley 1997 1/73 0/77 6.2 % 3.16 [ 0.13, 76.40 ]
Subtotal (95% CI) 287 289 25.4 % 1.02 [ 0.15, 7.10 ]
Total events: 1 (Doppler ultrasound), 1 (CTG)
Heterogeneity: Chi2 = 0.96, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.98)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 2/438 6/459 74.6 % 0.35 [ 0.07, 1.72 ]
Subtotal (95% CI) 438 459 74.6 % 0.35 [ 0.07, 1.72 ]
Total events: 2 (Doppler ultrasound), 6 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
Total (95% CI) 725 748 100.0 % 0.52 [ 0.16, 1.72 ]
Total events: 3 (Doppler ultrasound), 7 (CTG)
Heterogeneity: Chi2 = 1.55, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.28)
Test for subgroup differences: Chi2 = 0.70, df = 1 (P = 0.40), I2 =0.0%
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Analysis 3.4. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 4 Any
potentially preventable perinatal death*.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 4 Any potentially preventable perinatal death*
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 0/214 2/212 23.3 % 0.20 [ 0.01, 4.10 ]
Haley 1997 1/73 1/77 9.0 % 1.05 [ 0.07, 16.55 ]
Williams 2003 0/649 1/691 13.5 % 0.35 [ 0.01, 8.70 ]
Subtotal (95% CI) 936 980 45.7 % 0.41 [ 0.08, 2.11 ]
Total events: 1 (Doppler ultrasound), 4 (CTG)
Heterogeneity: Chi2 = 0.68, df = 2 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 2/438 6/459 54.3 % 0.35 [ 0.07, 1.72 ]
Subtotal (95% CI) 438 459 54.3 % 0.35 [ 0.07, 1.72 ]
Total events: 2 (Doppler ultrasound), 6 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
Total (95% CI) 1374 1439 100.0 % 0.38 [ 0.12, 1.18 ]
Total events: 3 (Doppler ultrasound), 10 (CTG)
Heterogeneity: Chi2 = 0.72, df = 3 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.095)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.89), I2 =0.0%
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Analysis 3.5. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 5
Apgar < 7 at 5 minutes.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 5 Apgar < 7 at 5 minutes
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 4/214 5/212 13.6 % 0.79 [ 0.22, 2.91 ]
Williams 2003 19/649 24/691 62.7 % 0.84 [ 0.47, 1.52 ]
Subtotal (95% CI) 863 903 76.3 % 0.83 [ 0.49, 1.43 ]
Total events: 23 (Doppler ultrasound), 29 (CTG)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 8/438 9/459 23.7 % 0.93 [ 0.36, 2.39 ]
Subtotal (95% CI) 438 459 23.7 % 0.93 [ 0.36, 2.39 ]
Total events: 8 (Doppler ultrasound), 9 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
Total (95% CI) 1301 1362 100.0 % 0.86 [ 0.54, 1.37 ]
Total events: 31 (Doppler ultrasound), 38 (CTG)
Heterogeneity: Chi2 = 0.05, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.65 (P = 0.52)
Test for subgroup differences: Chi2 = 0.04, df = 1 (P = 0.84), I2 =0.0%
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Analysis 3.6. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 6
Caesarean section (elective and emergency).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 6 Caesarean section (elective and emergency)
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 58/214 62/212 14.9 % 0.93 [ 0.68, 1.26 ]
Haley 1997 16/73 19/77 4.4 % 0.89 [ 0.50, 1.59 ]
Williams 2003 183/649 223/691 51.8 % 0.87 [ 0.74, 1.03 ]
Subtotal (95% CI) 936 980 71.2 % 0.89 [ 0.77, 1.02 ]
Total events: 257 (Doppler ultrasound), 304 (CTG)
Heterogeneity: Chi2 = 0.11, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.70 (P = 0.089)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 107/438 123/459 28.8 % 0.91 [ 0.73, 1.14 ]
Subtotal (95% CI) 438 459 28.8 % 0.91 [ 0.73, 1.14 ]
Total events: 107 (Doppler ultrasound), 123 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Total (95% CI) 1374 1439 100.0 % 0.89 [ 0.79, 1.01 ]
Total events: 364 (Doppler ultrasound), 427 (CTG)
Heterogeneity: Chi2 = 0.16, df = 3 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.062)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.83), I2 =0.0%
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Analysis 3.7. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 7
Caesarean section - elective.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 7 Caesarean section - elective
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 37/214 22/212 38.0 % 1.67 [ 1.02, 2.73 ]
Haley 1997 7/73 4/77 6.7 % 1.85 [ 0.56, 6.04 ]
Subtotal (95% CI) 287 289 44.6 % 1.69 [ 1.07, 2.67 ]
Total events: 44 (Doppler ultrasound), 26 (CTG)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 2.27 (P = 0.023)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 44/438 33/459 55.4 % 1.40 [ 0.91, 2.15 ]
Subtotal (95% CI) 438 459 55.4 % 1.40 [ 0.91, 2.15 ]
Total events: 44 (Doppler ultrasound), 33 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.52 (P = 0.13)
Total (95% CI) 725 748 100.0 % 1.53 [ 1.12, 2.09 ]
Total events: 88 (Doppler ultrasound), 59 (CTG)
Heterogeneity: Chi2 = 0.38, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 2.66 (P = 0.0078)
Test for subgroup differences: Chi2 = 0.36, df = 1 (P = 0.55), I2 =0.0%
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Analysis 3.8. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 8
Caesarean section - emergency.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 8 Caesarean section - emergency
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 21/214 40/212 28.2 % 0.52 [ 0.32, 0.85 ]
Haley 1997 9/73 15/77 10.2 % 0.63 [ 0.30, 1.36 ]
Subtotal (95% CI) 287 289 38.4 % 0.55 [ 0.36, 0.83 ]
Total events: 30 (Doppler ultrasound), 55 (CTG)
Heterogeneity: Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 2.83 (P = 0.0046)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 63/438 90/459 61.6 % 0.73 [ 0.55, 0.98 ]
Subtotal (95% CI) 438 459 61.6 % 0.73 [ 0.55, 0.98 ]
Total events: 63 (Doppler ultrasound), 90 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.06 (P = 0.039)
Total (95% CI) 725 748 100.0 % 0.66 [ 0.52, 0.84 ]
Total events: 93 (Doppler ultrasound), 145 (CTG)
Heterogeneity: Chi2 = 1.40, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 3.37 (P = 0.00076)
Test for subgroup differences: Chi2 = 1.24, df = 1 (P = 0.27), I2 =19%
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Analysis 3.9. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 9
Spontaneous vaginal birth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 9 Spontaneous vaginal birth
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 148/214 141/212 35.8 % 1.04 [ 0.91, 1.19 ]
Subtotal (95% CI) 214 212 35.8 % 1.04 [ 0.91, 1.19 ]
Total events: 148 (Doppler ultrasound), 141 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 264/438 260/459 64.2 % 1.06 [ 0.95, 1.19 ]
Subtotal (95% CI) 438 459 64.2 % 1.06 [ 0.95, 1.19 ]
Total events: 264 (Doppler ultrasound), 260 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
Total (95% CI) 652 671 100.0 % 1.06 [ 0.97, 1.15 ]
Total events: 412 (Doppler ultrasound), 401 (CTG)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.21)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
0.5 0.7 1 1.5 2
Favours Doppler Favours CTG
118Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.10. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 10
Operative vaginal birth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 10 Operative vaginal birth
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 8/214 9/212 4.6 % 0.88 [ 0.35, 2.24 ]
Williams 2003 112/649 117/691 57.6 % 1.02 [ 0.81, 1.29 ]
Subtotal (95% CI) 863 903 62.2 % 1.01 [ 0.80, 1.27 ]
Total events: 120 (Doppler ultrasound), 126 (CTG)
Heterogeneity: Chi2 = 0.09, df = 1 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 0.08 (P = 0.94)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 67/438 76/459 37.8 % 0.92 [ 0.68, 1.25 ]
Subtotal (95% CI) 438 459 37.8 % 0.92 [ 0.68, 1.25 ]
Total events: 67 (Doppler ultrasound), 76 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.61)
Total (95% CI) 1301 1362 100.0 % 0.98 [ 0.81, 1.17 ]
Total events: 187 (Doppler ultrasound), 202 (CTG)
Heterogeneity: Chi2 = 0.30, df = 2 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Chi2 = 0.21, df = 1 (P = 0.65), I2 =0.0%
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Analysis 3.11. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 11
Induction of labour.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 11 Induction of labour
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Almstrom 1992 22/214 46/212 52.7 % 0.47 [ 0.30, 0.76 ]
Haley 1997 17/73 18/77 47.3 % 1.00 [ 0.56, 1.78 ]
Subtotal (95% CI) 287 289 100.0 % 0.67 [ 0.32, 1.40 ]
Total events: 39 (Doppler ultrasound), 64 (CTG)
Heterogeneity: Tau2 = 0.21; Chi2 = 3.82, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 1.06 (P = 0.29)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 287 289 100.0 % 0.67 [ 0.32, 1.40 ]
Total events: 39 (Doppler ultrasound), 64 (CTG)
Heterogeneity: Tau2 = 0.21; Chi2 = 3.82, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 1.06 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 3.12. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 12
Infant requiring intubation/ventilation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 12 Infant requiring intubation/ventilation
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 1/214 1/212 50.8 % 0.99 [ 0.06, 15.74 ]
Haley 1997 2/73 1/77 49.2 % 2.11 [ 0.20, 22.77 ]
Subtotal (95% CI) 287 289 100.0 % 1.54 [ 0.26, 9.08 ]
Total events: 3 (Doppler ultrasound), 2 (CTG)
Heterogeneity: Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 287 289 100.0 % 1.54 [ 0.26, 9.08 ]
Total events: 3 (Doppler ultrasound), 2 (CTG)
Heterogeneity: Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 3.13. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 13
Neonatal fitting/seizures.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 13 Neonatal fitting/seizures
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Haley 1997 0/73 1/77 100.0 % 0.35 [ 0.01, 8.49 ]
Subtotal (95% CI) 73 77 100.0 % 0.35 [ 0.01, 8.49 ]
Total events: 0 (Doppler ultrasound), 1 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 73 77 100.0 % 0.35 [ 0.01, 8.49 ]
Total events: 0 (Doppler ultrasound), 1 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 3.14. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 14
Gestational age at birth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 14 Gestational age at birth
Study or subgroup Doppler US CTG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 38.8 (2) 212 38.6 (2.2) 35.6 % 0.20 [ -0.20, 0.60 ]
Haley 1997 73 39.2 (1.7) 77 38.8 (1.9) 17.1 % 0.40 [ -0.18, 0.98 ]
Subtotal (95% CI) 287 289 52.7 % 0.26 [ -0.06, 0.59 ]
Heterogeneity: Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 1.58 (P = 0.11)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 438 38.6 (2.51) 459 38.4 (2.78) 47.3 % 0.20 [ -0.15, 0.55 ]
Subtotal (95% CI) 438 459 47.3 % 0.20 [ -0.15, 0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.13 (P = 0.26)
Total (95% CI) 725 748 100.0 % 0.23 [ 0.00, 0.47 ]
Heterogeneity: Chi2 = 0.38, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.054)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
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Analysis 3.15. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 15
Neonatal admission to SCBU and/or NICU.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 15 Neonatal admission to SCBU and/or NICU
Study or subgroup Doppler ultrasound CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 76/214 92/212 46.5 % 0.82 [ 0.65, 1.04 ]
Haley 1997 12/73 17/77 8.3 % 0.74 [ 0.38, 1.45 ]
Williams 2003 16/649 23/691 11.2 % 0.74 [ 0.39, 1.39 ]
Subtotal (95% CI) 936 980 66.1 % 0.80 [ 0.64, 0.99 ]
Total events: 104 (Doppler ultrasound), 132 (CTG)
Heterogeneity: Chi2 = 0.14, df = 2 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.037)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler ultrasound), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 66/438 69/459 33.9 % 1.00 [ 0.73, 1.37 ]
Subtotal (95% CI) 438 459 33.9 % 1.00 [ 0.73, 1.37 ]
Total events: 66 (Doppler ultrasound), 69 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Total (95% CI) 1374 1439 100.0 % 0.87 [ 0.73, 1.03 ]
Total events: 170 (Doppler ultrasound), 201 (CTG)
Heterogeneity: Chi2 = 1.50, df = 3 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 1.59 (P = 0.11)
Test for subgroup differences: Chi2 = 1.43, df = 1 (P = 0.23), I2 =30%
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Analysis 3.16. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 16
Infant birthweight (grams).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 16 Infant birthweight (grams)
Study or subgroup Doppler US CTG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 2599 (478) 212 2536 (538) 21.2 % 63.00 [ -33.68, 159.68 ]
Haley 1997 73 2629 (433) 77 2572 (485) 9.2 % 57.00 [ -89.97, 203.97 ]
Williams 2003 649 3572 (552) 691 3530 (635) 49.1 % 42.00 [ -21.60, 105.60 ]
Subtotal (95% CI) 936 980 79.5 % 49.34 [ -0.62, 99.31 ]
Heterogeneity: Chi2 = 0.14, df = 2 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.94 (P = 0.053)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Hofmeyr 1991 438 2972 (733) 459 2976 (771) 20.5 % -4.00 [ -102.42, 94.42 ]
Subtotal (95% CI) 438 459 20.5 % -4.00 [ -102.42, 94.42 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
Total (95% CI) 1374 1439 100.0 % 38.41 [ -6.14, 82.97 ]
Heterogeneity: Chi2 = 1.04, df = 3 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.69 (P = 0.091)
Test for subgroup differences: Chi2 = 0.90, df = 1 (P = 0.34), I2 =0.0%
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Analysis 3.17. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 17
Length of infant hospital stay (days).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 17 Length of infant hospital stay (days)
Study or subgroup Doppler US CTG
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 12.5 (12) 212 16.3 (15) 73.8 % -0.28 [ -0.47, -0.09 ]
Haley 1997 73 1.34 (4.21) 77 2.22 (6.81) 26.2 % -0.15 [ -0.47, 0.17 ]
Subtotal (95% CI) 287 289 100.0 % -0.25 [ -0.41, -0.08 ]
Heterogeneity: Chi2 = 0.44, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 2.95 (P = 0.0032)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 287 289 100.0 % -0.25 [ -0.41, -0.08 ]
Heterogeneity: Chi2 = 0.44, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 2.95 (P = 0.0032)
Test for subgroup differences: Not applicable
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Analysis 3.18. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 18
Antenatal admissions (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 18 Antenatal admissions (not prespecified)
Study or subgroup Doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 69/214 97/212 100.0 % 0.70 [ 0.55, 0.90 ]
Subtotal (95% CI) 214 212 100.0 % 0.70 [ 0.55, 0.90 ]
Total events: 69 (Doppler US), 97 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.82 (P = 0.0048)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 214 212 100.0 % 0.70 [ 0.55, 0.90 ]
Total events: 69 (Doppler US), 97 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.82 (P = 0.0048)
Test for subgroup differences: Not applicable
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Analysis 3.19. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 19
Phototherapy for neonatal jaundice (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 19 Phototherapy for neonatal jaundice (not prespecified)
Study or subgroup Doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Haley 1997 0/73 3/77 100.0 % 0.15 [ 0.01, 2.87 ]
Subtotal (95% CI) 73 77 100.0 % 0.15 [ 0.01, 2.87 ]
Total events: 0 (Doppler US), 3 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 73 77 100.0 % 0.15 [ 0.01, 2.87 ]
Total events: 0 (Doppler US), 3 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 3.20. Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 20
Antenatal hospital stay (days) (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 3 Umbilical artery Doppler ultrasound alone versus CTG alone
Outcome: 20 Antenatal hospital stay (days) (not prespecified)
Study or subgroup Doppler US CTG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Almstrom 1992 214 9 (10.4) 212 9.6 (8.4) 100.0 % -0.60 [ -2.39, 1.19 ]
Subtotal (95% CI) 214 212 100.0 % -0.60 [ -2.39, 1.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
2 Multiple pregnancy
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Singleton plus multiple pregnancies or not stated
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 214 212 100.0 % -0.60 [ -2.39, 1.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups),
Outcome 1 Any perinatal death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 4 Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups)
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Doppler US No Doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 SGA/IUGR
Almstrom 1992 0/214 3/212 77.9 % 0.14 [ 0.01, 2.72 ]
Haley 1997 1/73 1/73 22.1 % 1.00 [ 0.06, 15.69 ]
Subtotal (95% CI) 287 285 100.0 % 0.33 [ 0.05, 2.09 ]
Total events: 1 (Doppler US), 4 (No Doppler US)
Heterogeneity: Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 1.18 (P = 0.24)
2 Hypertension/pre-eclampsia
Pattinson 1994 4/47 1/42 100.0 % 3.57 [ 0.42, 30.73 ]
Subtotal (95% CI) 47 42 100.0 % 3.57 [ 0.42, 30.73 ]
Total events: 4 (Doppler US), 1 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.16 (P = 0.25)
3 Diabetes
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Prolonged pregnancy
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 Previous pregnancy loss
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Doppler US), 0 (No Doppler US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Chi2 = 2.71, df = 1 (P = 0.10), I2 =63%
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Analysis 5.1. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any
perinatal death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 11/167 13/166 100.0 % 0.84 [ 0.39, 1.82 ]
Total (95% CI) 167 166 100.0 % 0.84 [ 0.39, 1.82 ]
Total events: 11 (Early doppler US), 13 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 5.2. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival
following severe neonatal morbidity.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 2 Survival following severe neonatal morbidity
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lees 2013 42/167 38/166 100.0 % 1.10 [ 0.75, 1.61 ]
Total (95% CI) 167 166 100.0 % 1.10 [ 0.75, 1.61 ]
Total events: 42 (Early doppler US), 38 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 5.3. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 3 Stillbirth
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 4/167 2/166 100.0 % 1.99 [ 0.37, 10.71 ]
Total (95% CI) 167 166 100.0 % 1.99 [ 0.37, 10.71 ]
Total events: 4 (Early doppler US), 2 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 5.4. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal
death.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 4 Neonatal death
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 6/167 10/166 100.0 % 0.60 [ 0.22, 1.60 ]
Total (95% CI) 167 166 100.0 % 0.60 [ 0.22, 1.60 ]
Total events: 6 (Early doppler US), 10 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 5.5. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any
potentially preventable perinatal death*.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 5 Any potentially preventable perinatal death*
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 10/167 12/166 100.0 % 0.83 [ 0.37, 1.86 ]
Total (95% CI) 167 166 100.0 % 0.83 [ 0.37, 1.86 ]
Total events: 10 (Early doppler US), 12 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
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Analysis 5.6. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 6 Fetal acidosis
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 1/167 4/166 100.0 % 0.25 [ 0.03, 2.20 ]
Total (95% CI) 167 166 100.0 % 0.25 [ 0.03, 2.20 ]
Total events: 1 (Early doppler US), 4 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 5.7. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at
5 minutes.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 7 Apgar < 7 at 5 minutes
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 14/167 16/166 100.0 % 0.87 [ 0.44, 1.72 ]
Total (95% CI) 167 166 100.0 % 0.87 [ 0.44, 1.72 ]
Total events: 14 (Early doppler US), 16 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 5.8. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant
requiring intubation/ventilation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 8 Infant requiring intubation/ventilation
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Lees 2013 63/167 72/166 100.0 % 0.87 [ 0.67, 1.13 ]
Total (95% CI) 167 166 100.0 % 0.87 [ 0.67, 1.13 ]
Total events: 63 (Early doppler US), 72 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 5.9. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 9
Intraventricular haemorrhage.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 9 Intraventricular haemorrhage
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 4/167 0/166 100.0 % 8.95 [ 0.49, 164.87 ]
Total (95% CI) 167 166 100.0 % 8.95 [ 0.49, 164.87 ]
Total events: 4 (Early doppler US), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
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(1) Early ductus venosus changes prompted delivery (GRADES 3 or 4 IVH)
Analysis 5.10. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 10
Bronchopulmonary dysplasia.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 10 Bronchopulmonary dysplasia
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 28/167 32/166 100.0 % 0.87 [ 0.55, 1.38 ]
Total (95% CI) 167 166 100.0 % 0.87 [ 0.55, 1.38 ]
Total events: 28 (Early doppler US), 32 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
Test for subgroup differences: Not applicable
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(1) Early ductus venosus changes prompted delivery (BPD > 28 days)
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Analysis 5.11. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 11
Necrotising enterocolitis.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 11 Necrotising enterocolitis
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 1/167 3/166 100.0 % 0.33 [ 0.03, 3.15 ]
Total (95% CI) 167 166 100.0 % 0.33 [ 0.03, 3.15 ]
Total events: 1 (Early doppler US), 3 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Not applicable
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Analysis 5.12. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant
birthweight (grams).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 12 Infant birthweight (grams)
Study or subgroup Early doppler US CTG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 167 1036 (356) 166 998 (288) 100.0 % 38.00 [ -31.53, 107.53 ]
Total (95% CI) 167 166 100.0 % 38.00 [ -31.53, 107.53 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
Test for subgroup differences: Not applicable
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Analysis 5.13. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long-term
infant neurodevelopmental outcome (impairment at 2 years).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 13 Long-term infant neurodevelopmental outcome (impairment at 2 years)
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 12/167 20/166 100.0 % 0.60 [ 0.30, 1.18 ]
Total (95% CI) 167 166 100.0 % 0.60 [ 0.30, 1.18 ]
Total events: 12 (Early doppler US), 20 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 5.14. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long-term
infant neurodevelopmental outcome (cerebral palsy at 2 years).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 14 Long-term infant neurodevelopmental outcome (cerebral palsy at 2 years)
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 1/167 5/166 100.0 % 0.20 [ 0.02, 1.68 ]
Total (95% CI) 167 166 100.0 % 0.20 [ 0.02, 1.68 ]
Total events: 1 (Early doppler US), 5 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 5.15. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant
survival at 2 years without neurodevelopmental impairment (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified)
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 119/167 111/166 100.0 % 1.07 [ 0.92, 1.23 ]
Total (95% CI) 167 166 100.0 % 1.07 [ 0.92, 1.23 ]
Total events: 119 (Early doppler US), 111 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 5.16. Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis
(proven) (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 5 Early ductus venosus Doppler ultrasound versus CTG
Outcome: 16 Sepsis (proven) (not prespecified)
Study or subgroup Early doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 31/167 33/166 100.0 % 0.93 [ 0.60, 1.45 ]
Total (95% CI) 167 166 100.0 % 0.93 [ 0.60, 1.45 ]
Total events: 31 (Early doppler US), 33 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal
death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 17/170 13/166 100.0 % 1.28 [ 0.64, 2.55 ]
Total (95% CI) 170 166 100.0 % 1.28 [ 0.64, 2.55 ]
Total events: 17 (Late doppler US), 13 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
(1) Late ductus venosus changes prompted delivery
Analysis 6.2. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival
following severe neonatal morbidity.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 2 Survival following severe neonatal morbidity
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lees 2013 38/170 38/166 100.0 % 0.98 [ 0.66, 1.45 ]
Total (95% CI) 170 166 100.0 % 0.98 [ 0.66, 1.45 ]
Total events: 38 (Late doppler US), 38 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.12 (P = 0.91)
Test for subgroup differences: Not applicable
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Analysis 6.3. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 3 Stillbirth
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 6/170 2/166 100.0 % 2.93 [ 0.60, 14.31 ]
Total (95% CI) 170 166 100.0 % 2.93 [ 0.60, 14.31 ]
Total events: 6 (Late doppler US), 2 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
142Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 6.4. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal
death.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 4 Neonatal death
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 11/170 10/166 100.0 % 1.07 [ 0.47, 2.46 ]
Total (95% CI) 170 166 100.0 % 1.07 [ 0.47, 2.46 ]
Total events: 11 (Late doppler US), 10 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
Analysis 6.5. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any
potentially preventable perinatal death*.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 5 Any potentially preventable perinatal death*
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 15/170 12/166 100.0 % 1.22 [ 0.59, 2.53 ]
Total (95% CI) 170 166 100.0 % 1.22 [ 0.59, 2.53 ]
Total events: 15 (Late doppler US), 12 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
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Analysis 6.6. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 6 Fetal acidosis
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 0/170 4/166 100.0 % 0.11 [ 0.01, 2.00 ]
Total (95% CI) 170 166 100.0 % 0.11 [ 0.01, 2.00 ]
Total events: 0 (Late doppler US), 4 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
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Analysis 6.7. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at
5 minutes.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 7 Apgar < 7 at 5 minutes
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 21/170 16/166 100.0 % 1.28 [ 0.69, 2.37 ]
Total (95% CI) 170 166 100.0 % 1.28 [ 0.69, 2.37 ]
Total events: 21 (Late doppler US), 16 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
(1) Late ductus venosus changes prompted delivery
Analysis 6.8. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant
requiring intubation/ventilation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 8 Infant requiring intubation/ventilation
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Lees 2013 69/170 72/166 100.0 % 0.94 [ 0.73, 1.20 ]
Total (95% CI) 170 166 100.0 % 0.94 [ 0.73, 1.20 ]
Total events: 69 (Late doppler US), 72 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.61)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours Doppler Favours no Doppler
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Analysis 6.9. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 9
Intraventricular haemorrhage.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 9 Intraventricular haemorrhage
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 8/170 0/166 100.0 % 16.60 [ 0.97, 285.35 ]
Total (95% CI) 170 166 100.0 % 16.60 [ 0.97, 285.35 ]
Total events: 8 (Late doppler US), 0 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.94 (P = 0.053)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
(1) Late ductus venosus changes prompted delivery (GRADES 3 and 4 IVH)
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Analysis 6.10. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 10
Bronchopulmonary dysplasia.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 10 Bronchopulmonary dysplasia
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 31/170 32/166 100.0 % 0.95 [ 0.61, 1.48 ]
Total (95% CI) 170 166 100.0 % 0.95 [ 0.61, 1.48 ]
Total events: 31 (Late doppler US), 32 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
(1) Late ductus venosus changes prompted delivery (BPD > 28 days)
Analysis 6.11. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 11
Necrotising enterocolitis.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 11 Necrotising enterocolitis
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 3/170 3/166 100.0 % 0.98 [ 0.20, 4.77 ]
Total (95% CI) 170 166 100.0 % 0.98 [ 0.20, 4.77 ]
Total events: 3 (Late doppler US), 3 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
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Analysis 6.12. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant
birthweight (grams).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 12 Infant birthweight (grams)
Study or subgroup Late doppler US CTG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 170 1023 (320) 166 998 (288) 100.0 % 25.00 [ -40.06, 90.06 ]
Total (95% CI) 170 166 100.0 % 25.00 [ -40.06, 90.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.75 (P = 0.45)
Test for subgroup differences: Not applicable
-500 -250 0 250 500
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Analysis 6.13. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long-term
infant neurodevelopmental outcome (impairment at 2 years).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 13 Long-term infant neurodevelopmental outcome (impairment at 2 years)
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 7/170 20/166 100.0 % 0.34 [ 0.15, 0.79 ]
Total (95% CI) 170 166 100.0 % 0.34 [ 0.15, 0.79 ]
Total events: 7 (Late doppler US), 20 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.52 (P = 0.012)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
Analysis 6.14. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long-term
infant neurodevelopmental outcome (cerebral palsy at 2 years).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 14 Long-term infant neurodevelopmental outcome (cerebral palsy at 2 years)
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 0/170 5/166 100.0 % 0.09 [ 0.00, 1.59 ]
Total (95% CI) 170 166 100.0 % 0.09 [ 0.00, 1.59 ]
Total events: 0 (Late doppler US), 5 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
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Analysis 6.15. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant
survival at 2 years without neurodevelopmental impairment (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified)
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 133/170 111/166 100.0 % 1.17 [ 1.02, 1.34 ]
Total (95% CI) 170 166 100.0 % 1.17 [ 1.02, 1.34 ]
Total events: 133 (Late doppler US), 111 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 2.31 (P = 0.021)
Test for subgroup differences: Not applicable
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150Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 6.16. Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis
(proven) (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 6 Late ductus venosus Doppler ultrasound versus CTG
Outcome: 16 Sepsis (proven) (not prespecified)
Study or subgroup Late doppler US CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 23/170 33/166 100.0 % 0.68 [ 0.42, 1.11 ]
Total (95% CI) 170 166 100.0 % 0.68 [ 0.42, 1.11 ]
Total events: 23 (Late doppler US), 33 (CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Doppler Favours no Doppler
Analysis 7.1. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 1 Any perinatal
death after randomisation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 1 Any perinatal death after randomisation
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 11/167 17/170 100.0 % 0.66 [ 0.32, 1.36 ]
Total (95% CI) 167 170 100.0 % 0.66 [ 0.32, 1.36 ]
Total events: 11 (Early doppler US), 17 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
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Analysis 7.2. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 2 Survival
following severe neonatal morbidity.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 2 Survival following severe neonatal morbidity
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lees 2013 42/167 38/170 100.0 % 1.13 [ 0.77, 1.65 ]
Total (95% CI) 167 170 100.0 % 1.13 [ 0.77, 1.65 ]
Total events: 42 (Early doppler US), 38 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 7.3. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 3 Stillbirth.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 3 Stillbirth
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 4/167 6/170 100.0 % 0.68 [ 0.20, 2.36 ]
Total (95% CI) 167 170 100.0 % 0.68 [ 0.20, 2.36 ]
Total events: 4 (Early doppler US), 6 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
Analysis 7.4. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 4 Neonatal
death.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 4 Neonatal death
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 6/167 11/170 100.0 % 0.56 [ 0.21, 1.47 ]
Total (95% CI) 167 170 100.0 % 0.56 [ 0.21, 1.47 ]
Total events: 6 (Early doppler US), 11 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.19 (P = 0.24)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
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Analysis 7.5. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 5 Any
potentially preventable perinatal death*.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 5 Any potentially preventable perinatal death*
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 10/167 15/170 100.0 % 0.68 [ 0.31, 1.47 ]
Total (95% CI) 167 170 100.0 % 0.68 [ 0.31, 1.47 ]
Total events: 10 (Early doppler US), 15 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
Analysis 7.6. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 6 Fetal acidosis.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 6 Fetal acidosis
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 1/167 0/170 100.0 % 3.05 [ 0.13, 74.43 ]
Total (95% CI) 167 170 100.0 % 3.05 [ 0.13, 74.43 ]
Total events: 1 (Early doppler US), 0 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
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Analysis 7.7. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 7 Apgar < 7 at 5
minutes.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 7 Apgar < 7 at 5 minutes
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 14/167 21/170 100.0 % 0.68 [ 0.36, 1.29 ]
Total (95% CI) 167 170 100.0 % 0.68 [ 0.36, 1.29 ]
Total events: 14 (Early doppler US), 21 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.18 (P = 0.24)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
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Analysis 7.8. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 8 Infant
requiring intubation/ventilation.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 8 Infant requiring intubation/ventilation
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Singleton pregnancy
Lees 2013 63/167 69/170 100.0 % 0.93 [ 0.71, 1.21 ]
Total (95% CI) 167 170 100.0 % 0.93 [ 0.71, 1.21 ]
Total events: 63 (Early doppler US), 69 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
favours early doppler US favours late doppler US
Analysis 7.9. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 9
Intraventricular haemorrhage.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 9 Intraventricular haemorrhage
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 4/167 8/170 100.0 % 0.51 [ 0.16, 1.66 ]
Total (95% CI) 167 170 100.0 % 0.51 [ 0.16, 1.66 ]
Total events: 4 (Early doppler US), 8 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
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(1) Early ductus venosus changes prompted delivery (GRADES 3 or 4 IVH)
Analysis 7.10. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 10
Bronchopulmonary dysplasia.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 10 Bronchopulmonary dysplasia
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 (1) 28/167 31/170 100.0 % 0.92 [ 0.58, 1.46 ]
Total (95% CI) 167 170 100.0 % 0.92 [ 0.58, 1.46 ]
Total events: 28 (Early doppler US), 31 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
(1) Early ductus venosus changes prompted delivery (BPD > 28 days)
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Analysis 7.11. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 11 Necrotising
enterocolitis.
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 11 Necrotising enterocolitis
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 1/167 3/170 100.0 % 0.34 [ 0.04, 3.23 ]
Total (95% CI) 167 170 100.0 % 0.34 [ 0.04, 3.23 ]
Total events: 1 (Early doppler US), 3 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
Analysis 7.12. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 12 Infant
birthweight (grams).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 12 Infant birthweight (grams)
Study or subgroup Early doppler US Late doppler US
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 167 1036 (356) 170 1023 (320) 100.0 % 13.00 [ -59.31, 85.31 ]
Total (95% CI) 167 170 100.0 % 13.00 [ -59.31, 85.31 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Not applicable
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Analysis 7.13. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 13 Long-term
infant neurodevelopmental outcome (impairment at 2 years).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 13 Long-term infant neurodevelopmental outcome (impairment at 2 years)
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 12/167 7/170 100.0 % 1.75 [ 0.70, 4.32 ]
Total (95% CI) 167 170 100.0 % 1.75 [ 0.70, 4.32 ]
Total events: 12 (Early doppler US), 7 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.20 (P = 0.23)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
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Analysis 7.14. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 14 Long-term
infant neurodevelopmental outcome (cerebral palsy at 2 years).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 14 Long-term infant neurodevelopmental outcome (cerebral palsy at 2 years)
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 1/167 0/170 100.0 % 3.05 [ 0.13, 74.43 ]
Total (95% CI) 167 170 100.0 % 3.05 [ 0.13, 74.43 ]
Total events: 1 (Early doppler US), 0 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
Analysis 7.15. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 15 Infant
survival at 2 years without neurodevelopmental impairment (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified)
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 119/167 133/170 100.0 % 0.91 [ 0.80, 1.03 ]
Total (95% CI) 167 170 100.0 % 0.91 [ 0.80, 1.03 ]
Total events: 119 (Early doppler US), 133 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
favours late doppler US favours early doppler US
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Analysis 7.16. Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 16 Sepsis
(proven) (not prespecified).
Review: Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Comparison: 7 Early ductus venosus Doppler ultrasound versus late
Outcome: 16 Sepsis (proven) (not prespecified)
Study or subgroup Early doppler US Late doppler US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton pregnancy
Lees 2013 31/167 23/170 100.0 % 1.37 [ 0.84, 2.25 ]
Total (95% CI) 167 170 100.0 % 1.37 [ 0.84, 2.25 ]
Total events: 31 (Early doppler US), 23 (Late doppler US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
favours early doppler US favours late doppler US
WH A T ’ S N E W
Date Event Description
31 March 2017 New citation required but conclusions have not changed One study previously in ongoing section was included
in this update (Lees 2013). The conclusions remain the
same.
31 March 2017 New search has been performed Search updated and no new studies identified. The qual-
ity of the evidence was assessed using the GRADE ap-
proach and a ’Summary of findings’ table was incorpo-
rated
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H I S T O R Y
Protocol first published: Issue 1, 2009
Review first published: Issue 1, 2010
Date Event Description
30 September 2013 New citation required but conclusions have not
changed
No new trials identified.
30 September 2013 New search has been performed Search updated. Methods updated.
C O N T R I B U T I O N S O F A U T H O R S
In an earlier version of this review, T Stampalija (TS) drafted the background section, with Z Alfirevic (ZA) providing comments and
suggestions. In this update, T Dowswell (TD) assisted with assessing new studies, grading the evidence and producing the ’Summary
of findings’ table. All authors commented on drafts.
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In the last 36 months, I have received funding from the WHO to work on other Cochrane reviews. The funders have no influence on
the content or conclusions of the reviews I work on.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The secondary outcome of ’any perinatal death after randomisation excludingmalformations’ was changed to ’any potentially preventable
perinatal death’, which was defined as ’perinatal death excluding chromosomal abnormalities, termination of pregnancies, birth before
fetal viability (less than 500 g) and fetal death before use of the intervention’.
The methods have been updated to the current Cochrane Pregnancy and Childbirth Group standard text, and a ’summary of findings’
table has been added to the updated review.
We included the following clinically relevant outcomes that were not prespecified in our protocol.
• Antenatal admissions.
• Birth less than 34 weeks.
• Phototherapy for neonatal jaundice.
• Abnormal neurological development at nine months.
• Hospitalisation for IUGR neonatal.
• Fetal distress in labour.
• Birthweight < 5 percentile.
• Periventricular leucomalacia.
• Antenatal hospital stay (days).
• Infant survival at two years.
• Sepsis (proven).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pregnancy,High-Risk; ∗Ultrasonography, Prenatal; Cardiotocography;CesareanSection [statistics&numerical data]; FetalMonitoring
[∗methods]; Labor, Induced [statistics & numerical data]; Perinatal Mortality; Randomized Controlled Trials as Topic; Stillbirth
[epidemiology]; Umbilical Arteries [∗diagnostic imaging; physiopathology]; Umbilical Cord [blood supply; ∗diagnostic imaging]
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